{"data":{"filter_options":{"titles":[{"name":"Managing Partner Atlanta Office","value":"Managing Partner Atlanta Office"},{"name":"Partner","value":"Partner"},{"name":"Partner / Head of Pro Bono","value":"Partner / Head of Pro Bono"},{"name":"Partner / Chief Operating Officer","value":"Partner / Chief Operating Officer"},{"name":"Partner / General Counsel","value":"Partner / General Counsel"},{"name":"Partner / Dir. E-Discovery Ops","value":"Partner / Dir. E-Discovery Ops"},{"name":"Partner / Chairman, Saudi Arabia Practice","value":"Partner / Chairman, Saudi Arabia Practice"},{"name":"K\u0026S Talent Partner","value":"K\u0026S Talent Partner"},{"name":"Partner / Chief Human Resources Officer","value":"Partner / Chief Human Resources Officer"},{"name":"Chairman","value":"Chairman"},{"name":"Senior Counsel","value":"Senior Counsel"},{"name":"Associate Director, E-Discovery Operations","value":"Associate Director, E-Discovery Operations"},{"name":"Counsel","value":"Counsel"},{"name":"Senior Associate","value":"Senior Associate"},{"name":"Associate","value":"Associate"},{"name":"Senior Attorney","value":"Senior Attorney"},{"name":"Senior Lawyer","value":"Senior Lawyer"},{"name":"Attorney","value":"Attorney"},{"name":"Senior Counsel and Policy Advisor","value":"Senior Counsel and Policy Advisor"},{"name":"Managing Director - Capital Solutions","value":"Managing Director - Capital Solutions"},{"name":"Senior Government Relations Advisor","value":"Senior Government Relations Advisor"},{"name":"Associate General Counsel","value":"Associate General Counsel"},{"name":"Senior Advisor","value":"Senior Advisor"},{"name":"Patent Agent","value":"Patent Agent"},{"name":"Consultant","value":"Consultant"},{"name":"Government Relations Advisor","value":"Government Relations Advisor"},{"name":"Chief of Lateral Partner Recruiting \u0026 Integration","value":"Chief of Lateral Partner Recruiting \u0026 Integration"},{"name":"Chief Financial Officer","value":"Chief Financial Officer"},{"name":"Chief Information Officer","value":"Chief Information Officer"},{"name":"Chief Revenue Officer","value":"Chief Revenue Officer"},{"name":"Chief Recruiting Officer","value":"Chief Recruiting Officer"},{"name":"Chief Lawyer Talent Development Officer","value":"Chief Lawyer Talent Development Officer"},{"name":"Chief Marketing Officer","value":"Chief Marketing Officer"},{"name":"Tax Consultant","value":"Tax Consultant"},{"name":"Director of Community Affairs","value":"Director of Community Affairs"},{"name":"Director of Facilities \u0026 Admin Operations","value":"Director of Facilities \u0026 Admin Operations"},{"name":"Senior Office Manager","value":"Senior Office Manager"},{"name":"Director of Operations","value":"Director of Operations"},{"name":"Pro Bono Deputy","value":"Pro Bono Deputy"},{"name":"Director of Office Operations","value":"Director of Office Operations"},{"name":"Director of Operations Europe","value":"Director of Operations Europe"},{"name":"Law Clerk","value":"Law Clerk"},{"name":"Deputy General Counsel","value":"Deputy General Counsel"}],"schools":[{"name":"(Commercial Law), in front of Monash University, Australia","value":3045},{"name":"Aberystwyth University","value":3004},{"name":"Albany Law School","value":2118},{"name":"American University Washington College of Law","value":3042},{"name":"American University, Washington College of Law","value":3024},{"name":"Appalachian School of Law","value":2891},{"name":"Ateneo de Manila University","value":2914},{"name":"Ave Maria School of Law","value":2892},{"name":"Baylor University School of Law","value":181},{"name":"Benjamin N. Cardozo School of Law","value":2619},{"name":"Binghamton University","value":3002},{"name":"Boston College Law School","value":245},{"name":"Boston University School of Law","value":247},{"name":"BPP Law School Leeds","value":2642},{"name":"BPP Law School London","value":2782},{"name":"BPP University","value":2984},{"name":"Brooklyn Law School","value":2705},{"name":"Cairo University, Law School","value":2962},{"name":"California Western School of Law","value":315},{"name":"Capital University Law School","value":327},{"name":"Case Western Reserve University School of Law","value":345},{"name":"Cecil C. Humphreys School of Law","value":2235},{"name":"Chapman University School of Law","value":377},{"name":"Charleston School of Law","value":2910},{"name":"City Law School, London","value":2998},{"name":"City Law School","value":2857},{"name":"Clark University","value":3006},{"name":"Cleveland-Marshall College of Law","value":426},{"name":"Columbia University School of International and Public Affairs","value":3008},{"name":"Columbia University School of Law","value":485},{"name":"Columbia University","value":3126},{"name":"Columbus School of Law, Catholic University of America","value":3010},{"name":"Columbus School of Law","value":350},{"name":"Concord Law School of Kaplan University","value":1026},{"name":"Cornell Law School","value":512},{"name":"Creighton University School of Law","value":518},{"name":"Creighton University","value":3025},{"name":"Cumberland School of Law","value":1759},{"name":"CUNY School of Law","value":2893},{"name":"David A. Clarke School of Law","value":2399},{"name":"Deakin University School of Law","value":2907},{"name":"DePaul University College of Law","value":565},{"name":"DePaul University College of Law","value":3060},{"name":"Dickinson School of Law","value":2719},{"name":"Drake University Law School","value":609},{"name":"Duke University School of Law","value":613},{"name":"Duquesne University School of Law","value":614},{"name":"Dwayne O. Andreas School of Law","value":173},{"name":"Edinburgh Law School","value":3160},{"name":"Emory University School of Law","value":659},{"name":"ESADE Business and Law School – Universidad Ramon Llull","value":3215},{"name":"Fachseminare von Fürstenberg","value":2918},{"name":"Faculté Libre de Droit, Université Catholique de Lille","value":3055},{"name":"Faculty of Law, University of Zagreb","value":2983},{"name":"Faculty of Law","value":2944},{"name":"Faculty of Law","value":3039},{"name":"Federal University of Rio de Janeiro","value":3022},{"name":"Federal University of Rio Grande do Sul School of Law (Brazil)","value":3062},{"name":"Florida A\u0026M University College of Law","value":699},{"name":"Florida Coastal School of Law","value":2894},{"name":"Florida International College of Law","value":707},{"name":"Florida State University College of Law","value":720},{"name":"Fordham University School of Law","value":722},{"name":"Franklin Pierce Law Center","value":734},{"name":"Friedrich-Schiller-Universität Jena","value":3015},{"name":"George Mason University School of Law","value":752},{"name":"George Washington University Law School","value":753},{"name":"Georgetown University Law Center","value":755},{"name":"Georgia State University College of Law","value":761},{"name":"Ghent Law School","value":2793},{"name":"Golden Gate University School of Law","value":770},{"name":"Gonzaga University School of Law","value":772},{"name":"Graduate Institute of International and Development Studies, Geneva","value":2997},{"name":"Hamline University School of Law","value":811},{"name":"Harvard Law School","value":824},{"name":"Hebrew University of Jerusalem Faculty of Law","value":2994},{"name":"Hofstra University School of Law","value":858},{"name":"Howard University School of Law","value":872},{"name":"Huazhong University of Science and Technology","value":3016},{"name":"Humboldt University of Berlin","value":3012},{"name":"Indiana University School of Law","value":2711},{"name":"Indiana University School of Law","value":890},{"name":"International Association of Privacy Professionals","value":3009},{"name":"J. Reuben Clark Law School","value":262},{"name":"Jacob D. Fuchsberg Law Center","value":2084},{"name":"James Cook University of North Queensland","value":3034},{"name":"Jean Moulin University Lyon 3, France","value":2938},{"name":"Johns Hopkins Bloomberg School of Public Health","value":2992},{"name":"Justus-Liebig-Universität Gießen Rechtswissenschaft (Germany)","value":3063},{"name":"Kansas City School of Law","value":2247},{"name":"Keio University","value":2968},{"name":"Kent College of Law","value":883},{"name":"Kline School of Law","value":611},{"name":"KU Leuven","value":3007},{"name":"Levin College of Law","value":2189},{"name":"Lewis and Clark Law School","value":1089},{"name":"Liberty University School of Law","value":1094},{"name":"Lincoln College of Law","value":2253},{"name":"LL.M. in International Crime and Justice UNICRI","value":2937},{"name":"Loyola Law School","value":2895},{"name":"Loyola University Chicago School of Law","value":1135},{"name":"Loyola University New Orleans College of Law","value":1136},{"name":"Marquette University Law School","value":1176},{"name":"McGeorge School of Law","value":2402},{"name":"McGill University","value":2659},{"name":"Melbourne Law School","value":2899},{"name":"Mercer University Walter F. George School of Law","value":1221},{"name":"Mexico Autonomous Institute of Technology","value":2996},{"name":"Michael E. Moritz College of Law","value":2728},{"name":"Michigan State University College of Law","value":1245},{"name":"Mississippi College School of Law","value":1285},{"name":"Moscow State University","value":2815},{"name":"National and Kapodistrian University of Athens","value":3032},{"name":"National Law University Jodhpur","value":3020},{"name":"National University of Singapore, Faculty of Law","value":2662},{"name":"New England School of Law","value":2886},{"name":"New York Law School","value":1403},{"name":"New York University School of Law","value":1406},{"name":"Norman Adrian Wiggins School of Law","value":323},{"name":"North Carolina Central University School of Law","value":1417},{"name":"Northeastern University School of Law","value":1430},{"name":"Northern Illinois University College of Law","value":1432},{"name":"Northwestern Pritzker School of Law","value":1451},{"name":"Notre Dame Law School","value":2278},{"name":"Ohio Northern University Law School","value":3036},{"name":"Oklahoma City University School of Law","value":1487},{"name":"Osgoode Hall Law School","value":3124},{"name":"Pace University School of Law","value":1516},{"name":"Panteion University","value":3033},{"name":"Paul M. Hebert Law Center","value":2713},{"name":"Pennsylvania State University, Dickinson School of Law","value":1562},{"name":"Pepperdine University School of Law","value":1570},{"name":"Pettit College of Law","value":1473},{"name":"Pontificia Universidad Catolica de Chile","value":3203},{"name":"Pontificia Universidad Catolica del Peru","value":3011},{"name":"Pontificia Universidad Javeriana","value":3013},{"name":"Pontificia Universidade Catolica de Sao Paulo","value":3095},{"name":"Prince Sultan University College of Law","value":3167},{"name":"Queens College, Cambridge","value":3003},{"name":"Quinnipiac University School of Law","value":1626},{"name":"Ralph R. Papitto School of Law","value":1686},{"name":"Regent University School of Law","value":1649},{"name":"Rice University","value":3043},{"name":"Ruprecht-Karls-Universität Heidelberg","value":3049},{"name":"Rutgers University School of Law-Newark","value":1699},{"name":"Rutgers University School of Law","value":1697},{"name":"S.J. Quinney College of Law","value":2408},{"name":"Saint Louis University School of Law","value":1732},{"name":"Salmon P. Chase College of Law","value":1433},{"name":"Sandra Day O'Connor College of Law","value":103},{"name":"Santa Clara University School of Law","value":1771},{"name":"Seattle University School of Law","value":1787},{"name":"Seton Hall University School of Law","value":1790},{"name":"Shepard Broad Law Center","value":1460},{"name":"South Texas College of Law","value":2721},{"name":"Southern Illinois University School of Law","value":1849},{"name":"Southern Methodist University Dedman School of Law","value":1852},{"name":"Southern University Law Center","value":1857},{"name":"Southwestern Law School","value":1876},{"name":"St. John's University School of Law","value":2724},{"name":"St. Mary's University School of Law","value":1896},{"name":"St. Thomas University School of Law","value":1746},{"name":"Stanford Law School","value":1904},{"name":"Stetson University College of Law","value":1910},{"name":"Sturm College of Law","value":2184},{"name":"Suffolk University Law School","value":1921},{"name":"Syracuse University College of Law","value":1956},{"name":"Temple University Beasley School of Law","value":1974},{"name":"Texas A\u0026M School of Law","value":1980},{"name":"Texas Tech University School of Law","value":1994},{"name":"Texas Wesleyan University School of Law","value":1996},{"name":"The College of Law Australia","value":3091},{"name":"The College of Law, London","value":2935},{"name":"The John Marshall Law School","value":2034},{"name":"The Judge Advocate General's Legal Center and School","value":2896},{"name":"The Ohio State University Moritz College of Law","value":2990},{"name":"The University of Akron School of Law","value":2143},{"name":"The University of Alabama School of Law","value":2045},{"name":"The University of Birmingham, U.K.","value":2796},{"name":"The University of Iowa College of Law","value":2206},{"name":"The University of Texas School of Law","value":2055},{"name":"The University of Tulsa College of Law","value":2407},{"name":"Thomas Jefferson School of Law","value":685},{"name":"Thomas M. Cooley Law School","value":2729},{"name":"Thurgood Marshall School of Law","value":1992},{"name":"Tianjin University of Commerce","value":2995},{"name":"Tulane University Law School","value":2113},{"name":"UC Davis School of Law","value":2160},{"name":"UCLA School of Law","value":2162},{"name":"Universidad Católica de Honduras","value":2916},{"name":"Universidad Francisco Marroquin","value":3090},{"name":"Universidad Panamericana","value":2904},{"name":"Universidad Torcuato di Tella","value":3035},{"name":"Universidade de São Paulo, Faculdade de Direito","value":3028},{"name":"Universidade Presbiteriana Mackenzie","value":2977},{"name":"Università Commerciale Luigi Bocconi","value":3135},{"name":"University at Buffalo Law School","value":1928},{"name":"University College Dublin Law School","value":2900},{"name":"University of Alberta Faculty of Law","value":3088},{"name":"University of Amsterdam","value":2980},{"name":"University of Arizona, James E. Rogers College of Law","value":2149},{"name":"University of Arkansas School of Law","value":2154},{"name":"University of Baltimore School of Law","value":2156},{"name":"University of California College of the Law","value":3196},{"name":"University of California Hastings College of Law","value":2158},{"name":"University of California Irvine School of Law","value":2161},{"name":"University of California, Berkeley, School of Law","value":2159},{"name":"University of California, Davis","value":3019},{"name":"University of Cambridge, U.K","value":2991},{"name":"University of Canterbury","value":2981},{"name":"University of Central Florida","value":3027},{"name":"University of Chester Law School","value":3005},{"name":"University of Chicago Law School","value":2174},{"name":"University of Chicago","value":3038},{"name":"University of Cincinnati College of Law","value":2175},{"name":"University of Colorado School of Law","value":2177},{"name":"University of Connecticut School of Law","value":2180},{"name":"University of Dayton School of Law","value":2182},{"name":"University of Detroit Mercy School of Law","value":2185},{"name":"University of East Anglia","value":3000},{"name":"University of Florida, Levin College of Law","value":3188},{"name":"University of Georgia School of Law","value":2190},{"name":"University of Houston Law Center","value":2197},{"name":"University of Hull","value":3040},{"name":"University of Idaho College of Law","value":2201},{"name":"University of Illinois College of Law","value":2204},{"name":"University of Kansas School of Law","value":2208},{"name":"University of Kentucky College of Law","value":2210},{"name":"University of La Verne College of Law","value":2211},{"name":"University of Law, London","value":2999},{"name":"University of Lethbridge","value":3030},{"name":"University of Louisville Brandeis School of Law","value":2214},{"name":"University of Maine School of Law","value":2391},{"name":"University of Maryland School of Law","value":2224},{"name":"University of Miami School of Law","value":2236},{"name":"University of Michigan Law School","value":2237},{"name":"University of Minnesota Law School","value":2243},{"name":"University of Mississippi School of Law","value":2244},{"name":"University of Missouri School of Law","value":2246},{"name":"University of Montana School of Law","value":2048},{"name":"University of Nebraska College of Law","value":2744},{"name":"University of New Mexico School of Law","value":2262},{"name":"University of North Carolina School of Law","value":2266},{"name":"University of North Dakota School of Law","value":2271},{"name":"University of Oklahoma Law Center","value":2747},{"name":"University of Oregon School of Law","value":2281},{"name":"University of Pennsylvania Law School","value":2282},{"name":"University of Pittsburgh School of Law","value":2354},{"name":"University of Richmond School of Law","value":2370},{"name":"University of San Diego School of Law","value":2377},{"name":"University of San Francisco School of Law","value":2378},{"name":"University of South Carolina School of Law","value":2750},{"name":"University of South Dakota School of Law","value":2387},{"name":"University of Southern California Gould School of Law","value":3051},{"name":"University of St. Thomas School of Law","value":2751},{"name":"University of Sydney Law School","value":3031},{"name":"University of Tennessee College of Law","value":2051},{"name":"University of the West of England, Bristol","value":3001},{"name":"University of Toledo College of Law","value":2406},{"name":"University of Toronto","value":2912},{"name":"University of Utah","value":3026},{"name":"University of Virginia School of Law","value":2410},{"name":"University of Washington School of Law","value":2412},{"name":"University of Wisconsin Law School","value":2419},{"name":"University of Wyoming College of Law","value":2429},{"name":"University of Zürich","value":3037},{"name":"University Paris Dauphine","value":2976},{"name":"University Paris II Assas","value":2975},{"name":"University Paris II Assas","value":3052},{"name":"USC Gould School of Law","value":2389},{"name":"Utrecht University","value":3085},{"name":"Valparaiso University School of Law","value":2441},{"name":"Vanderbilt University School of Law","value":2442},{"name":"Vermont Law School","value":2451},{"name":"Villanova University School of Law","value":2454},{"name":"Wake Forest University School of Law","value":2471},{"name":"Washburn University School of Law","value":2482},{"name":"Washington and Lee University School of Law","value":2484},{"name":"Washington College of Law","value":61},{"name":"Washington University in St. Louis School of Law","value":2489},{"name":"Wayne State University Law School","value":2493},{"name":"West Virginia University College of Law","value":2517},{"name":"Western New England College School of Law","value":2528},{"name":"Western State College of Law","value":2897},{"name":"Wharton School of Business","value":3044},{"name":"Whittier Law School","value":2564},{"name":"Widener University Delaware Law School","value":2569},{"name":"Willamette University College of Law","value":2573},{"name":"William \u0026 Mary Law School","value":462},{"name":"William H. Bowen School of Law","value":2150},{"name":"William Mitchell College of Law","value":2758},{"name":"William S. Boyd School of Law","value":2256},{"name":"William S. Richardson School of Law","value":2195},{"name":"Wilmington University","value":2993},{"name":"Yale Law School","value":2605}],"offices":[{"name":"Abu Dhabi","value":13},{"name":"Atlanta","value":1},{"name":"Austin","value":12},{"name":"Brussels","value":23},{"name":"Charlotte","value":8},{"name":"Chicago","value":21},{"name":"Dallas","value":28},{"name":"Denver","value":22},{"name":"Dubai","value":6},{"name":"Frankfurt","value":9},{"name":"Geneva","value":15},{"name":"Houston","value":4},{"name":"London","value":5},{"name":"Los Angeles","value":19},{"name":"Miami","value":25},{"name":"New York","value":3},{"name":"Northern Virginia","value":24},{"name":"Paris","value":14},{"name":"Riyadh","value":27},{"name":"Sacramento","value":20},{"name":"San Francisco","value":10},{"name":"Silicon Valley","value":11},{"name":"Singapore","value":16},{"name":"Sydney","value":26},{"name":"Tokyo","value":18},{"name":"Washington, D.C.","value":2}],"capabilities":[{"name":"Corporate, Finance and Investments","value":"cg-1"},{"name":"Activist Defense","value":72},{"name":"Capital Markets","value":26},{"name":"Construction and Procurement","value":40},{"name":"Corporate Governance","value":27},{"name":"Emerging Companies and Venture Capital","value":80},{"name":"Employee Benefits and Executive Compensation","value":28},{"name":"Energy and Infrastructure Projects","value":35},{"name":"Financial Restructuring","value":10},{"name":"Fund Finance","value":134},{"name":"Global Human Capital and Compliance ","value":121},{"name":"Investment Funds and Asset Management","value":78},{"name":"Leveraged Finance","value":29},{"name":"Mergers and Acquisitions (M\u0026A)","value":32},{"name":"Middle East and Islamic Finance and Investment","value":31},{"name":"Private Equity","value":33},{"name":"Public Companies","value":126},{"name":"Real Estate","value":36},{"name":"Structured Finance and Securitization","value":82},{"name":"Tax","value":37},{"name":"Technology Transactions","value":115},{"name":"Government Matters","value":"cg-2"},{"name":"Antitrust","value":1},{"name":"Data, Privacy and Security","value":6},{"name":"Environmental, Health and Safety","value":71},{"name":"FDA and Life Sciences","value":21},{"name":"Government Advocacy and Public Policy","value":23},{"name":"Government Contracts","value":116},{"name":"Healthcare","value":24},{"name":"Innovation Protection","value":135},{"name":"International Trade","value":25},{"name":"National Security and Corporate Espionage","value":110},{"name":"Securities Enforcement and Regulation","value":20},{"name":"Special Matters and Government Investigations","value":11},{"name":"Trial and Global Disputes","value":"cg-3"},{"name":"Antitrust ","value":129},{"name":"Appellate, Constitutional and Administrative Law","value":2},{"name":"Bankruptcy and Insolvency Litigation","value":38},{"name":"Class Action Defense","value":3},{"name":"Commercial Litigation","value":5},{"name":"Corporate and Securities Litigation","value":19},{"name":"E-Discovery","value":7},{"name":"Global Construction and Infrastructure Disputes","value":4},{"name":"Innovation Protection","value":136},{"name":"Intellectual Property","value":13},{"name":"International Arbitration and Litigation","value":14},{"name":"Labor and Employment","value":15},{"name":"Product Liability","value":17},{"name":"Professional Liability","value":18},{"name":"Toxic \u0026 Environmental Torts","value":16},{"name":"Industries / Issues","value":"cg-4"},{"name":"Artificial Intelligence (AI) and Machine Learning","value":133},{"name":"Automotive, Transportation and Mobility","value":106},{"name":"Buy American","value":124},{"name":"Crisis Management","value":111},{"name":"Doing Business in Latin America","value":132},{"name":"Energy Transition","value":131},{"name":"Energy","value":102},{"name":"Environmental Agenda","value":125},{"name":"Environmental, Social and Governance (ESG)","value":127},{"name":"Financial Services","value":107},{"name":"Focus on Women's Health","value":112},{"name":"Food and Beverage","value":105},{"name":"Higher Education","value":109},{"name":"Life Sciences and Healthcare","value":103},{"name":"Russia/Ukraine","value":128},{"name":"Special Purpose Acquisition Companies (SPACs)","value":123},{"name":"Technology","value":118}]},"title_id":null,"school_id":null,"office_id":null,"capability_id":"11","extra_filter_id":null,"extra_filter_type":null,"q":null,"starts_with":"B","per_page":12,"people":[{"id":427219,"version":1,"owner_type":"Person","owner_id":6490,"payload":{"bio":"\u003cp\u003eAdam Baker represents global financial institutions, healthcare and life sciences companies, and other public corporations in complex government and internal investigations and regulatory matters. He has extensive experience counseling clients facing investigations by the Department of Justice, Securities and Exchange Commission, State Attorneys General, Financial Industry Regulatory Authority, as well as other criminal and civil authorities. In particular, Adam has defended clients in matters implicating various federal laws and regulations, including insider trading, Foreign Corrupt Practices Act, Anti-Kickback Statute, healthcare fraud, and the Food, Drug \u0026amp; Cosmetic Act. [[--readmore--]]\u003c/p\u003e\n\u003cp\u003ePreviously, Adam served as a criminal Assistant United States Attorney in the Health Care Fraud/Opioid Abuse Prevention and Enforcement Unit in the District of New Jersey. In that role, he led a number of large-scale investigations and prosecutions of major pharmaceutical companies for healthcare fraud, diversion of controlled substances, and violations of the Federal Anti-Kickback Statute.\u0026nbsp; He also partnered with the DOJ\u0026rsquo;s Consumer Protection Branch on a significant investigation into potential violations by an opioid manufacturer and related individuals of the Food, Drug \u0026amp; Cosmetic Act.\u0026nbsp;\u0026nbsp;\u0026nbsp;\u003c/p\u003e\n\u003cp\u003ePrior to his government service, Adam was a Partner at another AmLaw 50 firm where he oversaw complex investigations and regulatory matters for financial institutions and its employees.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eAdam is active within the LGBTQ+ community. He helped found Boston Colleges\u0026rsquo; first gay-straight alliance and served on his prior firm\u0026rsquo;s Diversity \u0026amp; LGBTQ+ committees. He serves on Boston College Law School\u0026rsquo;s national alumni board and formerly served as a Corp member for Teach For America.\u0026nbsp;\u0026nbsp;\u003c/p\u003e","slug":"adam-baker","email":"abaker@kslaw.com","phone":null,"matters":["\u003cp\u003eConducted an internal investigation on behalf of the Special Committee of an international corporation concerning potential financial improprieties resulting in a restatement and violations of the Foreign Corrupt Practices Act, and represented the Special Committee in resulting parallel investigations by the DOJ and SEC.\u003c/p\u003e","\u003cp\u003eRepresented a multinational financial services institution in investigations by the SEC and FINRA related to potential insider trading by current and former employees involved in a nonpublic M\u0026amp;A deal.\u003c/p\u003e","\u003cp\u003eRepresented a multinational financial services institution in an internal investigation of potential violations of the Foreign Corrupt Practices Act and OFAC regulations by an employee who attempted to broker deals with the Iranian government.\u003c/p\u003e","\u003cp\u003eRepresented the former CEO of a publicly-traded company in insider trading investigations by the DOJ and SEC.\u003c/p\u003e","\u003cp\u003eRepresented a men\u0026rsquo;s college basketball coach in investigations by the DOJ and NCAA Enforcement regarding potential provision of payments and benefits to players.\u003c/p\u003e","\u003cp\u003eRepresented a key figure in the \u0026ldquo;Bridgegate\u0026rdquo; matter in parallel investigations by the New Jersey Legislative Select Committee and U.S. Attorney\u0026rsquo;s Office, District of New Jersey.\u003c/p\u003e","\u003cp\u003eRepresented a former Dewey \u0026amp; Leboeuf employee in the New York County District Attorney\u0026rsquo;s Office\u0026rsquo;s investigation of the downfall of the firm, successfully obtaining immunity for the client.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":11,"guid":"11.capabilities","index":0,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":1,"source":"capabilities"},{"id":24,"guid":"24.capabilities","index":2,"source":"capabilities"},{"id":20,"guid":"20.capabilities","index":3,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":4,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":5,"source":"capabilities"},{"id":952,"guid":"952.smart_tags","index":6,"source":"smartTags"},{"id":780,"guid":"780.smart_tags","index":7,"source":"smartTags"},{"id":750,"guid":"750.smart_tags","index":8,"source":"smartTags"},{"id":1248,"guid":"1248.smart_tags","index":9,"source":"smartTags"},{"id":1434,"guid":"1434.smart_tags","index":10,"source":"smartTags"}],"is_active":true,"last_name":"Baker","nick_name":"Adam","clerkships":[],"first_name":"Adam","title_rank":9999,"updated_by":32,"law_schools":[{"id":245,"meta":{"degree":"J.D.","honors":"","is_law_school":"1","graduation_date":"2008-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":" ","name_suffix":"","recognitions":null,"linked_in_url":"https://www.linkedin.com/in/adam-baker-4a471038/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eAdam Baker represents global financial institutions, healthcare and life sciences companies, and other public corporations in complex government and internal investigations and regulatory matters. He has extensive experience counseling clients facing investigations by the Department of Justice, Securities and Exchange Commission, State Attorneys General, Financial Industry Regulatory Authority, as well as other criminal and civil authorities. In particular, Adam has defended clients in matters implicating various federal laws and regulations, including insider trading, Foreign Corrupt Practices Act, Anti-Kickback Statute, healthcare fraud, and the Food, Drug \u0026amp; Cosmetic Act. [[--readmore--]]\u003c/p\u003e\n\u003cp\u003ePreviously, Adam served as a criminal Assistant United States Attorney in the Health Care Fraud/Opioid Abuse Prevention and Enforcement Unit in the District of New Jersey. In that role, he led a number of large-scale investigations and prosecutions of major pharmaceutical companies for healthcare fraud, diversion of controlled substances, and violations of the Federal Anti-Kickback Statute.\u0026nbsp; He also partnered with the DOJ\u0026rsquo;s Consumer Protection Branch on a significant investigation into potential violations by an opioid manufacturer and related individuals of the Food, Drug \u0026amp; Cosmetic Act.\u0026nbsp;\u0026nbsp;\u0026nbsp;\u003c/p\u003e\n\u003cp\u003ePrior to his government service, Adam was a Partner at another AmLaw 50 firm where he oversaw complex investigations and regulatory matters for financial institutions and its employees.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eAdam is active within the LGBTQ+ community. He helped found Boston Colleges\u0026rsquo; first gay-straight alliance and served on his prior firm\u0026rsquo;s Diversity \u0026amp; LGBTQ+ committees. He serves on Boston College Law School\u0026rsquo;s national alumni board and formerly served as a Corp member for Teach For America.\u0026nbsp;\u0026nbsp;\u003c/p\u003e","matters":["\u003cp\u003eConducted an internal investigation on behalf of the Special Committee of an international corporation concerning potential financial improprieties resulting in a restatement and violations of the Foreign Corrupt Practices Act, and represented the Special Committee in resulting parallel investigations by the DOJ and SEC.\u003c/p\u003e","\u003cp\u003eRepresented a multinational financial services institution in investigations by the SEC and FINRA related to potential insider trading by current and former employees involved in a nonpublic M\u0026amp;A deal.\u003c/p\u003e","\u003cp\u003eRepresented a multinational financial services institution in an internal investigation of potential violations of the Foreign Corrupt Practices Act and OFAC regulations by an employee who attempted to broker deals with the Iranian government.\u003c/p\u003e","\u003cp\u003eRepresented the former CEO of a publicly-traded company in insider trading investigations by the DOJ and SEC.\u003c/p\u003e","\u003cp\u003eRepresented a men\u0026rsquo;s college basketball coach in investigations by the DOJ and NCAA Enforcement regarding potential provision of payments and benefits to players.\u003c/p\u003e","\u003cp\u003eRepresented a key figure in the \u0026ldquo;Bridgegate\u0026rdquo; matter in parallel investigations by the New Jersey Legislative Select Committee and U.S. Attorney\u0026rsquo;s Office, District of New Jersey.\u003c/p\u003e","\u003cp\u003eRepresented a former Dewey \u0026amp; Leboeuf employee in the New York County District Attorney\u0026rsquo;s Office\u0026rsquo;s investigation of the downfall of the firm, successfully obtaining immunity for the client.\u003c/p\u003e"]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":10412}]},"capability_group_id":2},"created_at":"2025-05-26T04:59:19.000Z","updated_at":"2025-05-26T04:59:19.000Z","searchable_text":"Baker{{ FIELD }}Conducted an internal investigation on behalf of the Special Committee of an international corporation concerning potential financial improprieties resulting in a restatement and violations of the Foreign Corrupt Practices Act, and represented the Special Committee in resulting parallel investigations by the DOJ and SEC.{{ FIELD }}Represented a multinational financial services institution in investigations by the SEC and FINRA related to potential insider trading by current and former employees involved in a nonpublic M\u0026amp;A deal.{{ FIELD }}Represented a multinational financial services institution in an internal investigation of potential violations of the Foreign Corrupt Practices Act and OFAC regulations by an employee who attempted to broker deals with the Iranian government.{{ FIELD }}Represented the former CEO of a publicly-traded company in insider trading investigations by the DOJ and SEC.{{ FIELD }}Represented a men’s college basketball coach in investigations by the DOJ and NCAA Enforcement regarding potential provision of payments and benefits to players.{{ FIELD }}Represented a key figure in the “Bridgegate” matter in parallel investigations by the New Jersey Legislative Select Committee and U.S. Attorney’s Office, District of New Jersey.{{ FIELD }}Represented a former Dewey \u0026amp; Leboeuf employee in the New York County District Attorney’s Office’s investigation of the downfall of the firm, successfully obtaining immunity for the client.{{ FIELD }}Adam Baker represents global financial institutions, healthcare and life sciences companies, and other public corporations in complex government and internal investigations and regulatory matters. He has extensive experience counseling clients facing investigations by the Department of Justice, Securities and Exchange Commission, State Attorneys General, Financial Industry Regulatory Authority, as well as other criminal and civil authorities. In particular, Adam has defended clients in matters implicating various federal laws and regulations, including insider trading, Foreign Corrupt Practices Act, Anti-Kickback Statute, healthcare fraud, and the Food, Drug \u0026amp; Cosmetic Act. \nPreviously, Adam served as a criminal Assistant United States Attorney in the Health Care Fraud/Opioid Abuse Prevention and Enforcement Unit in the District of New Jersey. In that role, he led a number of large-scale investigations and prosecutions of major pharmaceutical companies for healthcare fraud, diversion of controlled substances, and violations of the Federal Anti-Kickback Statute.  He also partnered with the DOJ’s Consumer Protection Branch on a significant investigation into potential violations by an opioid manufacturer and related individuals of the Food, Drug \u0026amp; Cosmetic Act.   \nPrior to his government service, Adam was a Partner at another AmLaw 50 firm where he oversaw complex investigations and regulatory matters for financial institutions and its employees. \nAdam is active within the LGBTQ+ community. He helped found Boston Colleges’ first gay-straight alliance and served on his prior firm’s Diversity \u0026amp; LGBTQ+ committees. He serves on Boston College Law School’s national alumni board and formerly served as a Corp member for Teach For America.   Partner Boston College Boston College Law School Boston College Boston College Law School Fordham University Fordham University School of Law U.S. District Court for the Eastern District of New York U.S. District Court for the Southern District of New York New York Conducted an internal investigation on behalf of the Special Committee of an international corporation concerning potential financial improprieties resulting in a restatement and violations of the Foreign Corrupt Practices Act, and represented the Special Committee in resulting parallel investigations by the DOJ and SEC. Represented a multinational financial services institution in investigations by the SEC and FINRA related to potential insider trading by current and former employees involved in a nonpublic M\u0026amp;A deal. Represented a multinational financial services institution in an internal investigation of potential violations of the Foreign Corrupt Practices Act and OFAC regulations by an employee who attempted to broker deals with the Iranian government. Represented the former CEO of a publicly-traded company in insider trading investigations by the DOJ and SEC. Represented a men’s college basketball coach in investigations by the DOJ and NCAA Enforcement regarding potential provision of payments and benefits to players. Represented a key figure in the “Bridgegate” matter in parallel investigations by the New Jersey Legislative Select Committee and U.S. Attorney’s Office, District of New Jersey. Represented a former Dewey \u0026amp; Leboeuf employee in the New York County District Attorney’s Office’s investigation of the downfall of the firm, successfully obtaining immunity for the client.","searchable_name":"Adam Baker","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":32,"capability_group_featured":null,"home_page_featured":null},{"id":445014,"version":1,"owner_type":"Person","owner_id":3436,"payload":{"bio":"\u003cp\u003eLohr's practice focuses on high-stakes business disputes with an emphasis on antitrust matters and consumer protection matters. Lohr\u0026nbsp;represents clients in relation to high exposure civil litigation, including class actions, multi-district litigation, and matters with complex e-discovery issues. Lohr also represents clients in relation to government investigations and counsels clients regarding antitrust and consumer protection issues.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eLeadership and\u0026nbsp;Community Service\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eCenter for Puppetry Arts, Board member\u003c/p\u003e\n\u003cp\u003eGeorgia Lawyers for the Arts,\u0026nbsp;Board member\u003c/p\u003e\n\u003cp\u003eAtlanta Women's Foundation, Inspire Atlanta Leadership Program Class of 2019\u003c/p\u003e","slug":"lohr-beck","email":"lohr.beck@kslaw.com","phone":null,"matters":["\u003cp\u003eDefense of\u0026nbsp;\u003cstrong\u003eNovo Nordisk Inc.\u003c/strong\u003e\u0026nbsp;in a nationwide antitrust putative class action filed against pharmaceutical company manufacturers of diabetes medications alleging conspiracy to artificially fix prices of diabetes medications by agreeing to coordinate and eliminate, reduce, or limit the availability of Contract Pharmacy 340B Drug Discounts.\u003c/p\u003e","\u003cp\u003eDefense of \u003cstrong\u003eECI Management, LLC\u003c/strong\u003e in antitrust MDL proceeding in Nashville, Tennessee alleging that owners and managers of multifamily rental housing conspired to raise prices through use of algorithmic revenue management software.\u003c/p\u003e","\u003cp\u003eDefense of\u0026nbsp;\u003cstrong\u003eSix Continents Hotels, Inc.\u003c/strong\u003e\u0026nbsp;in a nationwide antitrust putative class action filed against Six Continents and other major hotel companies alleging that defendant hotel companies conspired to eliminate competition for branded keyword search advertising against each other, illegally raising consumers\u0026rsquo; costs to find and book hotel rooms, and seeking damages and injunctive relief under the Sherman Act.\u003c/p\u003e","\u003cp\u003eDefense of\u0026nbsp;\u003cstrong\u003eKemira Chemicals Inc.\u003c/strong\u003e\u0026nbsp;in MDL proceeding in Newark, New Jersey, alleging conspiracy to fix prices in sale of liquid aluminum sulfate.\u003c/p\u003e","\u003cp\u003eDefense of\u0026nbsp;\u003cstrong\u003eKan Am (US)\u003c/strong\u003e\u0026nbsp;in litigation filed by Simon Property Group affiliates in the Delaware Court of Chancery involving the interpretation of buy/sell provisions in joint venture agreements regarding major retail shopping malls throughout the United States.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[{"id":3205}]},"expertise":[{"id":74,"guid":"74.capabilities","index":0,"source":"capabilities"},{"id":1,"guid":"1.capabilities","index":1,"source":"capabilities"},{"id":3,"guid":"3.capabilities","index":2,"source":"capabilities"},{"id":5,"guid":"5.capabilities","index":3,"source":"capabilities"},{"id":11,"guid":"11.capabilities","index":4,"source":"capabilities"},{"id":129,"guid":"129.capabilities","index":5,"source":"capabilities"}],"is_active":true,"last_name":"Beck","nick_name":"Lohr","clerkships":[],"first_name":"Lohr","title_rank":9999,"updated_by":202,"law_schools":[{"id":659,"meta":{"degree":"J.D.","honors":"with honors, Order of the Coif","is_law_school":"1","graduation_date":"2014-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":"A.","name_suffix":"","recognitions":null,"linked_in_url":null,"seodescription":"Lohr Beck is a partner at King \u0026 Spalding. Read more about her.","primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eLohr's practice focuses on high-stakes business disputes with an emphasis on antitrust matters and consumer protection matters. Lohr\u0026nbsp;represents clients in relation to high exposure civil litigation, including class actions, multi-district litigation, and matters with complex e-discovery issues. Lohr also represents clients in relation to government investigations and counsels clients regarding antitrust and consumer protection issues.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eLeadership and\u0026nbsp;Community Service\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eCenter for Puppetry Arts, Board member\u003c/p\u003e\n\u003cp\u003eGeorgia Lawyers for the Arts,\u0026nbsp;Board member\u003c/p\u003e\n\u003cp\u003eAtlanta Women's Foundation, Inspire Atlanta Leadership Program Class of 2019\u003c/p\u003e","matters":["\u003cp\u003eDefense of\u0026nbsp;\u003cstrong\u003eNovo Nordisk Inc.\u003c/strong\u003e\u0026nbsp;in a nationwide antitrust putative class action filed against pharmaceutical company manufacturers of diabetes medications alleging conspiracy to artificially fix prices of diabetes medications by agreeing to coordinate and eliminate, reduce, or limit the availability of Contract Pharmacy 340B Drug Discounts.\u003c/p\u003e","\u003cp\u003eDefense of \u003cstrong\u003eECI Management, LLC\u003c/strong\u003e in antitrust MDL proceeding in Nashville, Tennessee alleging that owners and managers of multifamily rental housing conspired to raise prices through use of algorithmic revenue management software.\u003c/p\u003e","\u003cp\u003eDefense of\u0026nbsp;\u003cstrong\u003eSix Continents Hotels, Inc.\u003c/strong\u003e\u0026nbsp;in a nationwide antitrust putative class action filed against Six Continents and other major hotel companies alleging that defendant hotel companies conspired to eliminate competition for branded keyword search advertising against each other, illegally raising consumers\u0026rsquo; costs to find and book hotel rooms, and seeking damages and injunctive relief under the Sherman Act.\u003c/p\u003e","\u003cp\u003eDefense of\u0026nbsp;\u003cstrong\u003eKemira Chemicals Inc.\u003c/strong\u003e\u0026nbsp;in MDL proceeding in Newark, New Jersey, alleging conspiracy to fix prices in sale of liquid aluminum sulfate.\u003c/p\u003e","\u003cp\u003eDefense of\u0026nbsp;\u003cstrong\u003eKan Am (US)\u003c/strong\u003e\u0026nbsp;in litigation filed by Simon Property Group affiliates in the Delaware Court of Chancery involving the interpretation of buy/sell provisions in joint venture agreements regarding major retail shopping malls throughout the United States.\u003c/p\u003e"]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":11787}]},"capability_group_id":3},"created_at":"2026-01-13T21:27:06.000Z","updated_at":"2026-01-13T21:27:06.000Z","searchable_text":"Beck{{ FIELD }}Defense of Novo Nordisk Inc. in a nationwide antitrust putative class action filed against pharmaceutical company manufacturers of diabetes medications alleging conspiracy to artificially fix prices of diabetes medications by agreeing to coordinate and eliminate, reduce, or limit the availability of Contract Pharmacy 340B Drug Discounts.{{ FIELD }}Defense of ECI Management, LLC in antitrust MDL proceeding in Nashville, Tennessee alleging that owners and managers of multifamily rental housing conspired to raise prices through use of algorithmic revenue management software.{{ FIELD }}Defense of Six Continents Hotels, Inc. in a nationwide antitrust putative class action filed against Six Continents and other major hotel companies alleging that defendant hotel companies conspired to eliminate competition for branded keyword search advertising against each other, illegally raising consumers’ costs to find and book hotel rooms, and seeking damages and injunctive relief under the Sherman Act.{{ FIELD }}Defense of Kemira Chemicals Inc. in MDL proceeding in Newark, New Jersey, alleging conspiracy to fix prices in sale of liquid aluminum sulfate.{{ FIELD }}Defense of Kan Am (US) in litigation filed by Simon Property Group affiliates in the Delaware Court of Chancery involving the interpretation of buy/sell provisions in joint venture agreements regarding major retail shopping malls throughout the United States.{{ FIELD }}Lohr's practice focuses on high-stakes business disputes with an emphasis on antitrust matters and consumer protection matters. Lohr represents clients in relation to high exposure civil litigation, including class actions, multi-district litigation, and matters with complex e-discovery issues. Lohr also represents clients in relation to government investigations and counsels clients regarding antitrust and consumer protection issues. \nLeadership and Community Service\nCenter for Puppetry Arts, Board member\nGeorgia Lawyers for the Arts, Board member\nAtlanta Women's Foundation, Inspire Atlanta Leadership Program Class of 2019 Lohr Beck lawyer Partner George Washington University George Washington University Law School Emory University Emory University School of Law Georgia Defense of Novo Nordisk Inc. in a nationwide antitrust putative class action filed against pharmaceutical company manufacturers of diabetes medications alleging conspiracy to artificially fix prices of diabetes medications by agreeing to coordinate and eliminate, reduce, or limit the availability of Contract Pharmacy 340B Drug Discounts. Defense of ECI Management, LLC in antitrust MDL proceeding in Nashville, Tennessee alleging that owners and managers of multifamily rental housing conspired to raise prices through use of algorithmic revenue management software. Defense of Six Continents Hotels, Inc. in a nationwide antitrust putative class action filed against Six Continents and other major hotel companies alleging that defendant hotel companies conspired to eliminate competition for branded keyword search advertising against each other, illegally raising consumers’ costs to find and book hotel rooms, and seeking damages and injunctive relief under the Sherman Act. Defense of Kemira Chemicals Inc. in MDL proceeding in Newark, New Jersey, alleging conspiracy to fix prices in sale of liquid aluminum sulfate. Defense of Kan Am (US) in litigation filed by Simon Property Group affiliates in the Delaware Court of Chancery involving the interpretation of buy/sell provisions in joint venture agreements regarding major retail shopping malls throughout the United States.","searchable_name":"Lohr A. Beck","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":426841,"version":1,"owner_type":"Person","owner_id":5738,"payload":{"bio":"\u003cp\u003eCraig Bessenger focuses on complex civil litigation and white-collar criminal defense. His clients include Fortune 200 companies, entertainment companies, healthcare providers, and financial institutions. He represents both plaintiffs and defendants in federal and state courts. Craig has litigated business, partnership, and contractual disputes, professional liability, banking and mortgage cases, and intellectual property matters. His white-collar experience spans various areas, including securities, antitrust, healthcare, and environmental violations, complex fraud and money laundering schemes, and internal investigations.\u003c/p\u003e","slug":"craig-bessenger","email":"cbessenger@kslaw.com","phone":null,"matters":["\u003cp\u003eObtained summary judgment on behalf of the\u0026nbsp;\u003cstrong\u003emovie studio, directors, and producer\u003c/strong\u003e\u0026nbsp;involved in the creation of a multibillion-dollar movie franchise in a copyright infringement case.\u003c/p\u003e","\u003cp\u003eSuccessfully defended a\u0026nbsp;\u003cstrong\u003emajor movie studio\u003c/strong\u003e\u0026nbsp;against claims relating to the collection of foreign revenue, and obtained an affirmance of the trial court\u0026rsquo;s ruling on appeal.\u003c/p\u003e","\u003cp\u003eDefeated an anti-SLAPP motion brought against a\u0026nbsp;\u003cstrong\u003emajor media company\u003c/strong\u003e, and obtained an affirmance of the trial court\u0026rsquo;s ruling on appeal.\u003c/p\u003e","\u003cp\u003eAchieved a multimillion-dollar settlement in a professional liability action brought on behalf of a\u0026nbsp;\u003cstrong\u003eclosely held corporation\u003c/strong\u003e.\u003c/p\u003e","\u003cp\u003eRepresented publicly-traded\u0026nbsp;\u003cstrong\u003ehealthcare company\u003c/strong\u003e\u0026nbsp;in numerous class actions.\u003c/p\u003e","\u003cp\u003eRepresented a\u0026nbsp;\u003cstrong\u003eforeign national\u003c/strong\u003e\u0026nbsp;in a federal criminal investigation into an allegedly fraudulent scheme to circumvent state and federal environmental regulations.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003ebank directors\u003c/strong\u003e\u0026nbsp;in civil enforcement actions brought by federal regulatory authorities.\u003c/p\u003e","\u003cp\u003eRepresented a\u0026nbsp;\u003cstrong\u003emedical device manufacturer\u003c/strong\u003e\u0026nbsp;in an investigation by state regulatory authorities.\u003c/p\u003e","\u003cp\u003eRepresented a\u0026nbsp;\u003cstrong\u003eproducer of high-quality automotive images\u003c/strong\u003e\u0026nbsp;in a copyright infringement action against an online tech company arising from the unauthorized use of its photographs. A confidential settlement agreement was reached on the eve of trial.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":74,"guid":"74.capabilities","index":0,"source":"capabilities"},{"id":5,"guid":"5.capabilities","index":1,"source":"capabilities"},{"id":3,"guid":"3.capabilities","index":2,"source":"capabilities"},{"id":11,"guid":"11.capabilities","index":3,"source":"capabilities"},{"id":18,"guid":"18.capabilities","index":4,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":5,"source":"capabilities"},{"id":24,"guid":"24.capabilities","index":6,"source":"capabilities"},{"id":1248,"guid":"1248.smart_tags","index":7,"source":"smartTags"}],"is_active":true,"last_name":"Bessenger","nick_name":"Craig","clerkships":[{"name":"Judicial Clerk, Hon. A. Howard Matz, U.S. District Court for the Central District of California","years_held":"2010 - 2011"}],"first_name":"Craig","title_rank":9999,"updated_by":32,"law_schools":[{"id":2158,"meta":{"degree":"J.D.","honors":"Magna Cum Laude","is_law_school":"1","graduation_date":"2006-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":"H.","name_suffix":"","recognitions":null,"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eCraig Bessenger focuses on complex civil litigation and white-collar criminal defense. His clients include Fortune 200 companies, entertainment companies, healthcare providers, and financial institutions. He represents both plaintiffs and defendants in federal and state courts. Craig has litigated business, partnership, and contractual disputes, professional liability, banking and mortgage cases, and intellectual property matters. His white-collar experience spans various areas, including securities, antitrust, healthcare, and environmental violations, complex fraud and money laundering schemes, and internal investigations.\u003c/p\u003e","matters":["\u003cp\u003eObtained summary judgment on behalf of the\u0026nbsp;\u003cstrong\u003emovie studio, directors, and producer\u003c/strong\u003e\u0026nbsp;involved in the creation of a multibillion-dollar movie franchise in a copyright infringement case.\u003c/p\u003e","\u003cp\u003eSuccessfully defended a\u0026nbsp;\u003cstrong\u003emajor movie studio\u003c/strong\u003e\u0026nbsp;against claims relating to the collection of foreign revenue, and obtained an affirmance of the trial court\u0026rsquo;s ruling on appeal.\u003c/p\u003e","\u003cp\u003eDefeated an anti-SLAPP motion brought against a\u0026nbsp;\u003cstrong\u003emajor media company\u003c/strong\u003e, and obtained an affirmance of the trial court\u0026rsquo;s ruling on appeal.\u003c/p\u003e","\u003cp\u003eAchieved a multimillion-dollar settlement in a professional liability action brought on behalf of a\u0026nbsp;\u003cstrong\u003eclosely held corporation\u003c/strong\u003e.\u003c/p\u003e","\u003cp\u003eRepresented publicly-traded\u0026nbsp;\u003cstrong\u003ehealthcare company\u003c/strong\u003e\u0026nbsp;in numerous class actions.\u003c/p\u003e","\u003cp\u003eRepresented a\u0026nbsp;\u003cstrong\u003eforeign national\u003c/strong\u003e\u0026nbsp;in a federal criminal investigation into an allegedly fraudulent scheme to circumvent state and federal environmental regulations.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003ebank directors\u003c/strong\u003e\u0026nbsp;in civil enforcement actions brought by federal regulatory authorities.\u003c/p\u003e","\u003cp\u003eRepresented a\u0026nbsp;\u003cstrong\u003emedical device manufacturer\u003c/strong\u003e\u0026nbsp;in an investigation by state regulatory authorities.\u003c/p\u003e","\u003cp\u003eRepresented a\u0026nbsp;\u003cstrong\u003eproducer of high-quality automotive images\u003c/strong\u003e\u0026nbsp;in a copyright infringement action against an online tech company arising from the unauthorized use of its photographs. A confidential settlement agreement was reached on the eve of trial.\u003c/p\u003e"]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":8096}]},"capability_group_id":3},"created_at":"2025-05-26T04:57:19.000Z","updated_at":"2025-05-26T04:57:19.000Z","searchable_text":"Bessenger{{ FIELD }}Obtained summary judgment on behalf of the movie studio, directors, and producer involved in the creation of a multibillion-dollar movie franchise in a copyright infringement case.{{ FIELD }}Successfully defended a major movie studio against claims relating to the collection of foreign revenue, and obtained an affirmance of the trial court’s ruling on appeal.{{ FIELD }}Defeated an anti-SLAPP motion brought against a major media company, and obtained an affirmance of the trial court’s ruling on appeal.{{ FIELD }}Achieved a multimillion-dollar settlement in a professional liability action brought on behalf of a closely held corporation.{{ FIELD }}Represented publicly-traded healthcare company in numerous class actions.{{ FIELD }}Represented a foreign national in a federal criminal investigation into an allegedly fraudulent scheme to circumvent state and federal environmental regulations.{{ FIELD }}Represented bank directors in civil enforcement actions brought by federal regulatory authorities.{{ FIELD }}Represented a medical device manufacturer in an investigation by state regulatory authorities.{{ FIELD }}Represented a producer of high-quality automotive images in a copyright infringement action against an online tech company arising from the unauthorized use of its photographs. A confidential settlement agreement was reached on the eve of trial.{{ FIELD }}Craig Bessenger focuses on complex civil litigation and white-collar criminal defense. His clients include Fortune 200 companies, entertainment companies, healthcare providers, and financial institutions. He represents both plaintiffs and defendants in federal and state courts. Craig has litigated business, partnership, and contractual disputes, professional liability, banking and mortgage cases, and intellectual property matters. His white-collar experience spans various areas, including securities, antitrust, healthcare, and environmental violations, complex fraud and money laundering schemes, and internal investigations. Partner Brown University  University of California Hastings College of Law University of California Hastings College of Law U.S. District Court for the Central District of California U.S. District Court for the Northern District of California U.S. District Court for the Southern District of California California District of Columbia Judicial Clerk, Hon. A. Howard Matz, U.S. District Court for the Central District of California Obtained summary judgment on behalf of the movie studio, directors, and producer involved in the creation of a multibillion-dollar movie franchise in a copyright infringement case. Successfully defended a major movie studio against claims relating to the collection of foreign revenue, and obtained an affirmance of the trial court’s ruling on appeal. Defeated an anti-SLAPP motion brought against a major media company, and obtained an affirmance of the trial court’s ruling on appeal. Achieved a multimillion-dollar settlement in a professional liability action brought on behalf of a closely held corporation. Represented publicly-traded healthcare company in numerous class actions. Represented a foreign national in a federal criminal investigation into an allegedly fraudulent scheme to circumvent state and federal environmental regulations. Represented bank directors in civil enforcement actions brought by federal regulatory authorities. Represented a medical device manufacturer in an investigation by state regulatory authorities. Represented a producer of high-quality automotive images in a copyright infringement action against an online tech company arising from the unauthorized use of its photographs. A confidential settlement agreement was reached on the eve of trial.","searchable_name":"Craig H. Bessenger","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":32,"capability_group_featured":null,"home_page_featured":null},{"id":446151,"version":1,"owner_type":"Person","owner_id":6369,"payload":{"bio":"\u003cp\u003eMatthew Biben focuses his practice on complex negotiation and litigation of disputes, including regulatory and enforcement matters on behalf of both individuals and organizations. His diverse litigation practice includes representing financial institutions and FinTech companies in civil disputes, securities and bankruptcy litigation, and complex matters involving the government.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAs a former general counsel of a large bank and federal prosecutor, Matthew routinely acts as counsel in litigated disputes and internal investigations of both domestic and international matters involving, among others, the Department of Justice (DOJ), Securities Exchange Commission (SEC), Federal Reserve Board (FRB), Office of Comptroller of the Currency (OCC), Consumer Financial Protection Bureau (CFPB), New York Department of Financial Services (NYDFS), state attorneys general and foreign regulators.\u003c/p\u003e\n\u003cp\u003ePrior to joining private practice, Matthew served for three-and-a-half years at JPMorgan Chase, where he was Executive Vice President and General Counsel for Chase Consumer \u0026amp; Community Banking, which included JPMorgan Chase\u0026rsquo;s Private Wealth Management, Card and Merchant Services, Auto Finance, Student Loan, Consumer Banking, Business Banking and Mortgage Banking businesses.\u003c/p\u003e\n\u003cp\u003eMatthew also served as Executive Vice President and Deputy General Counsel of The Bank of New York Mellon Corporation for almost seven years, becoming the second youngest person in BNY\u0026rsquo;s history to be promoted to Executive Vice President. He also served as BNY Mellon\u0026rsquo;s Global Head of Litigation and supervised various corporate functions that included the Office of the Corporate Secretary.\u003c/p\u003e\n\u003cp\u003eMatthew spent the first 12 years of his career in government, serving in the U.S. Attorney\u0026rsquo;s Office for the Southern District of New York, where he was an Assistant U.S. Attorney in the Criminal Division and received the Attorney General\u0026rsquo;s Director Award for superior performance. Previously, he was an Assistant District Attorney in the New York County District Attorney\u0026rsquo;s Office. He argued numerous appeals in the Second Circuit Court of Appeals and was lead counsel in more than 25 federal and state trials.\u003c/p\u003e","slug":"matthew-biben","email":"mbiben@kslaw.com","phone":null,"matters":["\u003cp\u003e\u003cstrong\u003e\u003cem\u003eAnti-Money Laundering\u003c/em\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRoutinely advise banks and non-banks on BSA/AML compliance and enforcement issues including:\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eSociete Generale\u003c/strong\u003e\u0026nbsp;before the FRB and the Federal Reserve Bank of New York and separately before the NYDFS in negotiating a successful settlement regarding the bank\u0026rsquo;s BSA/AML compliance and risk management programs\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eMashreq Bank\u003c/strong\u003e\u0026nbsp;in negotiating a favorable settlement with the NYDFS, NYFed, FRB, and OFAC resolving wide ranging BSA/AML and Sanctions issues\u003c/p\u003e","\u003cp\u003eSuccessfully defended\u0026nbsp;\u003cstrong\u003eHabib Bank\u003c/strong\u003e\u0026nbsp;against a $630 million lawsuit by the NYDFS and negotiating a $225 million settlement relating to long-running AML/BSA compliance issues and assisting Habib in winding down the business of their NY branch\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eCoinbase\u003c/strong\u003e\u0026nbsp;in sweeping NYDFS investigation relating to BSA/AML and other compliance issues\u003c/p\u003e","\u003cp\u003eAdvised\u0026nbsp;\u003cstrong\u003ea large foreign bank\u003c/strong\u003e\u0026nbsp;in responding to the DOJ investigation of Mossack Fonseca \u0026amp; and the \u0026ldquo;Panama Papers\u0026rdquo;\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eComplex Civil Litigation\u003c/em\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eFanDuel\u003c/strong\u003e\u0026nbsp;and\u0026nbsp;\u003cstrong\u003eDraftKings\u003c/strong\u003e\u0026nbsp;in a landmark victory in the NY Court of Appeals legalizing interactive fantasy sports in New York State (garnering American Lawyer Litigator of the Week runner-up honors)\u003c/p\u003e","\u003cp\u003eRepresent\u0026nbsp;\u003cstrong\u003eFanDuel\u003c/strong\u003e\u0026nbsp;in a New York State Court litigation brought on by the former founders of FanDuel relating to merger acquisition violation\u003c/p\u003e","\u003cp\u003eRepresent\u0026nbsp;\u003cstrong\u003eBlackRock\u003c/strong\u003e\u0026nbsp;in litigation relating to mortgage-era fraud allegations\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eMacquarie Asset Management\u003c/strong\u003e\u0026nbsp;in a joint venture dispute relating to drag-along rights\u003c/p\u003e","\u003cp\u003eRepresent leading\u0026nbsp;\u003cstrong\u003eglobal investment bank\u003c/strong\u003e\u0026nbsp;in arbitration relating to a joint venture dispute\u003c/p\u003e","\u003cp\u003eRepresented ad hoc\u0026nbsp;\u003cstrong\u003e1st lien term lenders\u003c/strong\u003e\u0026nbsp;in the Mallinckrodt bankruptcy\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eFanDuel\u003c/strong\u003e\u0026nbsp;in a lawsuit and settlement with the New York Attorney General (NYAG) over the legality of daily fantasy sports and later resolving allegations of false advertising whereby the NYAG dropped its claims challenging the legality of FanDuel\u0026rsquo;s contests after a change in the New York State law permitting daily fantasy sports\u003c/p\u003e","\u003cp\u003eSuccessfully represented the Chairman of the board of\u003cstrong\u003e\u0026nbsp;Rio Tinto\u003c/strong\u003e\u0026nbsp;in a broad ranging SEC investigation into accounting fraud\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eBanks and Financial Institutions\u003c/em\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eIn addition to BSA/AML advice, I have extensively advised on bank regulatory compliance and enforcement issues, including the CFPB, the FRB, NYDFS, FDIC, OCC and others, including:\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eTruist\u003c/strong\u003e\u0026nbsp;in a long-running DOJ FIRREA investigation of their trust businesses in a cost-of-litigation settlement where all allegations were denied\u003c/p\u003e","\u003cp\u003eAdvised\u0026nbsp;\u003cstrong\u003ea global bank\u003c/strong\u003e\u0026nbsp;on fair lender compliance issue in relation to DFS investigation\u003c/p\u003e","\u003cp\u003eSuccessfully represented a\u0026nbsp;\u003cstrong\u003esuperregional bank\u003c/strong\u003e\u0026nbsp;in a CFPB into investigation into TISA compliance avoiding an enforcement action\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003efinancial institutions and individuals\u003c/strong\u003e\u0026nbsp;in SEC investigations, including the Chairman of the Board of a Fortune 100 company\u003c/p\u003e","\u003cp\u003eRepresented a leading\u0026nbsp;\u003cstrong\u003eFintech company\u003c/strong\u003e\u0026nbsp;in a CFPB investigation relating to FCRA and UDAAP allegations\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eToyota Financial Services\u003c/strong\u003e\u0026nbsp;in a DOJ and CFPB investigation and negotiating a favorable settlement relating to the indirect auto lender\u0026rsquo;s fair lending practices\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003ea senior executive of one of the largest global banks\u003c/strong\u003e\u0026nbsp;in a DOJ investigation of RMBS and a separate OCC investigation persuading both agencies after years of investigation to close their investigations without action\u003c/p\u003e","\u003cp\u003eLead an extensive internal investigation and representing\u0026nbsp;\u003cstrong\u003ea large foreign bank\u003c/strong\u003e\u0026nbsp;before the FRB and NYDFS concerning Regulation W compliance issues\u003c/p\u003e","\u003cp\u003eAdvised\u0026nbsp;\u003cstrong\u003ea large foreign bank\u003c/strong\u003e\u0026nbsp;in responding to a multi-state attorneys general investigation of its auto lending and securitization practices\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003esenior finance and actuarial employees\u003c/strong\u003e\u0026nbsp;of\u0026nbsp;\u003cstrong\u003eAMBAC\u003c/strong\u003e\u0026nbsp;in SEC investigation of accounting fraud\u003c/p\u003e","\u003cp\u003eRepresented the\u0026nbsp;\u003cstrong\u003eCFO of an insurance company\u003c/strong\u003e\u0026nbsp;in an investigation before the NYDFS which resulted in the matter being closed without action\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eAdmirals Bank\u003c/strong\u003e, as it restructured operations in the face of significant regulatory scrutiny and complex bank regulatory and enforcement issues\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eRoot Insurance\u003c/strong\u003e\u0026nbsp;in a New York Attorney General investigation relating to data breach allegations\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eGovernance\u003c/em\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eServed as a Director and Chair of the\u0026nbsp;\u003cstrong\u003eGovernance Committee\u003c/strong\u003e\u0026nbsp;of the largest privately held bank. BNY Melon Corporate Secretary was a direct report. Extensive pro bono governance work. Write and lecture on the topic. A sample of representations include:\u003c/p\u003e","\u003cp\u003eProvided\u0026nbsp;\u003cstrong\u003ethe Board of Directors of multiple financial institutions\u003c/strong\u003e\u0026nbsp;with advice on their annual self-evaluation as well as broader governance issues including expectations and guidance as applied to bank boards\u003c/p\u003e","\u003cp\u003eRepresented the\u0026nbsp;\u003cstrong\u003eBoard of Directors of Bed Bath \u0026amp; Beyond\u003c/strong\u003e\u0026nbsp;in an internal investigation concerning compensation and disclosure issues\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[{"id":3543}]},"expertise":[{"id":74,"guid":"74.capabilities","index":0,"source":"capabilities"},{"id":19,"guid":"19.capabilities","index":1,"source":"capabilities"},{"id":38,"guid":"38.capabilities","index":2,"source":"capabilities"},{"id":20,"guid":"20.capabilities","index":3,"source":"capabilities"},{"id":11,"guid":"11.capabilities","index":4,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":5,"source":"capabilities"},{"id":118,"guid":"118.capabilities","index":6,"source":"capabilities"},{"id":111,"guid":"111.capabilities","index":7,"source":"capabilities"},{"id":923,"guid":"923.smart_tags","index":8,"source":"smartTags"},{"id":699,"guid":"699.smart_tags","index":9,"source":"smartTags"},{"id":765,"guid":"765.smart_tags","index":10,"source":"smartTags"},{"id":1243,"guid":"1243.smart_tags","index":11,"source":"smartTags"},{"id":1248,"guid":"1248.smart_tags","index":12,"source":"smartTags"},{"id":1261,"guid":"1261.smart_tags","index":13,"source":"smartTags"},{"id":803,"guid":"803.smart_tags","index":14,"source":"smartTags"},{"id":1327,"guid":"1327.smart_tags","index":15,"source":"smartTags"}],"is_active":true,"last_name":"Biben","nick_name":"Matt","clerkships":[],"first_name":"Matthew","title_rank":9999,"updated_by":202,"law_schools":[],"middle_name":"L.","name_suffix":"","recognitions":[{"title":"Ranked for his “standout expertise” in the category of “Banking (Enforcement \u0026 Investigations)”","detail":"Chamber USA – Nationwide (Band 3) 2020-2026"},{"title":"Nationally recommended in the category of Financial Services Litigation, “tenacious but balanced litigator” ","detail":"The Legal 500 US 2016-2026"},{"title":"Recognized as Benchmark Litigation “Litigation Star”","detail":"Benchmark Litigation"},{"title":"Recognized as Lawdragon 500 Leading Global Entertainment, Sports \u0026 Media Lawyer","detail":"Lawdragon, 2024-2026"}],"linked_in_url":"https://www.linkedin.com/in/matthew-biben-480bb2a/","seodescription":"Matthew L. Biben is a partner of our Business Litigation Practice Group. Read more about him.","primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eMatthew Biben focuses his practice on complex negotiation and litigation of disputes, including regulatory and enforcement matters on behalf of both individuals and organizations. His diverse litigation practice includes representing financial institutions and FinTech companies in civil disputes, securities and bankruptcy litigation, and complex matters involving the government.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAs a former general counsel of a large bank and federal prosecutor, Matthew routinely acts as counsel in litigated disputes and internal investigations of both domestic and international matters involving, among others, the Department of Justice (DOJ), Securities Exchange Commission (SEC), Federal Reserve Board (FRB), Office of Comptroller of the Currency (OCC), Consumer Financial Protection Bureau (CFPB), New York Department of Financial Services (NYDFS), state attorneys general and foreign regulators.\u003c/p\u003e\n\u003cp\u003ePrior to joining private practice, Matthew served for three-and-a-half years at JPMorgan Chase, where he was Executive Vice President and General Counsel for Chase Consumer \u0026amp; Community Banking, which included JPMorgan Chase\u0026rsquo;s Private Wealth Management, Card and Merchant Services, Auto Finance, Student Loan, Consumer Banking, Business Banking and Mortgage Banking businesses.\u003c/p\u003e\n\u003cp\u003eMatthew also served as Executive Vice President and Deputy General Counsel of The Bank of New York Mellon Corporation for almost seven years, becoming the second youngest person in BNY\u0026rsquo;s history to be promoted to Executive Vice President. He also served as BNY Mellon\u0026rsquo;s Global Head of Litigation and supervised various corporate functions that included the Office of the Corporate Secretary.\u003c/p\u003e\n\u003cp\u003eMatthew spent the first 12 years of his career in government, serving in the U.S. Attorney\u0026rsquo;s Office for the Southern District of New York, where he was an Assistant U.S. Attorney in the Criminal Division and received the Attorney General\u0026rsquo;s Director Award for superior performance. Previously, he was an Assistant District Attorney in the New York County District Attorney\u0026rsquo;s Office. He argued numerous appeals in the Second Circuit Court of Appeals and was lead counsel in more than 25 federal and state trials.\u003c/p\u003e","matters":["\u003cp\u003e\u003cstrong\u003e\u003cem\u003eAnti-Money Laundering\u003c/em\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRoutinely advise banks and non-banks on BSA/AML compliance and enforcement issues including:\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eSociete Generale\u003c/strong\u003e\u0026nbsp;before the FRB and the Federal Reserve Bank of New York and separately before the NYDFS in negotiating a successful settlement regarding the bank\u0026rsquo;s BSA/AML compliance and risk management programs\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eMashreq Bank\u003c/strong\u003e\u0026nbsp;in negotiating a favorable settlement with the NYDFS, NYFed, FRB, and OFAC resolving wide ranging BSA/AML and Sanctions issues\u003c/p\u003e","\u003cp\u003eSuccessfully defended\u0026nbsp;\u003cstrong\u003eHabib Bank\u003c/strong\u003e\u0026nbsp;against a $630 million lawsuit by the NYDFS and negotiating a $225 million settlement relating to long-running AML/BSA compliance issues and assisting Habib in winding down the business of their NY branch\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eCoinbase\u003c/strong\u003e\u0026nbsp;in sweeping NYDFS investigation relating to BSA/AML and other compliance issues\u003c/p\u003e","\u003cp\u003eAdvised\u0026nbsp;\u003cstrong\u003ea large foreign bank\u003c/strong\u003e\u0026nbsp;in responding to the DOJ investigation of Mossack Fonseca \u0026amp; and the \u0026ldquo;Panama Papers\u0026rdquo;\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eComplex Civil Litigation\u003c/em\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eFanDuel\u003c/strong\u003e\u0026nbsp;and\u0026nbsp;\u003cstrong\u003eDraftKings\u003c/strong\u003e\u0026nbsp;in a landmark victory in the NY Court of Appeals legalizing interactive fantasy sports in New York State (garnering American Lawyer Litigator of the Week runner-up honors)\u003c/p\u003e","\u003cp\u003eRepresent\u0026nbsp;\u003cstrong\u003eFanDuel\u003c/strong\u003e\u0026nbsp;in a New York State Court litigation brought on by the former founders of FanDuel relating to merger acquisition violation\u003c/p\u003e","\u003cp\u003eRepresent\u0026nbsp;\u003cstrong\u003eBlackRock\u003c/strong\u003e\u0026nbsp;in litigation relating to mortgage-era fraud allegations\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eMacquarie Asset Management\u003c/strong\u003e\u0026nbsp;in a joint venture dispute relating to drag-along rights\u003c/p\u003e","\u003cp\u003eRepresent leading\u0026nbsp;\u003cstrong\u003eglobal investment bank\u003c/strong\u003e\u0026nbsp;in arbitration relating to a joint venture dispute\u003c/p\u003e","\u003cp\u003eRepresented ad hoc\u0026nbsp;\u003cstrong\u003e1st lien term lenders\u003c/strong\u003e\u0026nbsp;in the Mallinckrodt bankruptcy\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eFanDuel\u003c/strong\u003e\u0026nbsp;in a lawsuit and settlement with the New York Attorney General (NYAG) over the legality of daily fantasy sports and later resolving allegations of false advertising whereby the NYAG dropped its claims challenging the legality of FanDuel\u0026rsquo;s contests after a change in the New York State law permitting daily fantasy sports\u003c/p\u003e","\u003cp\u003eSuccessfully represented the Chairman of the board of\u003cstrong\u003e\u0026nbsp;Rio Tinto\u003c/strong\u003e\u0026nbsp;in a broad ranging SEC investigation into accounting fraud\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eBanks and Financial Institutions\u003c/em\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eIn addition to BSA/AML advice, I have extensively advised on bank regulatory compliance and enforcement issues, including the CFPB, the FRB, NYDFS, FDIC, OCC and others, including:\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eTruist\u003c/strong\u003e\u0026nbsp;in a long-running DOJ FIRREA investigation of their trust businesses in a cost-of-litigation settlement where all allegations were denied\u003c/p\u003e","\u003cp\u003eAdvised\u0026nbsp;\u003cstrong\u003ea global bank\u003c/strong\u003e\u0026nbsp;on fair lender compliance issue in relation to DFS investigation\u003c/p\u003e","\u003cp\u003eSuccessfully represented a\u0026nbsp;\u003cstrong\u003esuperregional bank\u003c/strong\u003e\u0026nbsp;in a CFPB into investigation into TISA compliance avoiding an enforcement action\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003efinancial institutions and individuals\u003c/strong\u003e\u0026nbsp;in SEC investigations, including the Chairman of the Board of a Fortune 100 company\u003c/p\u003e","\u003cp\u003eRepresented a leading\u0026nbsp;\u003cstrong\u003eFintech company\u003c/strong\u003e\u0026nbsp;in a CFPB investigation relating to FCRA and UDAAP allegations\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eToyota Financial Services\u003c/strong\u003e\u0026nbsp;in a DOJ and CFPB investigation and negotiating a favorable settlement relating to the indirect auto lender\u0026rsquo;s fair lending practices\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003ea senior executive of one of the largest global banks\u003c/strong\u003e\u0026nbsp;in a DOJ investigation of RMBS and a separate OCC investigation persuading both agencies after years of investigation to close their investigations without action\u003c/p\u003e","\u003cp\u003eLead an extensive internal investigation and representing\u0026nbsp;\u003cstrong\u003ea large foreign bank\u003c/strong\u003e\u0026nbsp;before the FRB and NYDFS concerning Regulation W compliance issues\u003c/p\u003e","\u003cp\u003eAdvised\u0026nbsp;\u003cstrong\u003ea large foreign bank\u003c/strong\u003e\u0026nbsp;in responding to a multi-state attorneys general investigation of its auto lending and securitization practices\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003esenior finance and actuarial employees\u003c/strong\u003e\u0026nbsp;of\u0026nbsp;\u003cstrong\u003eAMBAC\u003c/strong\u003e\u0026nbsp;in SEC investigation of accounting fraud\u003c/p\u003e","\u003cp\u003eRepresented the\u0026nbsp;\u003cstrong\u003eCFO of an insurance company\u003c/strong\u003e\u0026nbsp;in an investigation before the NYDFS which resulted in the matter being closed without action\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eAdmirals Bank\u003c/strong\u003e, as it restructured operations in the face of significant regulatory scrutiny and complex bank regulatory and enforcement issues\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eRoot Insurance\u003c/strong\u003e\u0026nbsp;in a New York Attorney General investigation relating to data breach allegations\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eGovernance\u003c/em\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eServed as a Director and Chair of the\u0026nbsp;\u003cstrong\u003eGovernance Committee\u003c/strong\u003e\u0026nbsp;of the largest privately held bank. BNY Melon Corporate Secretary was a direct report. Extensive pro bono governance work. Write and lecture on the topic. A sample of representations include:\u003c/p\u003e","\u003cp\u003eProvided\u0026nbsp;\u003cstrong\u003ethe Board of Directors of multiple financial institutions\u003c/strong\u003e\u0026nbsp;with advice on their annual self-evaluation as well as broader governance issues including expectations and guidance as applied to bank boards\u003c/p\u003e","\u003cp\u003eRepresented the\u0026nbsp;\u003cstrong\u003eBoard of Directors of Bed Bath \u0026amp; Beyond\u003c/strong\u003e\u0026nbsp;in an internal investigation concerning compensation and disclosure issues\u003c/p\u003e"],"recognitions":[{"title":"Ranked for his “standout expertise” in the category of “Banking (Enforcement \u0026 Investigations)”","detail":"Chamber USA – Nationwide (Band 3) 2020-2026"},{"title":"Nationally recommended in the category of Financial Services Litigation, “tenacious but balanced litigator” ","detail":"The Legal 500 US 2016-2026"},{"title":"Recognized as Benchmark Litigation “Litigation Star”","detail":"Benchmark Litigation"},{"title":"Recognized as Lawdragon 500 Leading Global Entertainment, Sports \u0026 Media Lawyer","detail":"Lawdragon, 2024-2026"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":9814}]},"capability_group_id":3},"created_at":"2026-02-24T23:17:27.000Z","updated_at":"2026-02-24T23:17:27.000Z","searchable_text":"Biben{{ FIELD }}{:title=\u0026gt;\"Ranked for his “standout expertise” in the category of “Banking (Enforcement \u0026amp; Investigations)”\", :detail=\u0026gt;\"Chamber USA – Nationwide (Band 3) 2020-2026\"}{{ FIELD }}{:title=\u0026gt;\"Nationally recommended in the category of Financial Services Litigation, “tenacious but balanced litigator” \", :detail=\u0026gt;\"The Legal 500 US 2016-2026\"}{{ FIELD }}{:title=\u0026gt;\"Recognized as Benchmark Litigation “Litigation Star”\", :detail=\u0026gt;\"Benchmark Litigation\"}{{ FIELD }}{:title=\u0026gt;\"Recognized as Lawdragon 500 Leading Global Entertainment, Sports \u0026amp; Media Lawyer\", :detail=\u0026gt;\"Lawdragon, 2024-2026\"}{{ FIELD }}Anti-Money Laundering\nRoutinely advise banks and non-banks on BSA/AML compliance and enforcement issues including:{{ FIELD }}Represented Societe Generale before the FRB and the Federal Reserve Bank of New York and separately before the NYDFS in negotiating a successful settlement regarding the bank’s BSA/AML compliance and risk management programs{{ FIELD }}Successfully represented Mashreq Bank in negotiating a favorable settlement with the NYDFS, NYFed, FRB, and OFAC resolving wide ranging BSA/AML and Sanctions issues{{ FIELD }}Successfully defended Habib Bank against a $630 million lawsuit by the NYDFS and negotiating a $225 million settlement relating to long-running AML/BSA compliance issues and assisting Habib in winding down the business of their NY branch{{ FIELD }}Successfully represented Coinbase in sweeping NYDFS investigation relating to BSA/AML and other compliance issues{{ FIELD }}Advised a large foreign bank in responding to the DOJ investigation of Mossack Fonseca \u0026amp; and the “Panama Papers”{{ FIELD }}Complex Civil Litigation\nRepresented FanDuel and DraftKings in a landmark victory in the NY Court of Appeals legalizing interactive fantasy sports in New York State (garnering American Lawyer Litigator of the Week runner-up honors){{ FIELD }}Represent FanDuel in a New York State Court litigation brought on by the former founders of FanDuel relating to merger acquisition violation{{ FIELD }}Represent BlackRock in litigation relating to mortgage-era fraud allegations{{ FIELD }}Represented Macquarie Asset Management in a joint venture dispute relating to drag-along rights{{ FIELD }}Represent leading global investment bank in arbitration relating to a joint venture dispute{{ FIELD }}Represented ad hoc 1st lien term lenders in the Mallinckrodt bankruptcy{{ FIELD }}Represented FanDuel in a lawsuit and settlement with the New York Attorney General (NYAG) over the legality of daily fantasy sports and later resolving allegations of false advertising whereby the NYAG dropped its claims challenging the legality of FanDuel’s contests after a change in the New York State law permitting daily fantasy sports{{ FIELD }}Successfully represented the Chairman of the board of Rio Tinto in a broad ranging SEC investigation into accounting fraud{{ FIELD }}Banks and Financial Institutions\nIn addition to BSA/AML advice, I have extensively advised on bank regulatory compliance and enforcement issues, including the CFPB, the FRB, NYDFS, FDIC, OCC and others, including:{{ FIELD }}Successfully represented Truist in a long-running DOJ FIRREA investigation of their trust businesses in a cost-of-litigation settlement where all allegations were denied{{ FIELD }}Advised a global bank on fair lender compliance issue in relation to DFS investigation{{ FIELD }}Successfully represented a superregional bank in a CFPB into investigation into TISA compliance avoiding an enforcement action{{ FIELD }}Represented financial institutions and individuals in SEC investigations, including the Chairman of the Board of a Fortune 100 company{{ FIELD }}Represented a leading Fintech company in a CFPB investigation relating to FCRA and UDAAP allegations{{ FIELD }}Successfully represented Toyota Financial Services in a DOJ and CFPB investigation and negotiating a favorable settlement relating to the indirect auto lender’s fair lending practices{{ FIELD }}Represented a senior executive of one of the largest global banks in a DOJ investigation of RMBS and a separate OCC investigation persuading both agencies after years of investigation to close their investigations without action{{ FIELD }}Lead an extensive internal investigation and representing a large foreign bank before the FRB and NYDFS concerning Regulation W compliance issues{{ FIELD }}Advised a large foreign bank in responding to a multi-state attorneys general investigation of its auto lending and securitization practices{{ FIELD }}Represented senior finance and actuarial employees of AMBAC in SEC investigation of accounting fraud{{ FIELD }}Represented the CFO of an insurance company in an investigation before the NYDFS which resulted in the matter being closed without action{{ FIELD }}Represented Admirals Bank, as it restructured operations in the face of significant regulatory scrutiny and complex bank regulatory and enforcement issues{{ FIELD }}Successfully represented Root Insurance in a New York Attorney General investigation relating to data breach allegations{{ FIELD }}Governance\nServed as a Director and Chair of the Governance Committee of the largest privately held bank. BNY Melon Corporate Secretary was a direct report. Extensive pro bono governance work. Write and lecture on the topic. A sample of representations include:{{ FIELD }}Provided the Board of Directors of multiple financial institutions with advice on their annual self-evaluation as well as broader governance issues including expectations and guidance as applied to bank boards{{ FIELD }}Represented the Board of Directors of Bed Bath \u0026amp; Beyond in an internal investigation concerning compensation and disclosure issues{{ FIELD }}Matthew Biben focuses his practice on complex negotiation and litigation of disputes, including regulatory and enforcement matters on behalf of both individuals and organizations. His diverse litigation practice includes representing financial institutions and FinTech companies in civil disputes, securities and bankruptcy litigation, and complex matters involving the government.\nAs a former general counsel of a large bank and federal prosecutor, Matthew routinely acts as counsel in litigated disputes and internal investigations of both domestic and international matters involving, among others, the Department of Justice (DOJ), Securities Exchange Commission (SEC), Federal Reserve Board (FRB), Office of Comptroller of the Currency (OCC), Consumer Financial Protection Bureau (CFPB), New York Department of Financial Services (NYDFS), state attorneys general and foreign regulators.\nPrior to joining private practice, Matthew served for three-and-a-half years at JPMorgan Chase, where he was Executive Vice President and General Counsel for Chase Consumer \u0026amp; Community Banking, which included JPMorgan Chase’s Private Wealth Management, Card and Merchant Services, Auto Finance, Student Loan, Consumer Banking, Business Banking and Mortgage Banking businesses.\nMatthew also served as Executive Vice President and Deputy General Counsel of The Bank of New York Mellon Corporation for almost seven years, becoming the second youngest person in BNY’s history to be promoted to Executive Vice President. He also served as BNY Mellon’s Global Head of Litigation and supervised various corporate functions that included the Office of the Corporate Secretary.\nMatthew spent the first 12 years of his career in government, serving in the U.S. Attorney’s Office for the Southern District of New York, where he was an Assistant U.S. Attorney in the Criminal Division and received the Attorney General’s Director Award for superior performance. Previously, he was an Assistant District Attorney in the New York County District Attorney’s Office. He argued numerous appeals in the Second Circuit Court of Appeals and was lead counsel in more than 25 federal and state trials. Matthew Biben lawyer Partner Ranked for his “standout expertise” in the category of “Banking (Enforcement \u0026amp; Investigations)” Chamber USA – Nationwide (Band 3) 2020-2026 Nationally recommended in the category of Financial Services Litigation, “tenacious but balanced litigator”  The Legal 500 US 2016-2026 Recognized as Benchmark Litigation “Litigation Star” Benchmark Litigation Recognized as Lawdragon 500 Leading Global Entertainment, Sports \u0026amp; Media Lawyer Lawdragon, 2024-2026 Cornell University Cornell Law School University of Pennsylvania University of Pennsylvania Law School Supreme Court of the United States U.S. Court of Appeals for the Second Circuit U.S. District Court for the Eastern District of New York U.S. District Court for the Southern District of New York New York University of Pennsylvania Carey Law School – Board of Trustees American Arbitration Association – Board Member New York Legal Assistance Group - Member Board of Directors New York Lawyers for the Public Interest - Director Anti-Money Laundering\nRoutinely advise banks and non-banks on BSA/AML compliance and enforcement issues including: Represented Societe Generale before the FRB and the Federal Reserve Bank of New York and separately before the NYDFS in negotiating a successful settlement regarding the bank’s BSA/AML compliance and risk management programs Successfully represented Mashreq Bank in negotiating a favorable settlement with the NYDFS, NYFed, FRB, and OFAC resolving wide ranging BSA/AML and Sanctions issues Successfully defended Habib Bank against a $630 million lawsuit by the NYDFS and negotiating a $225 million settlement relating to long-running AML/BSA compliance issues and assisting Habib in winding down the business of their NY branch Successfully represented Coinbase in sweeping NYDFS investigation relating to BSA/AML and other compliance issues Advised a large foreign bank in responding to the DOJ investigation of Mossack Fonseca \u0026amp; and the “Panama Papers” Complex Civil Litigation\nRepresented FanDuel and DraftKings in a landmark victory in the NY Court of Appeals legalizing interactive fantasy sports in New York State (garnering American Lawyer Litigator of the Week runner-up honors) Represent FanDuel in a New York State Court litigation brought on by the former founders of FanDuel relating to merger acquisition violation Represent BlackRock in litigation relating to mortgage-era fraud allegations Represented Macquarie Asset Management in a joint venture dispute relating to drag-along rights Represent leading global investment bank in arbitration relating to a joint venture dispute Represented ad hoc 1st lien term lenders in the Mallinckrodt bankruptcy Represented FanDuel in a lawsuit and settlement with the New York Attorney General (NYAG) over the legality of daily fantasy sports and later resolving allegations of false advertising whereby the NYAG dropped its claims challenging the legality of FanDuel’s contests after a change in the New York State law permitting daily fantasy sports Successfully represented the Chairman of the board of Rio Tinto in a broad ranging SEC investigation into accounting fraud Banks and Financial Institutions\nIn addition to BSA/AML advice, I have extensively advised on bank regulatory compliance and enforcement issues, including the CFPB, the FRB, NYDFS, FDIC, OCC and others, including: Successfully represented Truist in a long-running DOJ FIRREA investigation of their trust businesses in a cost-of-litigation settlement where all allegations were denied Advised a global bank on fair lender compliance issue in relation to DFS investigation Successfully represented a superregional bank in a CFPB into investigation into TISA compliance avoiding an enforcement action Represented financial institutions and individuals in SEC investigations, including the Chairman of the Board of a Fortune 100 company Represented a leading Fintech company in a CFPB investigation relating to FCRA and UDAAP allegations Successfully represented Toyota Financial Services in a DOJ and CFPB investigation and negotiating a favorable settlement relating to the indirect auto lender’s fair lending practices Represented a senior executive of one of the largest global banks in a DOJ investigation of RMBS and a separate OCC investigation persuading both agencies after years of investigation to close their investigations without action Lead an extensive internal investigation and representing a large foreign bank before the FRB and NYDFS concerning Regulation W compliance issues Advised a large foreign bank in responding to a multi-state attorneys general investigation of its auto lending and securitization practices Represented senior finance and actuarial employees of AMBAC in SEC investigation of accounting fraud Represented the CFO of an insurance company in an investigation before the NYDFS which resulted in the matter being closed without action Represented Admirals Bank, as it restructured operations in the face of significant regulatory scrutiny and complex bank regulatory and enforcement issues Successfully represented Root Insurance in a New York Attorney General investigation relating to data breach allegations Governance\nServed as a Director and Chair of the Governance Committee of the largest privately held bank. BNY Melon Corporate Secretary was a direct report. Extensive pro bono governance work. Write and lecture on the topic. A sample of representations include: Provided the Board of Directors of multiple financial institutions with advice on their annual self-evaluation as well as broader governance issues including expectations and guidance as applied to bank boards Represented the Board of Directors of Bed Bath \u0026amp; Beyond in an internal investigation concerning compensation and disclosure issues","searchable_name":"Matthew L. Biben (Matt)","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":447104,"version":1,"owner_type":"Person","owner_id":6224,"payload":{"bio":"\u003cp\u003eSara Brinkmann represents healthcare and life sciences clients in investigations and litigation in federal courts, state courts, arbitrations, and administrative proceedings across the country.\u0026nbsp; Sara has particular expertise in handling matters that arise under the federal False Claims Act and its state law analogues.\u0026nbsp; Sara also focuses on managed care litigation and has successfully recovered millions of dollars for healthcare providers in disputes against heath plans.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAn experienced litigator, Sara also represents her clients in disputes involving contracts, business torts, antitrust, and products liability issues. Sara's clients include hospitals, academic medical centers, medical groups, retail pharmacies, medical device companies, pharmaceutical companies, and other life sciences companies.\u0026nbsp;\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eIn additional to her litigation practice, she regularly advises clients on regulatory and compliance matters, including those that involved the Stark Law, the Anti-Kickback Statute, and other fraud and abuse laws. She also provides counseling and training regarding policies, compliance programs, self-disclosures, and billing matters.\u0026nbsp;\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eThrough \u003cem\u003eChambers USA\u003c/em\u003e, her clients have said:\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp; \"Sara Brinkmann is an excellent litigator. She is very knowledgeable, highly organized, and a pleasure to work with.\"\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp; \"She cares about each of her cases and comes up with creative ideas to problem-solve.\" \u003c/em\u003e\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp; \"Sara Brinkmann is a fantastic lawyer.\"\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003eSara is regularly recognized by publications like \u003cem\u003eChambers,\u0026nbsp;\u003c/em\u003e\u003cem\u003eBest Lawyers in America, \u003c/em\u003eand \u003cem\u003eSuper Lawyers\u003c/em\u003e. She is the past\u0026nbsp;Chair of the Health Law Section of the Houston Bar Association. She is also a frequent speaker and presenter on a variety of healthcare topics.\u003c/p\u003e","slug":"sara-brinkmann","email":"sbrinkmann@kslaw.com","phone":"+1 713 295 9930","matters":["\u003cp\u003eSuccessfully defended a nationwide retail pharmacy client in a False Claims Act case in the Southern District of Texas and on appeal in the Fifth Circuit Court of Appeals involving allegations of regulatory violations related to the dispensing of certain pharmaceuticals, resulting in a full dismissal of the case prior to discovery and was affirmed on appeal at the Fifth Circuit.\u003c/p\u003e","\u003cp\u003eSuccessfully defended a hospital system in a False Claims Act case in the Southern District of Texas involving allegations of Stark Law and Anti-Kickback Statute violations related to physician recruitment and compensation arrangements, resulting in a favorable settlement for the client.\u003c/p\u003e","\u003cp\u003eSuccessfully defended a hospital system in a False Claims Act case in the Eastern District of Wisconsin involving allegations of Stark Law and Anti-Kickback Statute violations related to physician group compensation, resulting in a favorable settlement for the client.\u003c/p\u003e","\u003cp\u003eSuccessfully defended an international medical device company in a False Claims Act case in the District of New Jersey involving allegations of coding errors on claim submissions, resulting in a favorable settlement for the client.\u003c/p\u003e","\u003cp\u003eSuccessfully defended nationwide retail pharmacy in a False Claims Act case in the Central District of Illinois involving allegations related to usual and customary pricing, resulting in the Court\u0026rsquo;s grant of a Motion for Summary Judgment and dismissal of case.\u003c/p\u003e","\u003cp\u003eSuccessfully defended several higher education institutions, academic medical centers, and life sciences companies in responding to Civil Investigative Demands and other government investigation, including conducting internal investigations and presenting to the government.\u003c/p\u003e","\u003cp\u003eAdvised several higher education institutions on legal and compliance issues, including developing, implementing, and providing training to employees.\u003c/p\u003e","\u003cp\u003eAdvised hospital systems regarding affiliation agreements and other complex transactions.\u003c/p\u003e","\u003cp\u003eAdvised and provided due diligence support to healthcare companies and hospital systems for mergers and acquisitions.\u003c/p\u003e","\u003cp\u003eAdvised hospital system regarding data privacy and HIPAA compliance issues in responding to third-party subpoenas.\u003c/p\u003e","\u003cp\u003eSuccessfully defended a government defense contractor in a False Claims Act case in the Eastern District of Texas involving allegations of kickbacks and failure to comply with certain Federal Acquisition Regulations.\u003c/p\u003e","\u003cp\u003eSuccessfully defended a pharmaceutical company in several product liability cases in federal and state courts across the country.\u003c/p\u003e","\u003cp\u003eSuccessfully represented hospitals systems and other healthcare providers in Texas federal and state court cases involving allegations of breach of contract, violations of Texas Deceptive Trade Practices Act and Texas Uniform Fraudulent Transfer Act, and health care liability claim cases.\u003c/p\u003e","\u003cp\u003eSuccessfully represented a hospital system in responding to Medicare RAC audits, securing full reimbursements for hospital system.\u003c/p\u003e","\u003cp\u003eRepresented a Louisiana hospital system in federal antitrust case.\u003c/p\u003e","\u003cp\u003eSuccessfully defended a managed care organization in response to investigation by the Texas Office of Inspector General, resulting in a favorable result for the client.\u003c/p\u003e","\u003cp\u003eSuccessfully represented a hospital system in responding to third-party subpoenas successfully securing full reimbursements for hospital systems, including obtaining recovery of attorneys\u0026rsquo; fees after prosecuting numerous motions to quash and motions for protection of medical and forensic records in civil, family, and criminal cases.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":81,"guid":"81.capabilities","index":0,"source":"capabilities"},{"id":24,"guid":"24.capabilities","index":1,"source":"capabilities"},{"id":11,"guid":"11.capabilities","index":2,"source":"capabilities"},{"id":74,"guid":"74.capabilities","index":3,"source":"capabilities"},{"id":21,"guid":"21.capabilities","index":4,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":5,"source":"capabilities"},{"id":109,"guid":"109.capabilities","index":6,"source":"capabilities"},{"id":102,"guid":"102.capabilities","index":7,"source":"capabilities"},{"id":952,"guid":"952.smart_tags","index":8,"source":"smartTags"},{"id":761,"guid":"761.smart_tags","index":9,"source":"smartTags"},{"id":780,"guid":"780.smart_tags","index":10,"source":"smartTags"}],"is_active":true,"last_name":"Brinkmann","nick_name":"Sara","clerkships":[{"name":"Law Clerk, Hon. David Hittner, Texas","years_held":"2009 - 2011"}],"first_name":"Sara","title_rank":9999,"updated_by":202,"law_schools":[{"id":2197,"meta":{"degree":"J.D.","honors":"cum laude","is_law_school":"1","graduation_date":"2009-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":" ","name_suffix":"","recognitions":[{"title":"\"She is very calm, organized and responsive.\"","detail":"Chambers USA, 2025"},{"title":"\"Sara has a very service-oriented ethos in how she practices.\"","detail":"Chambers USA, 2025"},{"title":"Ranked as a Band 3 lawyer for Healthcare: Government Matters \u0026 Regulation","detail":"Chambers USA, 2025"},{"title":"Ranked as a Key Lawyer for Healthcare: Service Providers","detail":"Legal 500 USA, 2025"},{"title":"\"Sara is very good at keeping larger business outcomes in mind.\"","detail":"Chambers USA 2024"},{"title":"\"Sara is intelligent and customer-focused, responsive and competent.\"","detail":"Chambers USA 2024"},{"title":"\"Sara is an exceptional attorney who provided outstanding legal analysis.\"","detail":"Chambers USA 2024"},{"title":"Ranked Band 3 for Healthcare in Texas","detail":"Chambers USA 2024"},{"title":"Women in the Law","detail":"Best Lawyers, 2022"},{"title":"Top Rated Houston, TX Health Care Attorney","detail":"Super Lawyers, 2023-2024"},{"title":"Top Women Attorneys in Texas","detail":"2024"},{"title":"Best Lawyers in America","detail":"Best Lawyers - Texas, 2021 - 2023"},{"title":"Top Ranked Lawyer, Healthcare","detail":"Chambers USA, Texas, 2021-2023"},{"title":"“Sara Brinkmann comes recommended for her expert handling of qui tam actions brought under the False Claims Act.”","detail":"Chambers USA 2022"},{"title":"“Sara offers notable experience in litigation and administrative proceedings.”","detail":"Chambers USA 2022"},{"title":"“Sara Brinkmann possesses significant experience and knowledge on complex issues.”","detail":"Chambers USA 2022"},{"title":"Sara is “organized and approachable, and offers thoughtful approaches on ways to achieve the desired result.”","detail":"Chambers USA 2022"},{"title":"“She is a really sharp lawyer.”","detail":"Chambers USA 2022"}],"linked_in_url":"https://www.linkedin.com/in/sara-brinkmann-23b78335","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eSara Brinkmann represents healthcare and life sciences clients in investigations and litigation in federal courts, state courts, arbitrations, and administrative proceedings across the country.\u0026nbsp; Sara has particular expertise in handling matters that arise under the federal False Claims Act and its state law analogues.\u0026nbsp; Sara also focuses on managed care litigation and has successfully recovered millions of dollars for healthcare providers in disputes against heath plans.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAn experienced litigator, Sara also represents her clients in disputes involving contracts, business torts, antitrust, and products liability issues. Sara's clients include hospitals, academic medical centers, medical groups, retail pharmacies, medical device companies, pharmaceutical companies, and other life sciences companies.\u0026nbsp;\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eIn additional to her litigation practice, she regularly advises clients on regulatory and compliance matters, including those that involved the Stark Law, the Anti-Kickback Statute, and other fraud and abuse laws. She also provides counseling and training regarding policies, compliance programs, self-disclosures, and billing matters.\u0026nbsp;\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eThrough \u003cem\u003eChambers USA\u003c/em\u003e, her clients have said:\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp; \"Sara Brinkmann is an excellent litigator. She is very knowledgeable, highly organized, and a pleasure to work with.\"\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp; \"She cares about each of her cases and comes up with creative ideas to problem-solve.\" \u003c/em\u003e\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp; \"Sara Brinkmann is a fantastic lawyer.\"\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003eSara is regularly recognized by publications like \u003cem\u003eChambers,\u0026nbsp;\u003c/em\u003e\u003cem\u003eBest Lawyers in America, \u003c/em\u003eand \u003cem\u003eSuper Lawyers\u003c/em\u003e. She is the past\u0026nbsp;Chair of the Health Law Section of the Houston Bar Association. She is also a frequent speaker and presenter on a variety of healthcare topics.\u003c/p\u003e","matters":["\u003cp\u003eSuccessfully defended a nationwide retail pharmacy client in a False Claims Act case in the Southern District of Texas and on appeal in the Fifth Circuit Court of Appeals involving allegations of regulatory violations related to the dispensing of certain pharmaceuticals, resulting in a full dismissal of the case prior to discovery and was affirmed on appeal at the Fifth Circuit.\u003c/p\u003e","\u003cp\u003eSuccessfully defended a hospital system in a False Claims Act case in the Southern District of Texas involving allegations of Stark Law and Anti-Kickback Statute violations related to physician recruitment and compensation arrangements, resulting in a favorable settlement for the client.\u003c/p\u003e","\u003cp\u003eSuccessfully defended a hospital system in a False Claims Act case in the Eastern District of Wisconsin involving allegations of Stark Law and Anti-Kickback Statute violations related to physician group compensation, resulting in a favorable settlement for the client.\u003c/p\u003e","\u003cp\u003eSuccessfully defended an international medical device company in a False Claims Act case in the District of New Jersey involving allegations of coding errors on claim submissions, resulting in a favorable settlement for the client.\u003c/p\u003e","\u003cp\u003eSuccessfully defended nationwide retail pharmacy in a False Claims Act case in the Central District of Illinois involving allegations related to usual and customary pricing, resulting in the Court\u0026rsquo;s grant of a Motion for Summary Judgment and dismissal of case.\u003c/p\u003e","\u003cp\u003eSuccessfully defended several higher education institutions, academic medical centers, and life sciences companies in responding to Civil Investigative Demands and other government investigation, including conducting internal investigations and presenting to the government.\u003c/p\u003e","\u003cp\u003eAdvised several higher education institutions on legal and compliance issues, including developing, implementing, and providing training to employees.\u003c/p\u003e","\u003cp\u003eAdvised hospital systems regarding affiliation agreements and other complex transactions.\u003c/p\u003e","\u003cp\u003eAdvised and provided due diligence support to healthcare companies and hospital systems for mergers and acquisitions.\u003c/p\u003e","\u003cp\u003eAdvised hospital system regarding data privacy and HIPAA compliance issues in responding to third-party subpoenas.\u003c/p\u003e","\u003cp\u003eSuccessfully defended a government defense contractor in a False Claims Act case in the Eastern District of Texas involving allegations of kickbacks and failure to comply with certain Federal Acquisition Regulations.\u003c/p\u003e","\u003cp\u003eSuccessfully defended a pharmaceutical company in several product liability cases in federal and state courts across the country.\u003c/p\u003e","\u003cp\u003eSuccessfully represented hospitals systems and other healthcare providers in Texas federal and state court cases involving allegations of breach of contract, violations of Texas Deceptive Trade Practices Act and Texas Uniform Fraudulent Transfer Act, and health care liability claim cases.\u003c/p\u003e","\u003cp\u003eSuccessfully represented a hospital system in responding to Medicare RAC audits, securing full reimbursements for hospital system.\u003c/p\u003e","\u003cp\u003eRepresented a Louisiana hospital system in federal antitrust case.\u003c/p\u003e","\u003cp\u003eSuccessfully defended a managed care organization in response to investigation by the Texas Office of Inspector General, resulting in a favorable result for the client.\u003c/p\u003e","\u003cp\u003eSuccessfully represented a hospital system in responding to third-party subpoenas successfully securing full reimbursements for hospital systems, including obtaining recovery of attorneys\u0026rsquo; fees after prosecuting numerous motions to quash and motions for protection of medical and forensic records in civil, family, and criminal cases.\u003c/p\u003e"],"recognitions":[{"title":"\"She is very calm, organized and responsive.\"","detail":"Chambers USA, 2025"},{"title":"\"Sara has a very service-oriented ethos in how she practices.\"","detail":"Chambers USA, 2025"},{"title":"Ranked as a Band 3 lawyer for Healthcare: Government Matters \u0026 Regulation","detail":"Chambers USA, 2025"},{"title":"Ranked as a Key Lawyer for Healthcare: Service Providers","detail":"Legal 500 USA, 2025"},{"title":"\"Sara is very good at keeping larger business outcomes in mind.\"","detail":"Chambers USA 2024"},{"title":"\"Sara is intelligent and customer-focused, responsive and competent.\"","detail":"Chambers USA 2024"},{"title":"\"Sara is an exceptional attorney who provided outstanding legal analysis.\"","detail":"Chambers USA 2024"},{"title":"Ranked Band 3 for Healthcare in Texas","detail":"Chambers USA 2024"},{"title":"Women in the Law","detail":"Best Lawyers, 2022"},{"title":"Top Rated Houston, TX Health Care Attorney","detail":"Super Lawyers, 2023-2024"},{"title":"Top Women Attorneys in Texas","detail":"2024"},{"title":"Best Lawyers in America","detail":"Best Lawyers - Texas, 2021 - 2023"},{"title":"Top Ranked Lawyer, Healthcare","detail":"Chambers USA, Texas, 2021-2023"},{"title":"“Sara Brinkmann comes recommended for her expert handling of qui tam actions brought under the False Claims Act.”","detail":"Chambers USA 2022"},{"title":"“Sara offers notable experience in litigation and administrative proceedings.”","detail":"Chambers USA 2022"},{"title":"“Sara Brinkmann possesses significant experience and knowledge on complex issues.”","detail":"Chambers USA 2022"},{"title":"Sara is “organized and approachable, and offers thoughtful approaches on ways to achieve the desired result.”","detail":"Chambers USA 2022"},{"title":"“She is a really sharp lawyer.”","detail":"Chambers USA 2022"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":9607}]},"capability_group_id":2},"created_at":"2026-03-27T19:04:30.000Z","updated_at":"2026-03-27T19:04:30.000Z","searchable_text":"Brinkmann{{ FIELD }}{:title=\u0026gt;\"\\\"She is very calm, organized and responsive.\\\"\", :detail=\u0026gt;\"Chambers USA, 2025\"}{{ FIELD }}{:title=\u0026gt;\"\\\"Sara has a very service-oriented ethos in how she practices.\\\"\", :detail=\u0026gt;\"Chambers USA, 2025\"}{{ FIELD }}{:title=\u0026gt;\"Ranked as a Band 3 lawyer for Healthcare: Government Matters \u0026amp; Regulation\", :detail=\u0026gt;\"Chambers USA, 2025\"}{{ FIELD }}{:title=\u0026gt;\"Ranked as a Key Lawyer for Healthcare: Service Providers\", :detail=\u0026gt;\"Legal 500 USA, 2025\"}{{ FIELD }}{:title=\u0026gt;\"\\\"Sara is very good at keeping larger business outcomes in mind.\\\"\", :detail=\u0026gt;\"Chambers USA 2024\"}{{ FIELD }}{:title=\u0026gt;\"\\\"Sara is intelligent and customer-focused, responsive and competent.\\\"\", :detail=\u0026gt;\"Chambers USA 2024\"}{{ FIELD }}{:title=\u0026gt;\"\\\"Sara is an exceptional attorney who provided outstanding legal analysis.\\\"\", :detail=\u0026gt;\"Chambers USA 2024\"}{{ FIELD }}{:title=\u0026gt;\"Ranked Band 3 for Healthcare in Texas\", :detail=\u0026gt;\"Chambers USA 2024\"}{{ FIELD }}{:title=\u0026gt;\"Women in the Law\", :detail=\u0026gt;\"Best Lawyers, 2022\"}{{ FIELD }}{:title=\u0026gt;\"Top Rated Houston, TX Health Care Attorney\", :detail=\u0026gt;\"Super Lawyers, 2023-2024\"}{{ FIELD }}{:title=\u0026gt;\"Top Women Attorneys in Texas\", :detail=\u0026gt;\"2024\"}{{ FIELD }}{:title=\u0026gt;\"Best Lawyers in America\", :detail=\u0026gt;\"Best Lawyers - Texas, 2021 - 2023\"}{{ FIELD }}{:title=\u0026gt;\"Top Ranked Lawyer, Healthcare\", :detail=\u0026gt;\"Chambers USA, Texas, 2021-2023\"}{{ FIELD }}{:title=\u0026gt;\"“Sara Brinkmann comes recommended for her expert handling of qui tam actions brought under the False Claims Act.”\", :detail=\u0026gt;\"Chambers USA 2022\"}{{ FIELD }}{:title=\u0026gt;\"“Sara offers notable experience in litigation and administrative proceedings.”\", :detail=\u0026gt;\"Chambers USA 2022\"}{{ FIELD }}{:title=\u0026gt;\"“Sara Brinkmann possesses significant experience and knowledge on complex issues.”\", :detail=\u0026gt;\"Chambers USA 2022\"}{{ FIELD }}{:title=\u0026gt;\"Sara is “organized and approachable, and offers thoughtful approaches on ways to achieve the desired result.”\", :detail=\u0026gt;\"Chambers USA 2022\"}{{ FIELD }}{:title=\u0026gt;\"“She is a really sharp lawyer.”\", :detail=\u0026gt;\"Chambers USA 2022\"}{{ FIELD }}Successfully defended a nationwide retail pharmacy client in a False Claims Act case in the Southern District of Texas and on appeal in the Fifth Circuit Court of Appeals involving allegations of regulatory violations related to the dispensing of certain pharmaceuticals, resulting in a full dismissal of the case prior to discovery and was affirmed on appeal at the Fifth Circuit.{{ FIELD }}Successfully defended a hospital system in a False Claims Act case in the Southern District of Texas involving allegations of Stark Law and Anti-Kickback Statute violations related to physician recruitment and compensation arrangements, resulting in a favorable settlement for the client.{{ FIELD }}Successfully defended a hospital system in a False Claims Act case in the Eastern District of Wisconsin involving allegations of Stark Law and Anti-Kickback Statute violations related to physician group compensation, resulting in a favorable settlement for the client.{{ FIELD }}Successfully defended an international medical device company in a False Claims Act case in the District of New Jersey involving allegations of coding errors on claim submissions, resulting in a favorable settlement for the client.{{ FIELD }}Successfully defended nationwide retail pharmacy in a False Claims Act case in the Central District of Illinois involving allegations related to usual and customary pricing, resulting in the Court’s grant of a Motion for Summary Judgment and dismissal of case.{{ FIELD }}Successfully defended several higher education institutions, academic medical centers, and life sciences companies in responding to Civil Investigative Demands and other government investigation, including conducting internal investigations and presenting to the government.{{ FIELD }}Advised several higher education institutions on legal and compliance issues, including developing, implementing, and providing training to employees.{{ FIELD }}Advised hospital systems regarding affiliation agreements and other complex transactions.{{ FIELD }}Advised and provided due diligence support to healthcare companies and hospital systems for mergers and acquisitions.{{ FIELD }}Advised hospital system regarding data privacy and HIPAA compliance issues in responding to third-party subpoenas.{{ FIELD }}Successfully defended a government defense contractor in a False Claims Act case in the Eastern District of Texas involving allegations of kickbacks and failure to comply with certain Federal Acquisition Regulations.{{ FIELD }}Successfully defended a pharmaceutical company in several product liability cases in federal and state courts across the country.{{ FIELD }}Successfully represented hospitals systems and other healthcare providers in Texas federal and state court cases involving allegations of breach of contract, violations of Texas Deceptive Trade Practices Act and Texas Uniform Fraudulent Transfer Act, and health care liability claim cases.{{ FIELD }}Successfully represented a hospital system in responding to Medicare RAC audits, securing full reimbursements for hospital system.{{ FIELD }}Represented a Louisiana hospital system in federal antitrust case.{{ FIELD }}Successfully defended a managed care organization in response to investigation by the Texas Office of Inspector General, resulting in a favorable result for the client.{{ FIELD }}Successfully represented a hospital system in responding to third-party subpoenas successfully securing full reimbursements for hospital systems, including obtaining recovery of attorneys’ fees after prosecuting numerous motions to quash and motions for protection of medical and forensic records in civil, family, and criminal cases.{{ FIELD }}Sara Brinkmann represents healthcare and life sciences clients in investigations and litigation in federal courts, state courts, arbitrations, and administrative proceedings across the country.  Sara has particular expertise in handling matters that arise under the federal False Claims Act and its state law analogues.  Sara also focuses on managed care litigation and has successfully recovered millions of dollars for healthcare providers in disputes against heath plans. \nAn experienced litigator, Sara also represents her clients in disputes involving contracts, business torts, antitrust, and products liability issues. Sara's clients include hospitals, academic medical centers, medical groups, retail pharmacies, medical device companies, pharmaceutical companies, and other life sciences companies.  \nIn additional to her litigation practice, she regularly advises clients on regulatory and compliance matters, including those that involved the Stark Law, the Anti-Kickback Statute, and other fraud and abuse laws. She also provides counseling and training regarding policies, compliance programs, self-disclosures, and billing matters.  \nThrough Chambers USA, her clients have said: \n     \"Sara Brinkmann is an excellent litigator. She is very knowledgeable, highly organized, and a pleasure to work with.\"\n     \"She cares about each of her cases and comes up with creative ideas to problem-solve.\" \n     \"Sara Brinkmann is a fantastic lawyer.\"\nSara is regularly recognized by publications like Chambers, Best Lawyers in America, and Super Lawyers. She is the past Chair of the Health Law Section of the Houston Bar Association. She is also a frequent speaker and presenter on a variety of healthcare topics. Partner \"She is very calm, organized and responsive.\" Chambers USA, 2025 \"Sara has a very service-oriented ethos in how she practices.\" Chambers USA, 2025 Ranked as a Band 3 lawyer for Healthcare: Government Matters \u0026amp; Regulation Chambers USA, 2025 Ranked as a Key Lawyer for Healthcare: Service Providers Legal 500 USA, 2025 \"Sara is very good at keeping larger business outcomes in mind.\" Chambers USA 2024 \"Sara is intelligent and customer-focused, responsive and competent.\" Chambers USA 2024 \"Sara is an exceptional attorney who provided outstanding legal analysis.\" Chambers USA 2024 Ranked Band 3 for Healthcare in Texas Chambers USA 2024 Women in the Law Best Lawyers, 2022 Top Rated Houston, TX Health Care Attorney Super Lawyers, 2023-2024 Top Women Attorneys in Texas 2024 Best Lawyers in America Best Lawyers - Texas, 2021 - 2023 Top Ranked Lawyer, Healthcare Chambers USA, Texas, 2021-2023 “Sara Brinkmann comes recommended for her expert handling of qui tam actions brought under the False Claims Act.” Chambers USA 2022 “Sara offers notable experience in litigation and administrative proceedings.” Chambers USA 2022 “Sara Brinkmann possesses significant experience and knowledge on complex issues.” Chambers USA 2022 Sara is “organized and approachable, and offers thoughtful approaches on ways to achieve the desired result.” Chambers USA 2022 “She is a really sharp lawyer.” Chambers USA 2022 Baylor University Baylor University School of Law University of Houston University of Houston Law Center University of Houston University of Houston Law Center Texas Houston Bar Association, Member (Health Law Section, Chair 2021-2022; Campaign for the Homeless Committee, Former Member; Law Week Committee, Former Member) Federal Bar Association, Member State Bar of Texas, Member Texas Bar Foundation, Fellow Defense Research Institute, Member Greater Houston Society for Healthcare Risk Management Law Clerk, Hon. David Hittner, Texas Successfully defended a nationwide retail pharmacy client in a False Claims Act case in the Southern District of Texas and on appeal in the Fifth Circuit Court of Appeals involving allegations of regulatory violations related to the dispensing of certain pharmaceuticals, resulting in a full dismissal of the case prior to discovery and was affirmed on appeal at the Fifth Circuit. Successfully defended a hospital system in a False Claims Act case in the Southern District of Texas involving allegations of Stark Law and Anti-Kickback Statute violations related to physician recruitment and compensation arrangements, resulting in a favorable settlement for the client. Successfully defended a hospital system in a False Claims Act case in the Eastern District of Wisconsin involving allegations of Stark Law and Anti-Kickback Statute violations related to physician group compensation, resulting in a favorable settlement for the client. Successfully defended an international medical device company in a False Claims Act case in the District of New Jersey involving allegations of coding errors on claim submissions, resulting in a favorable settlement for the client. Successfully defended nationwide retail pharmacy in a False Claims Act case in the Central District of Illinois involving allegations related to usual and customary pricing, resulting in the Court’s grant of a Motion for Summary Judgment and dismissal of case. Successfully defended several higher education institutions, academic medical centers, and life sciences companies in responding to Civil Investigative Demands and other government investigation, including conducting internal investigations and presenting to the government. Advised several higher education institutions on legal and compliance issues, including developing, implementing, and providing training to employees. Advised hospital systems regarding affiliation agreements and other complex transactions. Advised and provided due diligence support to healthcare companies and hospital systems for mergers and acquisitions. Advised hospital system regarding data privacy and HIPAA compliance issues in responding to third-party subpoenas. Successfully defended a government defense contractor in a False Claims Act case in the Eastern District of Texas involving allegations of kickbacks and failure to comply with certain Federal Acquisition Regulations. Successfully defended a pharmaceutical company in several product liability cases in federal and state courts across the country. Successfully represented hospitals systems and other healthcare providers in Texas federal and state court cases involving allegations of breach of contract, violations of Texas Deceptive Trade Practices Act and Texas Uniform Fraudulent Transfer Act, and health care liability claim cases. Successfully represented a hospital system in responding to Medicare RAC audits, securing full reimbursements for hospital system. Represented a Louisiana hospital system in federal antitrust case. Successfully defended a managed care organization in response to investigation by the Texas Office of Inspector General, resulting in a favorable result for the client. Successfully represented a hospital system in responding to third-party subpoenas successfully securing full reimbursements for hospital systems, including obtaining recovery of attorneys’ fees after prosecuting numerous motions to quash and motions for protection of medical and forensic records in civil, family, and criminal cases.","searchable_name":"Sara Brinkmann","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":442372,"version":1,"owner_type":"Person","owner_id":883,"payload":{"bio":"\u003cp\u003eMark Brown is nationally recognized in Food \u0026amp; Drug Administration regulatory matters, civil litigation, criminal investigations and prosecutions, compliance matters and comprehensive risk assessments. Mark advises pharmaceutical, medical device and biotech companies, and pharmacies, on a broad range of FDA requirements and FDA regulatory issues that arise in products liability litigation and other disputes. A former Associate Chief Counsel for FDA, Mark is the Chair of the FDA and Life Sciences practice.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eMark has developed a national reputation for successfully resolving difficult and complex FDA compliance matters and enforcement actions. For pharmaceutical, medical device and food companies, and pharmacies, he has successfully negotiated and managed numerous complex consent decrees of injunction, successfully defended an injunction action brought by FDA, and persuaded the government not to bring enforcement actions in other civil and criminal matters.\u003c/p\u003e\n\u003cp\u003eMark regularly counsels clients on drug safety issues, clinical trials, adverse event reporting, quality systems and manufacturing practices for drugs and devices. He also provides guidance concerning product failure investigations, factory inspections, recalls, product labeling, drug compounding, advertising, promotion, sales and marketing practices, and regularly advises clients on strategies for obtaining FDA approval and clearance for medical products.\u003c/p\u003e\n\u003cp\u003eMark also handles FDA-related issues in product liability and commercial litigation. He was an architect of the preemption defense for both pharmaceutical and medical device clients, developing supporting evidence, briefing and arguing federal preemption motions in various federal and state courts.\u003c/p\u003e\n\u003cp\u003eBefore joining the FDA, Mark was an attorney in the Bureau of Consumer Protection at the Federal Trade Commission, where he concentrated on consumer fraud, healthcare advertising and promotional activities. He developed FTC enforcement actions against weight-loss centers, in vitro fertilization clinics and Northern Virginia infertility doctor Cecil B. Jacobson, who was later convicted of defrauding patients.\u003c/p\u003e","slug":"mark-brown","email":"mbrown@kslaw.com","phone":null,"matters":["\u003cp\u003e\u003cem data-redactor-tag=\"em\"\u003e\u003cstrong data-redactor-tag=\"strong\"\u003ePhillip Morris USA\u003c/strong\u003e v. FDA\u003c/em\u003e, 202 F.Supp. 3d (D.D.C. 2016). Represented one of the plaintiffs in a successful legal challenge to an FDA guidance governing the Substantial Equivalence Review process for tobacco products.\u003c/p\u003e","\u003cp\u003e\u003cem data-redactor-tag=\"em\"\u003eUnited States v. \u003cstrong data-redactor-tag=\"strong\"\u003eFranck's Lab\u003c/strong\u003e\u003c/em\u003e\u003cstrong data-redactor-tag=\"strong\"\u003e,\u003c/strong\u003e 2011 WL 4031102 (M.D. Fla., Sept. 12, 2011). Lead counsel in successful defense of FDA enforcement action against pharmacy compounder of veterinary drugs.\u003c/p\u003e","\u003cp\u003eDuring his 30-year career, he has served as lead counsel and negotiator for numerous consent decrees of injunction, both during his tenure with FDA (1990\u0026ndash;1994), and since 1994 in private practice. For example, he has negotiated consent decrees some of the world's largest device manufacturers, including \u003cstrong data-redactor-tag=\"strong\"\u003eMedtronic\u003c/strong\u003e (2008 and 2015), \u003cstrong data-redactor-tag=\"strong\"\u003eThe General Electric Company\u003c/strong\u003e (2007) and \u003cstrong data-redactor-tag=\"strong\"\u003eBaxter Healthcare\u003c/strong\u003e (2006).\u003c/p\u003e","\u003cp\u003eSince 2002, served on the national counsel team for \u003cstrong data-redactor-tag=\"strong\"\u003eGlaxoSmithKline\u003c/strong\u003e in the Paxil Products Liability Litigation. Represented GSK on all FDA-related issues, including federal preemption. Argued and won a summary judgment motion on federal preemption grounds in \u003cem data-redactor-tag=\"em\"\u003eO'Neal v. \u003cstrong data-redactor-tag=\"strong\"\u003eSmithKline Beecham\u003c/strong\u003e\u003c/em\u003e (E.D. Cal 2008). In 2002, represented GSK in successfully defending an injunction seeking to enjoin GSK from making claims in direct-to-consumer television advertising for Paxil.\u003c/p\u003e","\u003cp\u003eFrom 1995 to 2001, served on \u003cstrong data-redactor-tag=\"strong\"\u003e3M\u003c/strong\u003e's National Trial Team in the Silicone Gel-Filled Breast Implant Litigation. Responsible for virtually all FDA issues and had primary responsibility for preparation and handling of defense expert witnesses, and cross-examination of adverse witnesses on FDA issues.\u003c/p\u003e","\u003cp\u003e\u003cem data-redactor-tag=\"em\"\u003eConnaught Laboratories v. \u003cstrong data-redactor-tag=\"strong\"\u003eSmithKline Beecham\u003c/strong\u003e\u003c/em\u003e\u003cstrong data-redactor-tag=\"strong\"\u003e,\u003c/strong\u003e 7 F.Supp. 2d 477 (D.Del. 1998), appeal dismissed, 165 F.3d 1368 (1999). Represented SmithKline Beecham in winning one of the few successful motions to compel FDA to provide testimony by its research scientists in patent litigation relating to purified form of pertactin, a component of the pertussis vaccine.\u003c/p\u003e","\u003cp\u003e\u003cem data-redactor-tag=\"em\"\u003e\u003cstrong data-redactor-tag=\"strong\"\u003eNext Nutrition\u003c/strong\u003e\u003cstrong data-redactor-tag=\"strong\"\u003e, Inc.\u003c/strong\u003e\u003c/em\u003e \u003cem data-redactor-tag=\"em\"\u003ev. SportPharma USA, Inc.\u003c/em\u003e, No. 97-CV-1898J (1997). Served as lead counsel to a dietary supplement company that brought an action under the Lanham Act alleging false and misleading comparative advertising relating to competing products. Successfully negotiated a favorable settlement by obtaining a consent decree of permanent injunction and a damage award.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003epharmaceutical manufacturers\u003c/strong\u003e in grand jury investigations regarding data integrity concerns in regulatory submissions to FDA, and alleged cGMP violations. In both cases, the U.S. Department of Justice declined to prosecute the company and individuals under investigation.\u003c/p\u003e","\u003cp\u003eConducted internal investigations into the sales and marketing practices of \u003cstrong data-redactor-tag=\"strong\"\u003emultiple international pharmaceutical and biotech companies\u003c/strong\u003e to develop a risk profile and recommendations for reducing potential liability and risk exposure.\u003c/p\u003e","\u003cp\u003eConducted comprehensive prelaunch risk assessments for \u003cstrong data-redactor-tag=\"strong\"\u003ea Top 10 pharmaceutical company\u003c/strong\u003e\u003cstrong data-redactor-tag=\"strong\"\u003e\u0026rsquo;s\u003c/strong\u003e blockbuster drug to identify potential medical, scientific, regulatory and products liability risk areas.\u003c/p\u003e","\u003cp\u003eConducted a risk assessment for \u003cstrong data-redactor-tag=\"strong\"\u003ea top tier biotechnology company\u0026rsquo;s\u003c/strong\u003e drug safety system to identify areas for possible improvement in pharmacovigilence planning, postmarket signal detection and investigation, and business decision-making.\u003c/p\u003e","\u003cp\u003eLed numerous internal investigations for \u003cstrong data-redactor-tag=\"strong\"\u003ebiotechnology, pharmaceutical and medical device manufacturers\u003c/strong\u003e into allegations made by current and former employees regarding product integrity issues, sales and marketing activities, and manufacturing quality issues.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003eseveral drug and device manufacturers\u003c/strong\u003e concerning product approvals, and in responding to FDA requests for information relating to promotion and advertising, manufacturing practices, field alerts, recalls and numerous post-market issues.\u003c/p\u003e","\u003cp\u003eRepresented one of the nation\u0026rsquo;s foremost cardiovascular institutes and some of the leading interventional cardiologists in responding to deficiencies identified during FDA inspections and developing appropriate corrective action to avoid further FDA regulatory enforcement.\u003c/p\u003e","\u003cp\u003eRepresented a device manufacturer in obtaining expedited PMA review and approval in 90 days for a first-of-a-kind device to treat aneurysms in the renal vascular arteries. Successfully obtained approval for a major PMA supplement for the same product.\u003c/p\u003e","\u003cp\u003eRepresented a device manufacturer and coordinated an extensive product investigation into reported failures of an implantable device featuring sophisticated failure analyses and clinical assessments.\u003c/p\u003e","\u003cp\u003eConducted extensive training on FDA regulatory, IRB and protocol requirements for clinical investigators participating in the study of implantable devices.\u003c/p\u003e","\u003cp\u003eAssisted numerous companies in preparing for FDA inspections, developing responses to FDA observations (FDA-483 forms) and warning letters related to manufacturing practices, quality systems, adverse event reporting, deviations from approved drug master files and manufacturing processes, and a variety of other regulatory matters. Assisted these companies in preparing for meetings with FDA compliance officials in District Offices, centers for drugs and devices, and the Office of Chief Counsel.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[{"id":51}]},"expertise":[{"id":21,"guid":"21.capabilities","index":0,"source":"capabilities"},{"id":11,"guid":"11.capabilities","index":1,"source":"capabilities"},{"id":2,"guid":"2.capabilities","index":2,"source":"capabilities"},{"id":106,"guid":"106.capabilities","index":3,"source":"capabilities"},{"id":3,"guid":"3.capabilities","index":4,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":5,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":6,"source":"capabilities"},{"id":17,"guid":"17.capabilities","index":7,"source":"capabilities"},{"id":80,"guid":"80.capabilities","index":8,"source":"capabilities"},{"id":122,"guid":"122.capabilities","index":9,"source":"capabilities"},{"id":1303,"guid":"1303.smart_tags","index":10,"source":"smartTags"},{"id":970,"guid":"970.smart_tags","index":11,"source":"smartTags"},{"id":114,"guid":"114.capabilities","index":12,"source":"capabilities"}],"is_active":true,"last_name":"Brown","nick_name":"Mark","clerkships":[],"first_name":"Mark","title_rank":9999,"updated_by":196,"law_schools":[],"middle_name":"S.","name_suffix":"","recognitions":[{"title":"Recognized by Super Lawyers as Top Rated FDA Attorney ","detail":"Law \u0026 Politics, 2007, 2010–2011, 2013–2017"},{"title":"Ranked Among the Best Life Sciences Lawyers in the U.S. ","detail":"Legal 500, 2016"},{"title":"Named Life Sciences Star ","detail":"LMG Life Sciences, 2012–2016"},{"title":"Recognized as one of Washington’s Best Lawyers ","detail":"Washingtonian magazine, 2004–2016"},{"title":"Superior Achievement Award ","detail":"U.S. Department of Health \u0026 Human Services, 1992"},{"title":"Commendable Service Award ","detail":"FDA, 1992–1994"}],"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eMark Brown is nationally recognized in Food \u0026amp; Drug Administration regulatory matters, civil litigation, criminal investigations and prosecutions, compliance matters and comprehensive risk assessments. Mark advises pharmaceutical, medical device and biotech companies, and pharmacies, on a broad range of FDA requirements and FDA regulatory issues that arise in products liability litigation and other disputes. A former Associate Chief Counsel for FDA, Mark is the Chair of the FDA and Life Sciences practice.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eMark has developed a national reputation for successfully resolving difficult and complex FDA compliance matters and enforcement actions. For pharmaceutical, medical device and food companies, and pharmacies, he has successfully negotiated and managed numerous complex consent decrees of injunction, successfully defended an injunction action brought by FDA, and persuaded the government not to bring enforcement actions in other civil and criminal matters.\u003c/p\u003e\n\u003cp\u003eMark regularly counsels clients on drug safety issues, clinical trials, adverse event reporting, quality systems and manufacturing practices for drugs and devices. He also provides guidance concerning product failure investigations, factory inspections, recalls, product labeling, drug compounding, advertising, promotion, sales and marketing practices, and regularly advises clients on strategies for obtaining FDA approval and clearance for medical products.\u003c/p\u003e\n\u003cp\u003eMark also handles FDA-related issues in product liability and commercial litigation. He was an architect of the preemption defense for both pharmaceutical and medical device clients, developing supporting evidence, briefing and arguing federal preemption motions in various federal and state courts.\u003c/p\u003e\n\u003cp\u003eBefore joining the FDA, Mark was an attorney in the Bureau of Consumer Protection at the Federal Trade Commission, where he concentrated on consumer fraud, healthcare advertising and promotional activities. He developed FTC enforcement actions against weight-loss centers, in vitro fertilization clinics and Northern Virginia infertility doctor Cecil B. Jacobson, who was later convicted of defrauding patients.\u003c/p\u003e","matters":["\u003cp\u003e\u003cem data-redactor-tag=\"em\"\u003e\u003cstrong data-redactor-tag=\"strong\"\u003ePhillip Morris USA\u003c/strong\u003e v. FDA\u003c/em\u003e, 202 F.Supp. 3d (D.D.C. 2016). Represented one of the plaintiffs in a successful legal challenge to an FDA guidance governing the Substantial Equivalence Review process for tobacco products.\u003c/p\u003e","\u003cp\u003e\u003cem data-redactor-tag=\"em\"\u003eUnited States v. \u003cstrong data-redactor-tag=\"strong\"\u003eFranck's Lab\u003c/strong\u003e\u003c/em\u003e\u003cstrong data-redactor-tag=\"strong\"\u003e,\u003c/strong\u003e 2011 WL 4031102 (M.D. Fla., Sept. 12, 2011). Lead counsel in successful defense of FDA enforcement action against pharmacy compounder of veterinary drugs.\u003c/p\u003e","\u003cp\u003eDuring his 30-year career, he has served as lead counsel and negotiator for numerous consent decrees of injunction, both during his tenure with FDA (1990\u0026ndash;1994), and since 1994 in private practice. For example, he has negotiated consent decrees some of the world's largest device manufacturers, including \u003cstrong data-redactor-tag=\"strong\"\u003eMedtronic\u003c/strong\u003e (2008 and 2015), \u003cstrong data-redactor-tag=\"strong\"\u003eThe General Electric Company\u003c/strong\u003e (2007) and \u003cstrong data-redactor-tag=\"strong\"\u003eBaxter Healthcare\u003c/strong\u003e (2006).\u003c/p\u003e","\u003cp\u003eSince 2002, served on the national counsel team for \u003cstrong data-redactor-tag=\"strong\"\u003eGlaxoSmithKline\u003c/strong\u003e in the Paxil Products Liability Litigation. Represented GSK on all FDA-related issues, including federal preemption. Argued and won a summary judgment motion on federal preemption grounds in \u003cem data-redactor-tag=\"em\"\u003eO'Neal v. \u003cstrong data-redactor-tag=\"strong\"\u003eSmithKline Beecham\u003c/strong\u003e\u003c/em\u003e (E.D. Cal 2008). In 2002, represented GSK in successfully defending an injunction seeking to enjoin GSK from making claims in direct-to-consumer television advertising for Paxil.\u003c/p\u003e","\u003cp\u003eFrom 1995 to 2001, served on \u003cstrong data-redactor-tag=\"strong\"\u003e3M\u003c/strong\u003e's National Trial Team in the Silicone Gel-Filled Breast Implant Litigation. Responsible for virtually all FDA issues and had primary responsibility for preparation and handling of defense expert witnesses, and cross-examination of adverse witnesses on FDA issues.\u003c/p\u003e","\u003cp\u003e\u003cem data-redactor-tag=\"em\"\u003eConnaught Laboratories v. \u003cstrong data-redactor-tag=\"strong\"\u003eSmithKline Beecham\u003c/strong\u003e\u003c/em\u003e\u003cstrong data-redactor-tag=\"strong\"\u003e,\u003c/strong\u003e 7 F.Supp. 2d 477 (D.Del. 1998), appeal dismissed, 165 F.3d 1368 (1999). Represented SmithKline Beecham in winning one of the few successful motions to compel FDA to provide testimony by its research scientists in patent litigation relating to purified form of pertactin, a component of the pertussis vaccine.\u003c/p\u003e","\u003cp\u003e\u003cem data-redactor-tag=\"em\"\u003e\u003cstrong data-redactor-tag=\"strong\"\u003eNext Nutrition\u003c/strong\u003e\u003cstrong data-redactor-tag=\"strong\"\u003e, Inc.\u003c/strong\u003e\u003c/em\u003e \u003cem data-redactor-tag=\"em\"\u003ev. SportPharma USA, Inc.\u003c/em\u003e, No. 97-CV-1898J (1997). Served as lead counsel to a dietary supplement company that brought an action under the Lanham Act alleging false and misleading comparative advertising relating to competing products. Successfully negotiated a favorable settlement by obtaining a consent decree of permanent injunction and a damage award.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003epharmaceutical manufacturers\u003c/strong\u003e in grand jury investigations regarding data integrity concerns in regulatory submissions to FDA, and alleged cGMP violations. In both cases, the U.S. Department of Justice declined to prosecute the company and individuals under investigation.\u003c/p\u003e","\u003cp\u003eConducted internal investigations into the sales and marketing practices of \u003cstrong data-redactor-tag=\"strong\"\u003emultiple international pharmaceutical and biotech companies\u003c/strong\u003e to develop a risk profile and recommendations for reducing potential liability and risk exposure.\u003c/p\u003e","\u003cp\u003eConducted comprehensive prelaunch risk assessments for \u003cstrong data-redactor-tag=\"strong\"\u003ea Top 10 pharmaceutical company\u003c/strong\u003e\u003cstrong data-redactor-tag=\"strong\"\u003e\u0026rsquo;s\u003c/strong\u003e blockbuster drug to identify potential medical, scientific, regulatory and products liability risk areas.\u003c/p\u003e","\u003cp\u003eConducted a risk assessment for \u003cstrong data-redactor-tag=\"strong\"\u003ea top tier biotechnology company\u0026rsquo;s\u003c/strong\u003e drug safety system to identify areas for possible improvement in pharmacovigilence planning, postmarket signal detection and investigation, and business decision-making.\u003c/p\u003e","\u003cp\u003eLed numerous internal investigations for \u003cstrong data-redactor-tag=\"strong\"\u003ebiotechnology, pharmaceutical and medical device manufacturers\u003c/strong\u003e into allegations made by current and former employees regarding product integrity issues, sales and marketing activities, and manufacturing quality issues.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003eseveral drug and device manufacturers\u003c/strong\u003e concerning product approvals, and in responding to FDA requests for information relating to promotion and advertising, manufacturing practices, field alerts, recalls and numerous post-market issues.\u003c/p\u003e","\u003cp\u003eRepresented one of the nation\u0026rsquo;s foremost cardiovascular institutes and some of the leading interventional cardiologists in responding to deficiencies identified during FDA inspections and developing appropriate corrective action to avoid further FDA regulatory enforcement.\u003c/p\u003e","\u003cp\u003eRepresented a device manufacturer in obtaining expedited PMA review and approval in 90 days for a first-of-a-kind device to treat aneurysms in the renal vascular arteries. Successfully obtained approval for a major PMA supplement for the same product.\u003c/p\u003e","\u003cp\u003eRepresented a device manufacturer and coordinated an extensive product investigation into reported failures of an implantable device featuring sophisticated failure analyses and clinical assessments.\u003c/p\u003e","\u003cp\u003eConducted extensive training on FDA regulatory, IRB and protocol requirements for clinical investigators participating in the study of implantable devices.\u003c/p\u003e","\u003cp\u003eAssisted numerous companies in preparing for FDA inspections, developing responses to FDA observations (FDA-483 forms) and warning letters related to manufacturing practices, quality systems, adverse event reporting, deviations from approved drug master files and manufacturing processes, and a variety of other regulatory matters. Assisted these companies in preparing for meetings with FDA compliance officials in District Offices, centers for drugs and devices, and the Office of Chief Counsel.\u003c/p\u003e"],"recognitions":[{"title":"Recognized by Super Lawyers as Top Rated FDA Attorney ","detail":"Law \u0026 Politics, 2007, 2010–2011, 2013–2017"},{"title":"Ranked Among the Best Life Sciences Lawyers in the U.S. ","detail":"Legal 500, 2016"},{"title":"Named Life Sciences Star ","detail":"LMG Life Sciences, 2012–2016"},{"title":"Recognized as one of Washington’s Best Lawyers ","detail":"Washingtonian magazine, 2004–2016"},{"title":"Superior Achievement Award ","detail":"U.S. Department of Health \u0026 Human Services, 1992"},{"title":"Commendable Service Award ","detail":"FDA, 1992–1994"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":746}]},"capability_group_id":2},"created_at":"2025-11-05T05:03:44.000Z","updated_at":"2025-11-05T05:03:44.000Z","searchable_text":"Brown{{ FIELD }}{:title=\u0026gt;\"Recognized by Super Lawyers as Top Rated FDA Attorney \", :detail=\u0026gt;\"Law \u0026amp; Politics, 2007, 2010–2011, 2013–2017\"}{{ FIELD }}{:title=\u0026gt;\"Ranked Among the Best Life Sciences Lawyers in the U.S. \", :detail=\u0026gt;\"Legal 500, 2016\"}{{ FIELD }}{:title=\u0026gt;\"Named Life Sciences Star \", :detail=\u0026gt;\"LMG Life Sciences, 2012–2016\"}{{ FIELD }}{:title=\u0026gt;\"Recognized as one of Washington’s Best Lawyers \", :detail=\u0026gt;\"Washingtonian magazine, 2004–2016\"}{{ FIELD }}{:title=\u0026gt;\"Superior Achievement Award \", :detail=\u0026gt;\"U.S. Department of Health \u0026amp; Human Services, 1992\"}{{ FIELD }}{:title=\u0026gt;\"Commendable Service Award \", :detail=\u0026gt;\"FDA, 1992–1994\"}{{ FIELD }}Phillip Morris USA v. FDA, 202 F.Supp. 3d (D.D.C. 2016). Represented one of the plaintiffs in a successful legal challenge to an FDA guidance governing the Substantial Equivalence Review process for tobacco products.{{ FIELD }}United States v. Franck's Lab, 2011 WL 4031102 (M.D. Fla., Sept. 12, 2011). Lead counsel in successful defense of FDA enforcement action against pharmacy compounder of veterinary drugs.{{ FIELD }}During his 30-year career, he has served as lead counsel and negotiator for numerous consent decrees of injunction, both during his tenure with FDA (1990–1994), and since 1994 in private practice. For example, he has negotiated consent decrees some of the world's largest device manufacturers, including Medtronic (2008 and 2015), The General Electric Company (2007) and Baxter Healthcare (2006).{{ FIELD }}Since 2002, served on the national counsel team for GlaxoSmithKline in the Paxil Products Liability Litigation. Represented GSK on all FDA-related issues, including federal preemption. Argued and won a summary judgment motion on federal preemption grounds in O'Neal v. SmithKline Beecham (E.D. Cal 2008). In 2002, represented GSK in successfully defending an injunction seeking to enjoin GSK from making claims in direct-to-consumer television advertising for Paxil.{{ FIELD }}From 1995 to 2001, served on 3M's National Trial Team in the Silicone Gel-Filled Breast Implant Litigation. Responsible for virtually all FDA issues and had primary responsibility for preparation and handling of defense expert witnesses, and cross-examination of adverse witnesses on FDA issues.{{ FIELD }}Connaught Laboratories v. SmithKline Beecham, 7 F.Supp. 2d 477 (D.Del. 1998), appeal dismissed, 165 F.3d 1368 (1999). Represented SmithKline Beecham in winning one of the few successful motions to compel FDA to provide testimony by its research scientists in patent litigation relating to purified form of pertactin, a component of the pertussis vaccine.{{ FIELD }}Next Nutrition, Inc. v. SportPharma USA, Inc., No. 97-CV-1898J (1997). Served as lead counsel to a dietary supplement company that brought an action under the Lanham Act alleging false and misleading comparative advertising relating to competing products. Successfully negotiated a favorable settlement by obtaining a consent decree of permanent injunction and a damage award.{{ FIELD }}Represented pharmaceutical manufacturers in grand jury investigations regarding data integrity concerns in regulatory submissions to FDA, and alleged cGMP violations. In both cases, the U.S. Department of Justice declined to prosecute the company and individuals under investigation.{{ FIELD }}Conducted internal investigations into the sales and marketing practices of multiple international pharmaceutical and biotech companies to develop a risk profile and recommendations for reducing potential liability and risk exposure.{{ FIELD }}Conducted comprehensive prelaunch risk assessments for a Top 10 pharmaceutical company’s blockbuster drug to identify potential medical, scientific, regulatory and products liability risk areas.{{ FIELD }}Conducted a risk assessment for a top tier biotechnology company’s drug safety system to identify areas for possible improvement in pharmacovigilence planning, postmarket signal detection and investigation, and business decision-making.{{ FIELD }}Led numerous internal investigations for biotechnology, pharmaceutical and medical device manufacturers into allegations made by current and former employees regarding product integrity issues, sales and marketing activities, and manufacturing quality issues.{{ FIELD }}Represented several drug and device manufacturers concerning product approvals, and in responding to FDA requests for information relating to promotion and advertising, manufacturing practices, field alerts, recalls and numerous post-market issues.{{ FIELD }}Represented one of the nation’s foremost cardiovascular institutes and some of the leading interventional cardiologists in responding to deficiencies identified during FDA inspections and developing appropriate corrective action to avoid further FDA regulatory enforcement.{{ FIELD }}Represented a device manufacturer in obtaining expedited PMA review and approval in 90 days for a first-of-a-kind device to treat aneurysms in the renal vascular arteries. Successfully obtained approval for a major PMA supplement for the same product.{{ FIELD }}Represented a device manufacturer and coordinated an extensive product investigation into reported failures of an implantable device featuring sophisticated failure analyses and clinical assessments.{{ FIELD }}Conducted extensive training on FDA regulatory, IRB and protocol requirements for clinical investigators participating in the study of implantable devices.{{ FIELD }}Assisted numerous companies in preparing for FDA inspections, developing responses to FDA observations (FDA-483 forms) and warning letters related to manufacturing practices, quality systems, adverse event reporting, deviations from approved drug master files and manufacturing processes, and a variety of other regulatory matters. Assisted these companies in preparing for meetings with FDA compliance officials in District Offices, centers for drugs and devices, and the Office of Chief Counsel.{{ FIELD }}Mark Brown is nationally recognized in Food \u0026amp; Drug Administration regulatory matters, civil litigation, criminal investigations and prosecutions, compliance matters and comprehensive risk assessments. Mark advises pharmaceutical, medical device and biotech companies, and pharmacies, on a broad range of FDA requirements and FDA regulatory issues that arise in products liability litigation and other disputes. A former Associate Chief Counsel for FDA, Mark is the Chair of the FDA and Life Sciences practice.\nMark has developed a national reputation for successfully resolving difficult and complex FDA compliance matters and enforcement actions. For pharmaceutical, medical device and food companies, and pharmacies, he has successfully negotiated and managed numerous complex consent decrees of injunction, successfully defended an injunction action brought by FDA, and persuaded the government not to bring enforcement actions in other civil and criminal matters.\nMark regularly counsels clients on drug safety issues, clinical trials, adverse event reporting, quality systems and manufacturing practices for drugs and devices. He also provides guidance concerning product failure investigations, factory inspections, recalls, product labeling, drug compounding, advertising, promotion, sales and marketing practices, and regularly advises clients on strategies for obtaining FDA approval and clearance for medical products.\nMark also handles FDA-related issues in product liability and commercial litigation. He was an architect of the preemption defense for both pharmaceutical and medical device clients, developing supporting evidence, briefing and arguing federal preemption motions in various federal and state courts.\nBefore joining the FDA, Mark was an attorney in the Bureau of Consumer Protection at the Federal Trade Commission, where he concentrated on consumer fraud, healthcare advertising and promotional activities. He developed FTC enforcement actions against weight-loss centers, in vitro fertilization clinics and Northern Virginia infertility doctor Cecil B. Jacobson, who was later convicted of defrauding patients. Mark S Brown Partner Recognized by Super Lawyers as Top Rated FDA Attorney  Law \u0026amp; Politics, 2007, 2010–2011, 2013–2017 Ranked Among the Best Life Sciences Lawyers in the U.S.  Legal 500, 2016 Named Life Sciences Star  LMG Life Sciences, 2012–2016 Recognized as one of Washington’s Best Lawyers  Washingtonian magazine, 2004–2016 Superior Achievement Award  U.S. Department of Health \u0026amp; Human Services, 1992 Commendable Service Award  FDA, 1992–1994 University of Michigan University of Michigan Law School St. Louis University  U.S. Court of Appeals for the Federal Circuit U.S. Court of Appeals for the Second Circuit U.S. Court of Appeals for the Seventh Circuit U.S. Court of Appeals for the Ninth Circuit U.S. Court of Appeals for the Tenth Circuit U.S. District Court for the District of Maryland U.S. District Court for the Eastern District of Wisconsin District of Columbia Maryland Pennsylvania District of Columbia Bar Maryland State Bar Phillip Morris USA v. FDA, 202 F.Supp. 3d (D.D.C. 2016). Represented one of the plaintiffs in a successful legal challenge to an FDA guidance governing the Substantial Equivalence Review process for tobacco products. United States v. Franck's Lab, 2011 WL 4031102 (M.D. Fla., Sept. 12, 2011). Lead counsel in successful defense of FDA enforcement action against pharmacy compounder of veterinary drugs. During his 30-year career, he has served as lead counsel and negotiator for numerous consent decrees of injunction, both during his tenure with FDA (1990–1994), and since 1994 in private practice. For example, he has negotiated consent decrees some of the world's largest device manufacturers, including Medtronic (2008 and 2015), The General Electric Company (2007) and Baxter Healthcare (2006). Since 2002, served on the national counsel team for GlaxoSmithKline in the Paxil Products Liability Litigation. Represented GSK on all FDA-related issues, including federal preemption. Argued and won a summary judgment motion on federal preemption grounds in O'Neal v. SmithKline Beecham (E.D. Cal 2008). In 2002, represented GSK in successfully defending an injunction seeking to enjoin GSK from making claims in direct-to-consumer television advertising for Paxil. From 1995 to 2001, served on 3M's National Trial Team in the Silicone Gel-Filled Breast Implant Litigation. Responsible for virtually all FDA issues and had primary responsibility for preparation and handling of defense expert witnesses, and cross-examination of adverse witnesses on FDA issues. Connaught Laboratories v. SmithKline Beecham, 7 F.Supp. 2d 477 (D.Del. 1998), appeal dismissed, 165 F.3d 1368 (1999). Represented SmithKline Beecham in winning one of the few successful motions to compel FDA to provide testimony by its research scientists in patent litigation relating to purified form of pertactin, a component of the pertussis vaccine. Next Nutrition, Inc. v. SportPharma USA, Inc., No. 97-CV-1898J (1997). Served as lead counsel to a dietary supplement company that brought an action under the Lanham Act alleging false and misleading comparative advertising relating to competing products. Successfully negotiated a favorable settlement by obtaining a consent decree of permanent injunction and a damage award. Represented pharmaceutical manufacturers in grand jury investigations regarding data integrity concerns in regulatory submissions to FDA, and alleged cGMP violations. In both cases, the U.S. Department of Justice declined to prosecute the company and individuals under investigation. Conducted internal investigations into the sales and marketing practices of multiple international pharmaceutical and biotech companies to develop a risk profile and recommendations for reducing potential liability and risk exposure. Conducted comprehensive prelaunch risk assessments for a Top 10 pharmaceutical company’s blockbuster drug to identify potential medical, scientific, regulatory and products liability risk areas. Conducted a risk assessment for a top tier biotechnology company’s drug safety system to identify areas for possible improvement in pharmacovigilence planning, postmarket signal detection and investigation, and business decision-making. Led numerous internal investigations for biotechnology, pharmaceutical and medical device manufacturers into allegations made by current and former employees regarding product integrity issues, sales and marketing activities, and manufacturing quality issues. Represented several drug and device manufacturers concerning product approvals, and in responding to FDA requests for information relating to promotion and advertising, manufacturing practices, field alerts, recalls and numerous post-market issues. Represented one of the nation’s foremost cardiovascular institutes and some of the leading interventional cardiologists in responding to deficiencies identified during FDA inspections and developing appropriate corrective action to avoid further FDA regulatory enforcement. Represented a device manufacturer in obtaining expedited PMA review and approval in 90 days for a first-of-a-kind device to treat aneurysms in the renal vascular arteries. Successfully obtained approval for a major PMA supplement for the same product. Represented a device manufacturer and coordinated an extensive product investigation into reported failures of an implantable device featuring sophisticated failure analyses and clinical assessments. Conducted extensive training on FDA regulatory, IRB and protocol requirements for clinical investigators participating in the study of implantable devices. Assisted numerous companies in preparing for FDA inspections, developing responses to FDA observations (FDA-483 forms) and warning letters related to manufacturing practices, quality systems, adverse event reporting, deviations from approved drug master files and manufacturing processes, and a variety of other regulatory matters. Assisted these companies in preparing for meetings with FDA compliance officials in District Offices, centers for drugs and devices, and the Office of Chief Counsel.","searchable_name":"Mark S. Brown","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":196,"capability_group_featured":null,"home_page_featured":null},{"id":427549,"version":1,"owner_type":"Person","owner_id":613,"payload":{"bio":"\u003cp\u003eChris Burris focuses on white-collar criminal defense, corporate internal investigations, regulatory enforcement action defense and complex litigation. As a partner in our Special Matters and Government Investigations practice, Chris defends corporations and individuals in a variety of criminal, regulatory, False Claims Act and other matters.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAs a defense lawyer, Chris represents leading corporations and individuals in criminal and regulatory enforcement matters. He has particular experience with defending clients in False Claims Act/\u003cem\u003equi tam\u003c/em\u003e\u0026nbsp;matters, handling dozens of cases concerning a variety of issues.\u003c/p\u003e\n\u003cp\u003eIn addition, Chris counsels clients in matters concerning privacy, information security and related issues. He also conducts internal investigations on behalf of management, boards of directors and audit committees.\u003c/p\u003e\n\u003cp\u003ePreviously, Chris served on active duty in the U.S. Navy Judge Advocate General\u0026rsquo;s Corps for nearly six years, where he gained broad experience in trial prosecution and defense, appeals and internal investigations. As a Commander in the Naval Reserves, he currently serves as the Executive Officer of the Navy Reserve unit overseeing issues involving international and operational law, admiralty and maritime law, environmental law, and information operations and intelligence law.\u003c/p\u003e","slug":"christopher-burris","email":"cburris@kslaw.com","phone":null,"matters":["\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea major international financial institution\u003c/strong\u003e in the internal investigation and self-disclosure of accusations of employee participation in an alleged Ponzi scheme.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea large publicly traded manufacturing company\u003c/strong\u003e in the internal investigation and self-disclosure of potential Bank Secrecy Act violations.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ean elected state official\u003c/strong\u003e during a federal investigation of public corruption, which led to no charges being filed.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ean owner of a large privately held manufacturing company\u003c/strong\u003e in the defense of a federal criminal tax investigation.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ean owner of a privately held national pharmaceutical distributor\u003c/strong\u003e in Section 2255 proceedings regarding his conviction on mail/wire fraud and RICO charges stemming from allegations of grey market recycling of drugs.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003enumerous national retail and specialty pharmacy chains\u003c/strong\u003e in multiple False Claims Act /\u003cem data-redactor-tag=\"em\"\u003equi tam\u003c/em\u003e matters focusing on a variety of issues, including allegations of the payment of kickbacks, improper submission of dosage quantities, the failure to timely refund credit balances, coordination of benefits issues, the submission of incorrect \u0026ldquo;usual and customary\u0026rdquo; prices to government payors and the dispensing of expired drugs.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea major national financial institution\u003c/strong\u003e in False Claims Act /\u003cem data-redactor-tag=\"em\"\u003equi tam\u003c/em\u003e litigation involving allegations of charging borrowers unallowable fees under the Veteran Administration's Home Loan Guaranty Program.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea major national skilled nursing facility chain\u003c/strong\u003e in False Claims Act /\u003cem data-redactor-tag=\"em\"\u003equi tam\u003c/em\u003e litigation focusing on quality of care issues.\u003c/p\u003e","\u003cp\u003eConducted independent internal investigations on various issues, including allegations of improper accounting, theft of corporate resources, backdated stock option, FCPA violations, and misconduct in the execution of government contracts and grant programs.\u003c/p\u003e","\u003cp\u003eConducted an internal review for \u003cstrong data-redactor-tag=\"strong\"\u003ean international nongovernmenta\u003c/strong\u003e\u003cstrong data-redactor-tag=\"strong\"\u003el organization\u003c/strong\u003e regarding potential FCPA issues related to an ongoing cooperative project with a foreign government.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea large publicly traded corporation\u003c/strong\u003e in one of the first national investigations by a multi-state attorneys' general task force focusing on the loss of consumer information held by the company.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea Fortune 500 financial services company\u003c/strong\u003e in a data breach response and in ensuing investigations by the Financial Industry Regulatory Authority (FINRA) and the Securities and Exchange Commission (SEC), which focused on Regulation S-P\u0026rsquo;s requirement to safeguard consumer financial and personal information.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea Fortune 100 healthcare company\u003c/strong\u003e in responding to a data security incident \u0026mdash; and an ensuing DHHS OCR investigation \u0026mdash; involving the theft of customers\u0026rsquo; personal and medical information. The internal investigation that was conducted led to DHHS OCR and customer disclosures pursuant to the requirements of HIPAA and various state data breach disclosure statutes.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea major international telecommunications company\u003c/strong\u003e in its response to the disclosure of the United States' Terrorist Surveillance Program (TSP), and issues and litigation arising from the company\u0026rsquo;s alleged cooperation with the TSP.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[{"id":24}]},"expertise":[{"id":107,"guid":"107.capabilities","index":0,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":1,"source":"capabilities"},{"id":2,"guid":"2.capabilities","index":2,"source":"capabilities"},{"id":24,"guid":"24.capabilities","index":3,"source":"capabilities"},{"id":20,"guid":"20.capabilities","index":4,"source":"capabilities"},{"id":6,"guid":"6.capabilities","index":5,"source":"capabilities"},{"id":750,"guid":"750.smart_tags","index":6,"source":"smartTags"},{"id":780,"guid":"780.smart_tags","index":7,"source":"smartTags"},{"id":766,"guid":"766.smart_tags","index":8,"source":"smartTags"},{"id":11,"guid":"11.capabilities","index":9,"source":"capabilities"},{"id":952,"guid":"952.smart_tags","index":10,"source":"smartTags"}],"is_active":true,"last_name":"Burris","nick_name":"Chris","clerkships":[],"first_name":"Christopher","title_rank":9999,"updated_by":101,"law_schools":[],"middle_name":"C.","name_suffix":"","recognitions":null,"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eChris Burris focuses on white-collar criminal defense, corporate internal investigations, regulatory enforcement action defense and complex litigation. As a partner in our Special Matters and Government Investigations practice, Chris defends corporations and individuals in a variety of criminal, regulatory, False Claims Act and other matters.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAs a defense lawyer, Chris represents leading corporations and individuals in criminal and regulatory enforcement matters. He has particular experience with defending clients in False Claims Act/\u003cem\u003equi tam\u003c/em\u003e\u0026nbsp;matters, handling dozens of cases concerning a variety of issues.\u003c/p\u003e\n\u003cp\u003eIn addition, Chris counsels clients in matters concerning privacy, information security and related issues. He also conducts internal investigations on behalf of management, boards of directors and audit committees.\u003c/p\u003e\n\u003cp\u003ePreviously, Chris served on active duty in the U.S. Navy Judge Advocate General\u0026rsquo;s Corps for nearly six years, where he gained broad experience in trial prosecution and defense, appeals and internal investigations. As a Commander in the Naval Reserves, he currently serves as the Executive Officer of the Navy Reserve unit overseeing issues involving international and operational law, admiralty and maritime law, environmental law, and information operations and intelligence law.\u003c/p\u003e","matters":["\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea major international financial institution\u003c/strong\u003e in the internal investigation and self-disclosure of accusations of employee participation in an alleged Ponzi scheme.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea large publicly traded manufacturing company\u003c/strong\u003e in the internal investigation and self-disclosure of potential Bank Secrecy Act violations.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ean elected state official\u003c/strong\u003e during a federal investigation of public corruption, which led to no charges being filed.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ean owner of a large privately held manufacturing company\u003c/strong\u003e in the defense of a federal criminal tax investigation.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ean owner of a privately held national pharmaceutical distributor\u003c/strong\u003e in Section 2255 proceedings regarding his conviction on mail/wire fraud and RICO charges stemming from allegations of grey market recycling of drugs.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003enumerous national retail and specialty pharmacy chains\u003c/strong\u003e in multiple False Claims Act /\u003cem data-redactor-tag=\"em\"\u003equi tam\u003c/em\u003e matters focusing on a variety of issues, including allegations of the payment of kickbacks, improper submission of dosage quantities, the failure to timely refund credit balances, coordination of benefits issues, the submission of incorrect \u0026ldquo;usual and customary\u0026rdquo; prices to government payors and the dispensing of expired drugs.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea major national financial institution\u003c/strong\u003e in False Claims Act /\u003cem data-redactor-tag=\"em\"\u003equi tam\u003c/em\u003e litigation involving allegations of charging borrowers unallowable fees under the Veteran Administration's Home Loan Guaranty Program.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea major national skilled nursing facility chain\u003c/strong\u003e in False Claims Act /\u003cem data-redactor-tag=\"em\"\u003equi tam\u003c/em\u003e litigation focusing on quality of care issues.\u003c/p\u003e","\u003cp\u003eConducted independent internal investigations on various issues, including allegations of improper accounting, theft of corporate resources, backdated stock option, FCPA violations, and misconduct in the execution of government contracts and grant programs.\u003c/p\u003e","\u003cp\u003eConducted an internal review for \u003cstrong data-redactor-tag=\"strong\"\u003ean international nongovernmenta\u003c/strong\u003e\u003cstrong data-redactor-tag=\"strong\"\u003el organization\u003c/strong\u003e regarding potential FCPA issues related to an ongoing cooperative project with a foreign government.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea large publicly traded corporation\u003c/strong\u003e in one of the first national investigations by a multi-state attorneys' general task force focusing on the loss of consumer information held by the company.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea Fortune 500 financial services company\u003c/strong\u003e in a data breach response and in ensuing investigations by the Financial Industry Regulatory Authority (FINRA) and the Securities and Exchange Commission (SEC), which focused on Regulation S-P\u0026rsquo;s requirement to safeguard consumer financial and personal information.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea Fortune 100 healthcare company\u003c/strong\u003e in responding to a data security incident \u0026mdash; and an ensuing DHHS OCR investigation \u0026mdash; involving the theft of customers\u0026rsquo; personal and medical information. The internal investigation that was conducted led to DHHS OCR and customer disclosures pursuant to the requirements of HIPAA and various state data breach disclosure statutes.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea major international telecommunications company\u003c/strong\u003e in its response to the disclosure of the United States' Terrorist Surveillance Program (TSP), and issues and litigation arising from the company\u0026rsquo;s alleged cooperation with the TSP.\u003c/p\u003e"]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":4195}]},"capability_group_id":2},"created_at":"2025-05-26T05:02:00.000Z","updated_at":"2025-05-26T05:02:00.000Z","searchable_text":"Burris{{ FIELD }}Represented a major international financial institution in the internal investigation and self-disclosure of accusations of employee participation in an alleged Ponzi scheme.{{ FIELD }}Represented a large publicly traded manufacturing company in the internal investigation and self-disclosure of potential Bank Secrecy Act violations.{{ FIELD }}Represented an elected state official during a federal investigation of public corruption, which led to no charges being filed.{{ FIELD }}Represented an owner of a large privately held manufacturing company in the defense of a federal criminal tax investigation.{{ FIELD }}Represented an owner of a privately held national pharmaceutical distributor in Section 2255 proceedings regarding his conviction on mail/wire fraud and RICO charges stemming from allegations of grey market recycling of drugs.{{ FIELD }}Represented numerous national retail and specialty pharmacy chains in multiple False Claims Act /qui tam matters focusing on a variety of issues, including allegations of the payment of kickbacks, improper submission of dosage quantities, the failure to timely refund credit balances, coordination of benefits issues, the submission of incorrect “usual and customary” prices to government payors and the dispensing of expired drugs.{{ FIELD }}Represented a major national financial institution in False Claims Act /qui tam litigation involving allegations of charging borrowers unallowable fees under the Veteran Administration's Home Loan Guaranty Program.{{ FIELD }}Represented a major national skilled nursing facility chain in False Claims Act /qui tam litigation focusing on quality of care issues.{{ FIELD }}Conducted independent internal investigations on various issues, including allegations of improper accounting, theft of corporate resources, backdated stock option, FCPA violations, and misconduct in the execution of government contracts and grant programs.{{ FIELD }}Conducted an internal review for an international nongovernmental organization regarding potential FCPA issues related to an ongoing cooperative project with a foreign government.{{ FIELD }}Represented a large publicly traded corporation in one of the first national investigations by a multi-state attorneys' general task force focusing on the loss of consumer information held by the company.{{ FIELD }}Represented a Fortune 500 financial services company in a data breach response and in ensuing investigations by the Financial Industry Regulatory Authority (FINRA) and the Securities and Exchange Commission (SEC), which focused on Regulation S-P’s requirement to safeguard consumer financial and personal information.{{ FIELD }}Represented a Fortune 100 healthcare company in responding to a data security incident — and an ensuing DHHS OCR investigation — involving the theft of customers’ personal and medical information. The internal investigation that was conducted led to DHHS OCR and customer disclosures pursuant to the requirements of HIPAA and various state data breach disclosure statutes.{{ FIELD }}Represented a major international telecommunications company in its response to the disclosure of the United States' Terrorist Surveillance Program (TSP), and issues and litigation arising from the company’s alleged cooperation with the TSP.{{ FIELD }}Chris Burris focuses on white-collar criminal defense, corporate internal investigations, regulatory enforcement action defense and complex litigation. As a partner in our Special Matters and Government Investigations practice, Chris defends corporations and individuals in a variety of criminal, regulatory, False Claims Act and other matters.\nAs a defense lawyer, Chris represents leading corporations and individuals in criminal and regulatory enforcement matters. He has particular experience with defending clients in False Claims Act/qui tam matters, handling dozens of cases concerning a variety of issues.\nIn addition, Chris counsels clients in matters concerning privacy, information security and related issues. He also conducts internal investigations on behalf of management, boards of directors and audit committees.\nPreviously, Chris served on active duty in the U.S. Navy Judge Advocate General’s Corps for nearly six years, where he gained broad experience in trial prosecution and defense, appeals and internal investigations. As a Commander in the Naval Reserves, he currently serves as the Executive Officer of the Navy Reserve unit overseeing issues involving international and operational law, admiralty and maritime law, environmental law, and information operations and intelligence law. Christopher C Burris Partner Vanderbilt University Vanderbilt University School of Law University of North Carolina at Chapel Hill University of North Carolina School of Law Georgetown University Georgetown University Law Center Supreme Court of the United States U.S. District Court for the Western District of North Carolina Georgia North Carolina Represented a major international financial institution in the internal investigation and self-disclosure of accusations of employee participation in an alleged Ponzi scheme. Represented a large publicly traded manufacturing company in the internal investigation and self-disclosure of potential Bank Secrecy Act violations. Represented an elected state official during a federal investigation of public corruption, which led to no charges being filed. Represented an owner of a large privately held manufacturing company in the defense of a federal criminal tax investigation. Represented an owner of a privately held national pharmaceutical distributor in Section 2255 proceedings regarding his conviction on mail/wire fraud and RICO charges stemming from allegations of grey market recycling of drugs. Represented numerous national retail and specialty pharmacy chains in multiple False Claims Act /qui tam matters focusing on a variety of issues, including allegations of the payment of kickbacks, improper submission of dosage quantities, the failure to timely refund credit balances, coordination of benefits issues, the submission of incorrect “usual and customary” prices to government payors and the dispensing of expired drugs. Represented a major national financial institution in False Claims Act /qui tam litigation involving allegations of charging borrowers unallowable fees under the Veteran Administration's Home Loan Guaranty Program. Represented a major national skilled nursing facility chain in False Claims Act /qui tam litigation focusing on quality of care issues. Conducted independent internal investigations on various issues, including allegations of improper accounting, theft of corporate resources, backdated stock option, FCPA violations, and misconduct in the execution of government contracts and grant programs. Conducted an internal review for an international nongovernmental organization regarding potential FCPA issues related to an ongoing cooperative project with a foreign government. Represented a large publicly traded corporation in one of the first national investigations by a multi-state attorneys' general task force focusing on the loss of consumer information held by the company. Represented a Fortune 500 financial services company in a data breach response and in ensuing investigations by the Financial Industry Regulatory Authority (FINRA) and the Securities and Exchange Commission (SEC), which focused on Regulation S-P’s requirement to safeguard consumer financial and personal information. Represented a Fortune 100 healthcare company in responding to a data security incident — and an ensuing DHHS OCR investigation — involving the theft of customers’ personal and medical information. The internal investigation that was conducted led to DHHS OCR and customer disclosures pursuant to the requirements of HIPAA and various state data breach disclosure statutes. Represented a major international telecommunications company in its response to the disclosure of the United States' Terrorist Surveillance Program (TSP), and issues and litigation arising from the company’s alleged cooperation with the TSP.","searchable_name":"Christopher C. Burris (Chris)","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":101,"capability_group_featured":null,"home_page_featured":null},{"id":442383,"version":1,"owner_type":"Person","owner_id":1005,"payload":{"bio":"\u003cp\u003eRandy Butterfield helps lead the firm\u0026rsquo;s Atlanta Environmental, Health and Safety Practice Group, where he concentrates his practice on environmental and toxic tort litigation as well as\u0026nbsp;emergency incident response. Randy's practice focuses in particular on assisting clients in the wake of catastrophic emergency incidents, such as explosions, fires, industrial accidents, chemical releases, spills, and other environmental and industrial calamities. In that capacity, Randy is frequently called upon in the immediate aftermath of these emergencies to provide time-critical crisis management addressing a wide range of pressing concerns, including forensic investigation; workplace safety; site security and evidence preservation; regulatory disclosures, investigation, and potential enforcement; environmental remediation; internal investigations; and insurance coverage. Recent incidents on which Randy has helped lead the response have involved over $2 billion in property damages, business losses, and insurance claims; significant personal injury lawsuits; as well as enforcement actions from federal and state regulators.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eIn addition, Randy has handled numerous mass joinder and class action cases involving personal injury and property damage claims, both at the trial and appellate levels. Randy has played a particularly significant role in preparing and defending the defense experts\u0026mdash;as well as deposing and critiquing plaintiffs\u0026rsquo; experts\u0026mdash;on a wide variety of technical topics, such as air and groundwater modeling, emission inventories, dose reconstruction, geostatistics, human health risk assessment, toxicology, epidemiology,\u0026nbsp;fate and transport,\u0026nbsp;remediation,\u0026nbsp;property valuation, and damage assessments. Over his career, Randy\u0026rsquo;s litigation matters have involved nearly every major piece of environmental legislation as well as the entire spectrum of common law tort claims.\u003c/p\u003e\n\u003cp\u003eRandy has published several articles involving the potential application and use of federal and state regulatory standards in the toxic tort context. He has also co-authored a chapter on legal defenses in toxic tort cases in a treatise published by the American Bar Association as well as a chapter on administrative appeals published by LexisNexis. Randy served on the Environmental and Toxic Tort Section of the Atlanta Bar Association, including as Board Chair in 2018. Randy also served on\u0026nbsp;\u003cem\u003eLaw360\u003c/em\u003e\u0026rsquo;s Environmental Editorial Advisory Board from 2021-2022.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eBooks, Articles \u0026amp; Presentations\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u0026bull; LexisNexis Practice Guide:\u0026nbsp;\u003cem\u003eGeorgia Environmental Law\u003c/em\u003e, 2022 ed.\u003c/p\u003e\n\u003cp\u003e\u0026bull; Randy J. Butterfield, moderator, Roundtable with Georgia Office of State Administrative Hearing Judges\u0026nbsp;\u0026amp; Litigants, Atlanta Bar Association, Toxic Tort and Environmental Law CLE, Feb. 1, 2018\u003c/p\u003e\n\u003cp\u003e\u0026bull; Randy J. Butterfield \u0026amp; Stephen A. McCullers,\u0026nbsp;\u003cem\u003eRaising the Class Action Certification Bar in Georgia:\u0026nbsp;\u003c/em\u003eGeorgia-Pacific Consumer Products, LP v. Ratner, Perspectives on Georgia\u0026rsquo;s Environment (State Bar of\u0026nbsp;Georgia), Spring 2015, at 6-9\u003c/p\u003e\n\u003cp\u003e\u0026bull; Randy J. Butterfield,\u0026nbsp;\u003cem\u003eRecent \u0026amp; Recurring Issues in Toxic Tort Cases\u003c/em\u003e, State Bar of Georgia, Toxic Tort\u0026nbsp;Litigation CLE, Mar. 2014\u003c/p\u003e\n\u003cp\u003e\u0026bull; J Kevin Buster \u0026amp; Randy J. Butterfield,\u0026nbsp;\u003cem\u003eCommon Defenses in Toxic Tort Litigation\u003c/em\u003e\u0026nbsp;(book chapter) (ABA\u0026nbsp;2d ed. 2013)\u003c/p\u003e\n\u003cp\u003e\u0026bull; Randy J. Butterfield, Note,\u0026nbsp;\u003cem\u003eRecovering Environmental Cleanup Costs Under the Resource Conservation\u0026nbsp;and Recovery Act: A Potential Solution to a Persistent Problem\u003c/em\u003e, 49 Vand. L. Rev. 689 (1997)\u003c/p\u003e","slug":"randall-butterfield","email":"rbutterfield@kslaw.com","phone":null,"matters":["\u003cp\u003eA midstream energy company in connection with investigations by Federal and State environmental agencies as well as the Occupational Safety and Health Administration (OSHA) into an explosion and fire at a natural gas processing facility resulting in catastrophic loss. Oversaw root cause investigation, coordinated responses to agency inquiries, and provided advice and counsel in connection with successful insurance recovery.\u003c/p\u003e","\u003cp\u003eOne of the world\u0026rsquo;s largest producers of methanol from natural gas as standby incident response counsel, including in connection with environmental investigations into spills and releases.\u003c/p\u003e","\u003cp\u003eAn LNG facility in connection with government investigations by the Pipeline and Hazardous Materials Safety Administration (PHMSA) and the U.S. Chemical Safety and Hazard Investigation Board (CSB) arising out of an explosion that resulted in operational shutdown and extensive damage to piping and other equipment and in connection with insurance coverage concerns.\u003c/p\u003e","\u003cp\u003eA Fortune 50 energy company in connection with the February 2023 Norfolk Southern freight train derailment in East Palestine, Ohio.\u003c/p\u003e","\u003cp\u003eAn international chemical manufacturer in response to an explosion at its largest U.S. manufacturing facility, including helping to lead the emergency incident response and internal investigation as well as responding to regulatory inquiries by, among others OSHA; State and Federal environmental agencies; the CSB; and the Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF).\u003c/p\u003e","\u003cp\u003eThe country\u0026rsquo;s largest specialty paper company following the catastrophic explosion of two continuous pulp digesters. Helped lead the team handling the emergency response, including handling the root cause investigation, successfully resolving investigations by the U.S. Environmental Protection Agency, OSHA, CSB, and numerous state regulatory agencies, and securing a significant settlement of its insurance claim.\u003c/p\u003e","\u003cp\u003eA worldwide mining and petroleum company as standby incident response counsel.\u003c/p\u003e","\u003cp\u003eAn engineering and construction company in connection with a trench collapse resulting in a fatality, including responding to OSHA\u0026rsquo;s resulting investigation and implementing a nationwide safety audit.\u003c/p\u003e","\u003cp\u003eA carbon capture company in connection with building collapse resulting in extensive damages to multiple rail cars. Led root cause investigation.\u003c/p\u003e","\u003cp\u003eA water and wastewater treatment provider in connection with a civil and criminal investigation into wastewater treatment plant compliance involving allegations of falsification of records.\u003c/p\u003e","\u003cp\u003eOne of the largest specialty pulp and paper manufacturers in the United States in connection with investigations by EPA, OSHA, and various state and local agencies arising out of a catastrophic explosion.\u003c/p\u003e","\u003cp\u003eA chemical facility following release of trichlorosilane during line break that resulted in serious injuries to contractors.\u003c/p\u003e","\u003cp\u003eA chemical facility in connection with explosion caused by the failure of an expansion joint, resulting in numerous injuries and one fatality.\u003c/p\u003e","\u003cp\u003eA medical sterilization company in pending litigation involving air emissions of ethylene oxide (EtO) from its facility in Colorado.\u003c/p\u003e","\u003cp\u003eA world-leading manufacturer to defend the claims of 3,000 plaintiffs stemming from air emissions of lead, arsenic, and other substances from a polymetallic smelter in Peru.\u003c/p\u003e","\u003cp\u003eSuccessfully resolved regulatory enforcement actions against a Fortune 100 company involving EPA\u0026rsquo;s Lead Renovation, Repair and Painting (\u0026ldquo;RRP\u0026rdquo;) Rule under the Toxic Substances Control Act (\u0026ldquo;TSCA\u0026rdquo;).\u003c/p\u003e","\u003cp\u003eA large paper manufacturer following a catastrophic fire at its New Jersey production facility. Helped lead the core team that successfully resolved all State and Federal regulatory investigations and secured a significant settlement of its insurance claims.\u003c/p\u003e","\u003cp\u003eRayonier Performance Fibers in securing renewal of the NPDES discharge permit for its Jesup pulp mill, the world's largest producer of cellulose specialty products. The permit had been reversed by the administrative law judge, who imposed a novel and unreasonable construction of the narrative water quality standard. That erroneous decision, which threatened the permitting program for all industrial and municipal dischargers in Georgia, was reversed on appeal, ultimately leading to affirmance of the renewed permit.\u0026nbsp;\u003cem\u003eAltamaha Riverkeeper, Inc. v. Rayonier Performance Fibers, LLC\u003c/em\u003e, 816 S.E.2d 125 (Ga. Ct. App. 2018), cert. denied (Aug. 5, 2019).\u003c/p\u003e","\u003cp\u003eRayonier Performance Fibers in a citizen suit alleging that the pulp mill was violating its NPDES discharge permit. District court granted summary judgment in favor of Rayonier on all counts.\u0026nbsp;\u003cem\u003eAltamaha Riverkeeper, Inc. v. Rayonier, Inc.\u003c/em\u003e, No. CV 214-44, 2015 U.S. Dist. LEXIS 42849 (S.D. Ga. Mar. 31, 2015).\u003c/p\u003e","\u003cp\u003eSea Island Company in securing, and successfully defending to an Administrative Law Judge and then to Superior Court, the state Shore Protection Act permit for a controversial beach nourishment, dune construction, and groin project along three miles of beachfront property. In subsequent related litigation brought in federal court, obtained summary judgment upholding the contested permits.\u0026nbsp;\u003cem\u003eAltamaha Riverkeeper v. U.S. Army Corps of Eng\u0026rsquo;rs\u003c/em\u003e, No. CV 418-251, 2020 WL 5837650 (S.D. Ga. Sept. 30, 2020).\u003c/p\u003e","\u003cp\u003eA large electric utility company in toxic tort litigation involving approximately 150 residents living near Plant Scherer, one of the largest coal-fired power plants in the country. Following oral argument on an early motion to dismiss, plaintiffs voluntarily dismissed all claims.\u003c/p\u003e","\u003cp\u003eA carbon black manufacturer in mass joinder actions filed in West Virginia by hundreds of current and former neighbors, asserting nuisance, trespass, negligence and medical monitoring claims.\u003c/p\u003e","\u003cp\u003eDefense contractors in a putative personal injury and property damage class action seeking some $200 million for alleged exposure to lead, PCBs, and other chemicals associated with historic forge and foundry operations in Anniston, Alabama. Cases ultimately resolved in nuisance value settlements.\u003c/p\u003e","\u003cp\u003eThe City of Atlanta and other local governments in the tri-state \u0026ldquo;water wars\u0026rdquo; litigation involving Georgia, Alabama, and Florida, including the successful defense of Florida\u0026rsquo;s claims that the operation of Georgia reservoirs on the Chattahoochee River have harmed endangered species.\u003c/p\u003e","\u003cp\u003eA chemical manufacturer against claims related to the contamination of a former fertilizer manufacturing facility. Following extensive fact and expert discovery, the district court granted summary judgment in favor of the company on all claims, a decision later affirmed by the U.S. Court of Appeals for the Fourth Circuit.\u003c/p\u003e","\u003cp\u003eA Fortune 50 energy company in the appeal of a $27 million jury verdict in a \u0026ldquo;dram shop\u0026rdquo; case asserting agency liability based upon the use of brand standards for independent service stations. The South Carolina Supreme Court reversed the jury verdict and rendered judgment in favor of the company.\u003c/p\u003e","\u003cp\u003eA chemical manufacturer in a mixture of class actions and individual lawsuits filed in state and federal courts concerning alleged mercury and PCB contamination from the company\u0026rsquo;s former chlor-alkali plant.\u003c/p\u003e","\u003cp\u003eMore than a dozen manufacturers, distributors, or sellers of welding products in several Georgia cases brought on behalf of approximately 500 plaintiffs who alleged personal injury due to inhalation of manganese particles produced by the welding process.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":71,"guid":"71.capabilities","index":0,"source":"capabilities"},{"id":16,"guid":"16.capabilities","index":1,"source":"capabilities"},{"id":1015,"guid":"1015.smart_tags","index":2,"source":"smartTags"},{"id":111,"guid":"111.capabilities","index":3,"source":"capabilities"},{"id":1236,"guid":"1236.smart_tags","index":4,"source":"smartTags"},{"id":1168,"guid":"1168.smart_tags","index":5,"source":"smartTags"},{"id":102,"guid":"102.capabilities","index":6,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":7,"source":"capabilities"},{"id":17,"guid":"17.capabilities","index":8,"source":"capabilities"},{"id":764,"guid":"764.smart_tags","index":9,"source":"smartTags"},{"id":11,"guid":"11.capabilities","index":10,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":11,"source":"capabilities"}],"is_active":true,"last_name":"Butterfield","nick_name":"Randy","clerkships":[{"name":"Law Clerk, Chief Judge Robert L. Echols, U.S. District Court for the Middle District of Tennessee","years_held":"1997 - 1999"}],"first_name":"Randall","title_rank":9999,"updated_by":34,"law_schools":[],"middle_name":"J.","name_suffix":"","recognitions":[{"title":"Law360 Selects Nine from King \u0026 Spalding to Serve on 2021 Editorial Advisory Boards","detail":"Law 360, April 2021"}],"linked_in_url":"https://www.linkedin.com/in/randy-butterfield-237ab87/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eRandy Butterfield helps lead the firm\u0026rsquo;s Atlanta Environmental, Health and Safety Practice Group, where he concentrates his practice on environmental and toxic tort litigation as well as\u0026nbsp;emergency incident response. Randy's practice focuses in particular on assisting clients in the wake of catastrophic emergency incidents, such as explosions, fires, industrial accidents, chemical releases, spills, and other environmental and industrial calamities. In that capacity, Randy is frequently called upon in the immediate aftermath of these emergencies to provide time-critical crisis management addressing a wide range of pressing concerns, including forensic investigation; workplace safety; site security and evidence preservation; regulatory disclosures, investigation, and potential enforcement; environmental remediation; internal investigations; and insurance coverage. Recent incidents on which Randy has helped lead the response have involved over $2 billion in property damages, business losses, and insurance claims; significant personal injury lawsuits; as well as enforcement actions from federal and state regulators.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eIn addition, Randy has handled numerous mass joinder and class action cases involving personal injury and property damage claims, both at the trial and appellate levels. Randy has played a particularly significant role in preparing and defending the defense experts\u0026mdash;as well as deposing and critiquing plaintiffs\u0026rsquo; experts\u0026mdash;on a wide variety of technical topics, such as air and groundwater modeling, emission inventories, dose reconstruction, geostatistics, human health risk assessment, toxicology, epidemiology,\u0026nbsp;fate and transport,\u0026nbsp;remediation,\u0026nbsp;property valuation, and damage assessments. Over his career, Randy\u0026rsquo;s litigation matters have involved nearly every major piece of environmental legislation as well as the entire spectrum of common law tort claims.\u003c/p\u003e\n\u003cp\u003eRandy has published several articles involving the potential application and use of federal and state regulatory standards in the toxic tort context. He has also co-authored a chapter on legal defenses in toxic tort cases in a treatise published by the American Bar Association as well as a chapter on administrative appeals published by LexisNexis. Randy served on the Environmental and Toxic Tort Section of the Atlanta Bar Association, including as Board Chair in 2018. Randy also served on\u0026nbsp;\u003cem\u003eLaw360\u003c/em\u003e\u0026rsquo;s Environmental Editorial Advisory Board from 2021-2022.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eBooks, Articles \u0026amp; Presentations\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u0026bull; LexisNexis Practice Guide:\u0026nbsp;\u003cem\u003eGeorgia Environmental Law\u003c/em\u003e, 2022 ed.\u003c/p\u003e\n\u003cp\u003e\u0026bull; Randy J. Butterfield, moderator, Roundtable with Georgia Office of State Administrative Hearing Judges\u0026nbsp;\u0026amp; Litigants, Atlanta Bar Association, Toxic Tort and Environmental Law CLE, Feb. 1, 2018\u003c/p\u003e\n\u003cp\u003e\u0026bull; Randy J. Butterfield \u0026amp; Stephen A. McCullers,\u0026nbsp;\u003cem\u003eRaising the Class Action Certification Bar in Georgia:\u0026nbsp;\u003c/em\u003eGeorgia-Pacific Consumer Products, LP v. Ratner, Perspectives on Georgia\u0026rsquo;s Environment (State Bar of\u0026nbsp;Georgia), Spring 2015, at 6-9\u003c/p\u003e\n\u003cp\u003e\u0026bull; Randy J. Butterfield,\u0026nbsp;\u003cem\u003eRecent \u0026amp; Recurring Issues in Toxic Tort Cases\u003c/em\u003e, State Bar of Georgia, Toxic Tort\u0026nbsp;Litigation CLE, Mar. 2014\u003c/p\u003e\n\u003cp\u003e\u0026bull; J Kevin Buster \u0026amp; Randy J. Butterfield,\u0026nbsp;\u003cem\u003eCommon Defenses in Toxic Tort Litigation\u003c/em\u003e\u0026nbsp;(book chapter) (ABA\u0026nbsp;2d ed. 2013)\u003c/p\u003e\n\u003cp\u003e\u0026bull; Randy J. Butterfield, Note,\u0026nbsp;\u003cem\u003eRecovering Environmental Cleanup Costs Under the Resource Conservation\u0026nbsp;and Recovery Act: A Potential Solution to a Persistent Problem\u003c/em\u003e, 49 Vand. L. Rev. 689 (1997)\u003c/p\u003e","matters":["\u003cp\u003eA midstream energy company in connection with investigations by Federal and State environmental agencies as well as the Occupational Safety and Health Administration (OSHA) into an explosion and fire at a natural gas processing facility resulting in catastrophic loss. Oversaw root cause investigation, coordinated responses to agency inquiries, and provided advice and counsel in connection with successful insurance recovery.\u003c/p\u003e","\u003cp\u003eOne of the world\u0026rsquo;s largest producers of methanol from natural gas as standby incident response counsel, including in connection with environmental investigations into spills and releases.\u003c/p\u003e","\u003cp\u003eAn LNG facility in connection with government investigations by the Pipeline and Hazardous Materials Safety Administration (PHMSA) and the U.S. Chemical Safety and Hazard Investigation Board (CSB) arising out of an explosion that resulted in operational shutdown and extensive damage to piping and other equipment and in connection with insurance coverage concerns.\u003c/p\u003e","\u003cp\u003eA Fortune 50 energy company in connection with the February 2023 Norfolk Southern freight train derailment in East Palestine, Ohio.\u003c/p\u003e","\u003cp\u003eAn international chemical manufacturer in response to an explosion at its largest U.S. manufacturing facility, including helping to lead the emergency incident response and internal investigation as well as responding to regulatory inquiries by, among others OSHA; State and Federal environmental agencies; the CSB; and the Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF).\u003c/p\u003e","\u003cp\u003eThe country\u0026rsquo;s largest specialty paper company following the catastrophic explosion of two continuous pulp digesters. Helped lead the team handling the emergency response, including handling the root cause investigation, successfully resolving investigations by the U.S. Environmental Protection Agency, OSHA, CSB, and numerous state regulatory agencies, and securing a significant settlement of its insurance claim.\u003c/p\u003e","\u003cp\u003eA worldwide mining and petroleum company as standby incident response counsel.\u003c/p\u003e","\u003cp\u003eAn engineering and construction company in connection with a trench collapse resulting in a fatality, including responding to OSHA\u0026rsquo;s resulting investigation and implementing a nationwide safety audit.\u003c/p\u003e","\u003cp\u003eA carbon capture company in connection with building collapse resulting in extensive damages to multiple rail cars. Led root cause investigation.\u003c/p\u003e","\u003cp\u003eA water and wastewater treatment provider in connection with a civil and criminal investigation into wastewater treatment plant compliance involving allegations of falsification of records.\u003c/p\u003e","\u003cp\u003eOne of the largest specialty pulp and paper manufacturers in the United States in connection with investigations by EPA, OSHA, and various state and local agencies arising out of a catastrophic explosion.\u003c/p\u003e","\u003cp\u003eA chemical facility following release of trichlorosilane during line break that resulted in serious injuries to contractors.\u003c/p\u003e","\u003cp\u003eA chemical facility in connection with explosion caused by the failure of an expansion joint, resulting in numerous injuries and one fatality.\u003c/p\u003e","\u003cp\u003eA medical sterilization company in pending litigation involving air emissions of ethylene oxide (EtO) from its facility in Colorado.\u003c/p\u003e","\u003cp\u003eA world-leading manufacturer to defend the claims of 3,000 plaintiffs stemming from air emissions of lead, arsenic, and other substances from a polymetallic smelter in Peru.\u003c/p\u003e","\u003cp\u003eSuccessfully resolved regulatory enforcement actions against a Fortune 100 company involving EPA\u0026rsquo;s Lead Renovation, Repair and Painting (\u0026ldquo;RRP\u0026rdquo;) Rule under the Toxic Substances Control Act (\u0026ldquo;TSCA\u0026rdquo;).\u003c/p\u003e","\u003cp\u003eA large paper manufacturer following a catastrophic fire at its New Jersey production facility. Helped lead the core team that successfully resolved all State and Federal regulatory investigations and secured a significant settlement of its insurance claims.\u003c/p\u003e","\u003cp\u003eRayonier Performance Fibers in securing renewal of the NPDES discharge permit for its Jesup pulp mill, the world's largest producer of cellulose specialty products. The permit had been reversed by the administrative law judge, who imposed a novel and unreasonable construction of the narrative water quality standard. That erroneous decision, which threatened the permitting program for all industrial and municipal dischargers in Georgia, was reversed on appeal, ultimately leading to affirmance of the renewed permit.\u0026nbsp;\u003cem\u003eAltamaha Riverkeeper, Inc. v. Rayonier Performance Fibers, LLC\u003c/em\u003e, 816 S.E.2d 125 (Ga. Ct. App. 2018), cert. denied (Aug. 5, 2019).\u003c/p\u003e","\u003cp\u003eRayonier Performance Fibers in a citizen suit alleging that the pulp mill was violating its NPDES discharge permit. District court granted summary judgment in favor of Rayonier on all counts.\u0026nbsp;\u003cem\u003eAltamaha Riverkeeper, Inc. v. Rayonier, Inc.\u003c/em\u003e, No. CV 214-44, 2015 U.S. Dist. LEXIS 42849 (S.D. Ga. Mar. 31, 2015).\u003c/p\u003e","\u003cp\u003eSea Island Company in securing, and successfully defending to an Administrative Law Judge and then to Superior Court, the state Shore Protection Act permit for a controversial beach nourishment, dune construction, and groin project along three miles of beachfront property. In subsequent related litigation brought in federal court, obtained summary judgment upholding the contested permits.\u0026nbsp;\u003cem\u003eAltamaha Riverkeeper v. U.S. Army Corps of Eng\u0026rsquo;rs\u003c/em\u003e, No. CV 418-251, 2020 WL 5837650 (S.D. Ga. Sept. 30, 2020).\u003c/p\u003e","\u003cp\u003eA large electric utility company in toxic tort litigation involving approximately 150 residents living near Plant Scherer, one of the largest coal-fired power plants in the country. Following oral argument on an early motion to dismiss, plaintiffs voluntarily dismissed all claims.\u003c/p\u003e","\u003cp\u003eA carbon black manufacturer in mass joinder actions filed in West Virginia by hundreds of current and former neighbors, asserting nuisance, trespass, negligence and medical monitoring claims.\u003c/p\u003e","\u003cp\u003eDefense contractors in a putative personal injury and property damage class action seeking some $200 million for alleged exposure to lead, PCBs, and other chemicals associated with historic forge and foundry operations in Anniston, Alabama. Cases ultimately resolved in nuisance value settlements.\u003c/p\u003e","\u003cp\u003eThe City of Atlanta and other local governments in the tri-state \u0026ldquo;water wars\u0026rdquo; litigation involving Georgia, Alabama, and Florida, including the successful defense of Florida\u0026rsquo;s claims that the operation of Georgia reservoirs on the Chattahoochee River have harmed endangered species.\u003c/p\u003e","\u003cp\u003eA chemical manufacturer against claims related to the contamination of a former fertilizer manufacturing facility. Following extensive fact and expert discovery, the district court granted summary judgment in favor of the company on all claims, a decision later affirmed by the U.S. Court of Appeals for the Fourth Circuit.\u003c/p\u003e","\u003cp\u003eA Fortune 50 energy company in the appeal of a $27 million jury verdict in a \u0026ldquo;dram shop\u0026rdquo; case asserting agency liability based upon the use of brand standards for independent service stations. The South Carolina Supreme Court reversed the jury verdict and rendered judgment in favor of the company.\u003c/p\u003e","\u003cp\u003eA chemical manufacturer in a mixture of class actions and individual lawsuits filed in state and federal courts concerning alleged mercury and PCB contamination from the company\u0026rsquo;s former chlor-alkali plant.\u003c/p\u003e","\u003cp\u003eMore than a dozen manufacturers, distributors, or sellers of welding products in several Georgia cases brought on behalf of approximately 500 plaintiffs who alleged personal injury due to inhalation of manganese particles produced by the welding process.\u003c/p\u003e"],"recognitions":[{"title":"Law360 Selects Nine from King \u0026 Spalding to Serve on 2021 Editorial Advisory Boards","detail":"Law 360, April 2021"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":757}]},"capability_group_id":2},"created_at":"2025-11-05T05:04:00.000Z","updated_at":"2025-11-05T05:04:00.000Z","searchable_text":"Butterfield{{ FIELD }}{:title=\u0026gt;\"Law360 Selects Nine from King \u0026amp; Spalding to Serve on 2021 Editorial Advisory Boards\", :detail=\u0026gt;\"Law 360, April 2021\"}{{ FIELD }}A midstream energy company in connection with investigations by Federal and State environmental agencies as well as the Occupational Safety and Health Administration (OSHA) into an explosion and fire at a natural gas processing facility resulting in catastrophic loss. Oversaw root cause investigation, coordinated responses to agency inquiries, and provided advice and counsel in connection with successful insurance recovery.{{ FIELD }}One of the world’s largest producers of methanol from natural gas as standby incident response counsel, including in connection with environmental investigations into spills and releases.{{ FIELD }}An LNG facility in connection with government investigations by the Pipeline and Hazardous Materials Safety Administration (PHMSA) and the U.S. Chemical Safety and Hazard Investigation Board (CSB) arising out of an explosion that resulted in operational shutdown and extensive damage to piping and other equipment and in connection with insurance coverage concerns.{{ FIELD }}A Fortune 50 energy company in connection with the February 2023 Norfolk Southern freight train derailment in East Palestine, Ohio.{{ FIELD }}An international chemical manufacturer in response to an explosion at its largest U.S. manufacturing facility, including helping to lead the emergency incident response and internal investigation as well as responding to regulatory inquiries by, among others OSHA; State and Federal environmental agencies; the CSB; and the Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF).{{ FIELD }}The country’s largest specialty paper company following the catastrophic explosion of two continuous pulp digesters. Helped lead the team handling the emergency response, including handling the root cause investigation, successfully resolving investigations by the U.S. Environmental Protection Agency, OSHA, CSB, and numerous state regulatory agencies, and securing a significant settlement of its insurance claim.{{ FIELD }}A worldwide mining and petroleum company as standby incident response counsel.{{ FIELD }}An engineering and construction company in connection with a trench collapse resulting in a fatality, including responding to OSHA’s resulting investigation and implementing a nationwide safety audit.{{ FIELD }}A carbon capture company in connection with building collapse resulting in extensive damages to multiple rail cars. Led root cause investigation.{{ FIELD }}A water and wastewater treatment provider in connection with a civil and criminal investigation into wastewater treatment plant compliance involving allegations of falsification of records.{{ FIELD }}One of the largest specialty pulp and paper manufacturers in the United States in connection with investigations by EPA, OSHA, and various state and local agencies arising out of a catastrophic explosion.{{ FIELD }}A chemical facility following release of trichlorosilane during line break that resulted in serious injuries to contractors.{{ FIELD }}A chemical facility in connection with explosion caused by the failure of an expansion joint, resulting in numerous injuries and one fatality.{{ FIELD }}A medical sterilization company in pending litigation involving air emissions of ethylene oxide (EtO) from its facility in Colorado.{{ FIELD }}A world-leading manufacturer to defend the claims of 3,000 plaintiffs stemming from air emissions of lead, arsenic, and other substances from a polymetallic smelter in Peru.{{ FIELD }}Successfully resolved regulatory enforcement actions against a Fortune 100 company involving EPA’s Lead Renovation, Repair and Painting (“RRP”) Rule under the Toxic Substances Control Act (“TSCA”).{{ FIELD }}A large paper manufacturer following a catastrophic fire at its New Jersey production facility. Helped lead the core team that successfully resolved all State and Federal regulatory investigations and secured a significant settlement of its insurance claims.{{ FIELD }}Rayonier Performance Fibers in securing renewal of the NPDES discharge permit for its Jesup pulp mill, the world's largest producer of cellulose specialty products. The permit had been reversed by the administrative law judge, who imposed a novel and unreasonable construction of the narrative water quality standard. That erroneous decision, which threatened the permitting program for all industrial and municipal dischargers in Georgia, was reversed on appeal, ultimately leading to affirmance of the renewed permit. Altamaha Riverkeeper, Inc. v. Rayonier Performance Fibers, LLC, 816 S.E.2d 125 (Ga. Ct. App. 2018), cert. denied (Aug. 5, 2019).{{ FIELD }}Rayonier Performance Fibers in a citizen suit alleging that the pulp mill was violating its NPDES discharge permit. District court granted summary judgment in favor of Rayonier on all counts. Altamaha Riverkeeper, Inc. v. Rayonier, Inc., No. CV 214-44, 2015 U.S. Dist. LEXIS 42849 (S.D. Ga. Mar. 31, 2015).{{ FIELD }}Sea Island Company in securing, and successfully defending to an Administrative Law Judge and then to Superior Court, the state Shore Protection Act permit for a controversial beach nourishment, dune construction, and groin project along three miles of beachfront property. In subsequent related litigation brought in federal court, obtained summary judgment upholding the contested permits. Altamaha Riverkeeper v. U.S. Army Corps of Eng’rs, No. CV 418-251, 2020 WL 5837650 (S.D. Ga. Sept. 30, 2020).{{ FIELD }}A large electric utility company in toxic tort litigation involving approximately 150 residents living near Plant Scherer, one of the largest coal-fired power plants in the country. Following oral argument on an early motion to dismiss, plaintiffs voluntarily dismissed all claims.{{ FIELD }}A carbon black manufacturer in mass joinder actions filed in West Virginia by hundreds of current and former neighbors, asserting nuisance, trespass, negligence and medical monitoring claims.{{ FIELD }}Defense contractors in a putative personal injury and property damage class action seeking some $200 million for alleged exposure to lead, PCBs, and other chemicals associated with historic forge and foundry operations in Anniston, Alabama. Cases ultimately resolved in nuisance value settlements.{{ FIELD }}The City of Atlanta and other local governments in the tri-state “water wars” litigation involving Georgia, Alabama, and Florida, including the successful defense of Florida’s claims that the operation of Georgia reservoirs on the Chattahoochee River have harmed endangered species.{{ FIELD }}A chemical manufacturer against claims related to the contamination of a former fertilizer manufacturing facility. Following extensive fact and expert discovery, the district court granted summary judgment in favor of the company on all claims, a decision later affirmed by the U.S. Court of Appeals for the Fourth Circuit.{{ FIELD }}A Fortune 50 energy company in the appeal of a $27 million jury verdict in a “dram shop” case asserting agency liability based upon the use of brand standards for independent service stations. The South Carolina Supreme Court reversed the jury verdict and rendered judgment in favor of the company.{{ FIELD }}A chemical manufacturer in a mixture of class actions and individual lawsuits filed in state and federal courts concerning alleged mercury and PCB contamination from the company’s former chlor-alkali plant.{{ FIELD }}More than a dozen manufacturers, distributors, or sellers of welding products in several Georgia cases brought on behalf of approximately 500 plaintiffs who alleged personal injury due to inhalation of manganese particles produced by the welding process.{{ FIELD }}Randy Butterfield helps lead the firm’s Atlanta Environmental, Health and Safety Practice Group, where he concentrates his practice on environmental and toxic tort litigation as well as emergency incident response. Randy's practice focuses in particular on assisting clients in the wake of catastrophic emergency incidents, such as explosions, fires, industrial accidents, chemical releases, spills, and other environmental and industrial calamities. In that capacity, Randy is frequently called upon in the immediate aftermath of these emergencies to provide time-critical crisis management addressing a wide range of pressing concerns, including forensic investigation; workplace safety; site security and evidence preservation; regulatory disclosures, investigation, and potential enforcement; environmental remediation; internal investigations; and insurance coverage. Recent incidents on which Randy has helped lead the response have involved over $2 billion in property damages, business losses, and insurance claims; significant personal injury lawsuits; as well as enforcement actions from federal and state regulators.\nIn addition, Randy has handled numerous mass joinder and class action cases involving personal injury and property damage claims, both at the trial and appellate levels. Randy has played a particularly significant role in preparing and defending the defense experts—as well as deposing and critiquing plaintiffs’ experts—on a wide variety of technical topics, such as air and groundwater modeling, emission inventories, dose reconstruction, geostatistics, human health risk assessment, toxicology, epidemiology, fate and transport, remediation, property valuation, and damage assessments. Over his career, Randy’s litigation matters have involved nearly every major piece of environmental legislation as well as the entire spectrum of common law tort claims.\nRandy has published several articles involving the potential application and use of federal and state regulatory standards in the toxic tort context. He has also co-authored a chapter on legal defenses in toxic tort cases in a treatise published by the American Bar Association as well as a chapter on administrative appeals published by LexisNexis. Randy served on the Environmental and Toxic Tort Section of the Atlanta Bar Association, including as Board Chair in 2018. Randy also served on Law360’s Environmental Editorial Advisory Board from 2021-2022.\nBooks, Articles \u0026amp; Presentations\n• LexisNexis Practice Guide: Georgia Environmental Law, 2022 ed.\n• Randy J. Butterfield, moderator, Roundtable with Georgia Office of State Administrative Hearing Judges \u0026amp; Litigants, Atlanta Bar Association, Toxic Tort and Environmental Law CLE, Feb. 1, 2018\n• Randy J. Butterfield \u0026amp; Stephen A. McCullers, Raising the Class Action Certification Bar in Georgia: Georgia-Pacific Consumer Products, LP v. Ratner, Perspectives on Georgia’s Environment (State Bar of Georgia), Spring 2015, at 6-9\n• Randy J. Butterfield, Recent \u0026amp; Recurring Issues in Toxic Tort Cases, State Bar of Georgia, Toxic Tort Litigation CLE, Mar. 2014\n• J Kevin Buster \u0026amp; Randy J. Butterfield, Common Defenses in Toxic Tort Litigation (book chapter) (ABA 2d ed. 2013)\n• Randy J. Butterfield, Note, Recovering Environmental Cleanup Costs Under the Resource Conservation and Recovery Act: A Potential Solution to a Persistent Problem, 49 Vand. L. Rev. 689 (1997) Partner Law360 Selects Nine from King \u0026amp; Spalding to Serve on 2021 Editorial Advisory Boards Law 360, April 2021 Arizona State University Sandra Day O'Connor College of Law Vanderbilt University Vanderbilt University School of Law U.S. Court of Appeals for the Fourth Circuit U.S. Court of Appeals for the Fifth Circuit U.S. Court of Appeals for the Eleventh Circuit U.S. District Court for the Northern District of Georgia Georgia Texas Court of Appeals of Georgia Supreme Court of Georgia State Bar of Georgia, Environmental Law Section Atlanta Bar Association, Environmental and Toxic Tort Section (past President) American Bar Association, Section on Natural Resources, Energy and Environmental Law Defense Research Institute (DRI) Law Clerk, Chief Judge Robert L. Echols, U.S. District Court for the Middle District of Tennessee A midstream energy company in connection with investigations by Federal and State environmental agencies as well as the Occupational Safety and Health Administration (OSHA) into an explosion and fire at a natural gas processing facility resulting in catastrophic loss. Oversaw root cause investigation, coordinated responses to agency inquiries, and provided advice and counsel in connection with successful insurance recovery. One of the world’s largest producers of methanol from natural gas as standby incident response counsel, including in connection with environmental investigations into spills and releases. An LNG facility in connection with government investigations by the Pipeline and Hazardous Materials Safety Administration (PHMSA) and the U.S. Chemical Safety and Hazard Investigation Board (CSB) arising out of an explosion that resulted in operational shutdown and extensive damage to piping and other equipment and in connection with insurance coverage concerns. A Fortune 50 energy company in connection with the February 2023 Norfolk Southern freight train derailment in East Palestine, Ohio. An international chemical manufacturer in response to an explosion at its largest U.S. manufacturing facility, including helping to lead the emergency incident response and internal investigation as well as responding to regulatory inquiries by, among others OSHA; State and Federal environmental agencies; the CSB; and the Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF). The country’s largest specialty paper company following the catastrophic explosion of two continuous pulp digesters. Helped lead the team handling the emergency response, including handling the root cause investigation, successfully resolving investigations by the U.S. Environmental Protection Agency, OSHA, CSB, and numerous state regulatory agencies, and securing a significant settlement of its insurance claim. A worldwide mining and petroleum company as standby incident response counsel. An engineering and construction company in connection with a trench collapse resulting in a fatality, including responding to OSHA’s resulting investigation and implementing a nationwide safety audit. A carbon capture company in connection with building collapse resulting in extensive damages to multiple rail cars. Led root cause investigation. A water and wastewater treatment provider in connection with a civil and criminal investigation into wastewater treatment plant compliance involving allegations of falsification of records. One of the largest specialty pulp and paper manufacturers in the United States in connection with investigations by EPA, OSHA, and various state and local agencies arising out of a catastrophic explosion. A chemical facility following release of trichlorosilane during line break that resulted in serious injuries to contractors. A chemical facility in connection with explosion caused by the failure of an expansion joint, resulting in numerous injuries and one fatality. A medical sterilization company in pending litigation involving air emissions of ethylene oxide (EtO) from its facility in Colorado. A world-leading manufacturer to defend the claims of 3,000 plaintiffs stemming from air emissions of lead, arsenic, and other substances from a polymetallic smelter in Peru. Successfully resolved regulatory enforcement actions against a Fortune 100 company involving EPA’s Lead Renovation, Repair and Painting (“RRP”) Rule under the Toxic Substances Control Act (“TSCA”). A large paper manufacturer following a catastrophic fire at its New Jersey production facility. Helped lead the core team that successfully resolved all State and Federal regulatory investigations and secured a significant settlement of its insurance claims. Rayonier Performance Fibers in securing renewal of the NPDES discharge permit for its Jesup pulp mill, the world's largest producer of cellulose specialty products. The permit had been reversed by the administrative law judge, who imposed a novel and unreasonable construction of the narrative water quality standard. That erroneous decision, which threatened the permitting program for all industrial and municipal dischargers in Georgia, was reversed on appeal, ultimately leading to affirmance of the renewed permit. Altamaha Riverkeeper, Inc. v. Rayonier Performance Fibers, LLC, 816 S.E.2d 125 (Ga. Ct. App. 2018), cert. denied (Aug. 5, 2019). Rayonier Performance Fibers in a citizen suit alleging that the pulp mill was violating its NPDES discharge permit. District court granted summary judgment in favor of Rayonier on all counts. Altamaha Riverkeeper, Inc. v. Rayonier, Inc., No. CV 214-44, 2015 U.S. Dist. LEXIS 42849 (S.D. Ga. Mar. 31, 2015). Sea Island Company in securing, and successfully defending to an Administrative Law Judge and then to Superior Court, the state Shore Protection Act permit for a controversial beach nourishment, dune construction, and groin project along three miles of beachfront property. In subsequent related litigation brought in federal court, obtained summary judgment upholding the contested permits. Altamaha Riverkeeper v. U.S. Army Corps of Eng’rs, No. CV 418-251, 2020 WL 5837650 (S.D. Ga. Sept. 30, 2020). A large electric utility company in toxic tort litigation involving approximately 150 residents living near Plant Scherer, one of the largest coal-fired power plants in the country. Following oral argument on an early motion to dismiss, plaintiffs voluntarily dismissed all claims. A carbon black manufacturer in mass joinder actions filed in West Virginia by hundreds of current and former neighbors, asserting nuisance, trespass, negligence and medical monitoring claims. Defense contractors in a putative personal injury and property damage class action seeking some $200 million for alleged exposure to lead, PCBs, and other chemicals associated with historic forge and foundry operations in Anniston, Alabama. Cases ultimately resolved in nuisance value settlements. The City of Atlanta and other local governments in the tri-state “water wars” litigation involving Georgia, Alabama, and Florida, including the successful defense of Florida’s claims that the operation of Georgia reservoirs on the Chattahoochee River have harmed endangered species. A chemical manufacturer against claims related to the contamination of a former fertilizer manufacturing facility. Following extensive fact and expert discovery, the district court granted summary judgment in favor of the company on all claims, a decision later affirmed by the U.S. Court of Appeals for the Fourth Circuit. A Fortune 50 energy company in the appeal of a $27 million jury verdict in a “dram shop” case asserting agency liability based upon the use of brand standards for independent service stations. The South Carolina Supreme Court reversed the jury verdict and rendered judgment in favor of the company. A chemical manufacturer in a mixture of class actions and individual lawsuits filed in state and federal courts concerning alleged mercury and PCB contamination from the company’s former chlor-alkali plant. More than a dozen manufacturers, distributors, or sellers of welding products in several Georgia cases brought on behalf of approximately 500 plaintiffs who alleged personal injury due to inhalation of manganese particles produced by the welding process.","searchable_name":"Randall J. Butterfield (Randy)","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":34,"capability_group_featured":null,"home_page_featured":null},{"id":444778,"version":1,"owner_type":"Person","owner_id":6627,"payload":{"bio":"\u003cp\u003eAnkit Bahri is a Counsel in the Singapore office and a member of the firm\u0026rsquo;s Government Matters Group.\u0026nbsp; As both a private practice attorney and in-house counsel, Ankit has represented multi-national clients in a wide range of contentious matters, including investigations, compliance advisory, litigation, and international arbitration.\u0026nbsp; In particular, Ankit has assisted clients in the energy, engineering and construction, financial services, pharmaceutical, shipping, and technology sectors.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eA U.S.-trained attorney, Ankit has advised clients on government and regulatory investigations relating to fraud, sanctions compliance, money laundering, securities enforcement, and public corruption.\u0026nbsp; Ankit has worked on investigations involving various international regulators, including the U.S. Department of Justice, the U.S. Securities and Exchange Commission, the U.S. Office of Foreign Assets Control, the U.S. Commodities Futures Trading Commission, the U.K. Financial Conduct Authority, the U.K. Prudential Regulation Authority, and the Monetary Authority of Singapore.\u003c/p\u003e\n\u003cp\u003eIn 2021, Ankit was seconded to the Singapore office of a large public pension fund, where he helped manage compliance reviews, focused on identifying potential concerns relating to bribery, corruption, and money laundering, of the fund\u0026rsquo;s investment opportunities in Asia and Australia.\u0026nbsp; He has continued to advise clients on compliance due diligence matters since his return to private practice.\u003c/p\u003e\n\u003cp\u003eBetween 2019 and 2020, Ankit worked in the Disputes and Government Investigations Legal team at Standard Chartered Bank in Singapore, where he managed government and regulatory investigations, as well as local and cross-border disputes, in jurisdictions across South and Southeast Asia. \u0026nbsp;He also managed internal investigations for the Bank into allegations of employee misconduct, bribery, corruption, and money laundering.\u003c/p\u003e\n\u003cp\u003eAnkit also has substantial experience representing clients in domestic and cross-border litigation in U.S. federal and state courts and in disputes arising under the ICC, SIAC, HKIAC, LMAA, and LCIA Rules of Arbitration.\u0026nbsp; Ankit's experience spans disputes arising under contract, tort, antitrust, intellectual property, legal malpractice, anticorruption, and securities laws.\u003c/p\u003e\n\u003cp\u003eAt the start of his career, Ankit practiced at two top-tier U.S. law firms in New York and Washington, D.C., where he worked on a wide variety of matters including commercial litigation, international arbitration, white collar and criminal defense, patent law, and government investigations.\u003c/p\u003e","slug":"ankit-bahri","email":"abahri@kslaw.com","phone":null,"matters":["\u003cp\u003e\u003cstrong\u003eInvestigations and Criminal Matters\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eCurrently retained, along with Richard Sharpe, as standing risk and compliance counsel for one of the world\u0026rsquo;s largest, U.S. listed, Private Equity/Private Credit funds for all of their Asia Pacific-focused investments.\u003c/p\u003e","\u003cp\u003eConducting an investigation into allegations of financial misconduct (including money laundering) within an Indian listed group of companies, and specifically involving the family of the Founder and Chairman of the group.\u003c/p\u003e","\u003cp\u003eConducting an investigation, on behalf of the Audit Committee of the Board of a large UK-based technology start-up, into allegations of money laundering and financial misconduct made against the CEO by Indian law enforcement.\u003c/p\u003e","\u003cp\u003eRepresenting one of the top private universities in the world in connection with multiple investigations by the U.S. House of Representatives in connection with the University's response to antisemitism and Islamophobia on its campus.\u003c/p\u003e","\u003cp\u003eLed compliance reviews of proposed investment opportunities for one of the largest public pension funds in the world. Managed external counsel and background service providers to conduct investigations and due diligence focused on bribery, corruption, money laundering, and sanctions issues into target entities and individuals.\u003c/p\u003e","\u003cp\u003eLeading compliance reviews and risk assessments for a large Private Equity firm's portfolio companies in India and Indonesia.\u003c/p\u003e","\u003cp\u003eConducted a holistic compliance review and risk assessment for a Fortune 500 Company's China operations\u003c/p\u003e","\u003cp\u003eRepresented a multinational steel producer in conducting a global health and safety review of its manufacturing sites across 30+ jurisdictions. Attended a week-long site assessment at one of the client's largest manufacturing plants, located in Gujarat, India.\u003c/p\u003e","\u003cp\u003eRepresented an individual client in a criminal corruption trial in U.S. federal court in Arkansas arising out of bribery and corruption charges filed by the U.S. Department of Justice.\u003c/p\u003e","\u003cp\u003eRepresented a reinsurance company and its principals in investigations initiated by the U.S. Department of Justice and Securities and Exchange Commission, as well as related civil lawsuits arising out of failed investments by the reinsurance company on behalf of its clients.\u003c/p\u003e","\u003cp\u003eRepresented an international airline before the U.S. Commodities Futures Trading Commission in relation to market manipulation allegations. Prepared submissions to the regulator that successfully warded off any enforcement action.\u003c/p\u003e","\u003cp\u003eRepresented an individual defendant in\u0026nbsp;\u003cem\u003epro bono\u003c/em\u003e\u0026nbsp;murder trial in Maryland state court.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eCivil Litigation and Arbitration\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRepresented a pharmaceutical major in HKIAC arbitration seeking damages for fraudulently induced investments in China. Claims were favorable resolved for the client prior to the hearing.\u003c/p\u003e","\u003cp\u003eRepresented one of the world\u0026rsquo;s largest shipbuilders in two LMAA arbitrations arising out of termination of drillship resale contracts by a drilling contractor. After a 3-week hearing, the Tribunal ruled in the client\u0026rsquo;s favor on almost all of the claims and counterclaims.\u003c/p\u003e","\u003cp\u003eRepresented a Fortune 500 company in multiple actions, including AAA arbitration, against former employees for misappropriation of confidential information in Singapore. Claims were successfully resolved for the client and misappropriated data was destroyed or returned.\u003c/p\u003e","\u003cp\u003eRepresented a U.S. energy company in SIAC arbitration against its Indian licensee. Claims were resolved early and favorably for the client.\u003c/p\u003e","\u003cp\u003eRepresented leading software technology company in the successful defense of a patent infringement action in U.S. federal court that sought to invalidate much of the client's business. Summary judgment was granted in favor of the client on all issues.\u003c/p\u003e","\u003cp\u003eRepresented a leading technology company in a series of class actions filed by customers in courts across the U.S. based on the disclosure of potential security vulnerabilities.\u003c/p\u003e","\u003cp\u003eRepresented JPMorgan Chase and related entities (including Bear Stearns and Washington Mutual) in numerous residential mortgage-backed securities actions filed in U.S. federal and state courts in the wake of the 2008 financial crisis.\u003c/p\u003e","\u003cp\u003eRepresented Morgan Stanley in a U.S. federal class action that alleged a conspiracy to block exchange trading of credit default swaps. The case was settled at an early stage.\u003c/p\u003e","\u003cp\u003eRepresented two large U.S. law firms in pre-complaint mediations arising out of claims of legal malpractice. Both mediations led to a settlement of the claims and a successful outcome for the clients.\u003c/p\u003e","\u003cp\u003eRepresented a pharmaceutical manufacturer in an ICC arbitration arising out of a licensing dispute with one of its competitors in the industry. Claims were resolved through settlement prior to the final hearing.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":11,"guid":"11.capabilities","index":0,"source":"capabilities"},{"id":1188,"guid":"1188.smart_tags","index":1,"source":"smartTags"},{"id":103,"guid":"103.capabilities","index":2,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":3,"source":"capabilities"},{"id":102,"guid":"102.capabilities","index":4,"source":"capabilities"},{"id":766,"guid":"766.smart_tags","index":5,"source":"smartTags"},{"id":1327,"guid":"1327.smart_tags","index":6,"source":"smartTags"}],"is_active":true,"last_name":"Bahri","nick_name":"Ankit","clerkships":[{"name":"Intern, Judge Dolores K. Sloviter, U.S. Court of Appeals for the Third Circuit","years_held":"2011 - 2011"}],"first_name":"Ankit","title_rank":9999,"updated_by":202,"law_schools":[{"id":2237,"meta":{"degree":"J.D.","honors":"magna cum laude \u0026 Order of the Coif","is_law_school":"1","graduation_date":"2013-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":" ","name_suffix":"","recognitions":null,"linked_in_url":"https://www.linkedin.com/in/ankit-bahri-9640962b","seodescription":null,"primary_title_id":14,"translated_fields":{"en":{"bio":"\u003cp\u003eAnkit Bahri is a Counsel in the Singapore office and a member of the firm\u0026rsquo;s Government Matters Group.\u0026nbsp; As both a private practice attorney and in-house counsel, Ankit has represented multi-national clients in a wide range of contentious matters, including investigations, compliance advisory, litigation, and international arbitration.\u0026nbsp; In particular, Ankit has assisted clients in the energy, engineering and construction, financial services, pharmaceutical, shipping, and technology sectors.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eA U.S.-trained attorney, Ankit has advised clients on government and regulatory investigations relating to fraud, sanctions compliance, money laundering, securities enforcement, and public corruption.\u0026nbsp; Ankit has worked on investigations involving various international regulators, including the U.S. Department of Justice, the U.S. Securities and Exchange Commission, the U.S. Office of Foreign Assets Control, the U.S. Commodities Futures Trading Commission, the U.K. Financial Conduct Authority, the U.K. Prudential Regulation Authority, and the Monetary Authority of Singapore.\u003c/p\u003e\n\u003cp\u003eIn 2021, Ankit was seconded to the Singapore office of a large public pension fund, where he helped manage compliance reviews, focused on identifying potential concerns relating to bribery, corruption, and money laundering, of the fund\u0026rsquo;s investment opportunities in Asia and Australia.\u0026nbsp; He has continued to advise clients on compliance due diligence matters since his return to private practice.\u003c/p\u003e\n\u003cp\u003eBetween 2019 and 2020, Ankit worked in the Disputes and Government Investigations Legal team at Standard Chartered Bank in Singapore, where he managed government and regulatory investigations, as well as local and cross-border disputes, in jurisdictions across South and Southeast Asia. \u0026nbsp;He also managed internal investigations for the Bank into allegations of employee misconduct, bribery, corruption, and money laundering.\u003c/p\u003e\n\u003cp\u003eAnkit also has substantial experience representing clients in domestic and cross-border litigation in U.S. federal and state courts and in disputes arising under the ICC, SIAC, HKIAC, LMAA, and LCIA Rules of Arbitration.\u0026nbsp; Ankit's experience spans disputes arising under contract, tort, antitrust, intellectual property, legal malpractice, anticorruption, and securities laws.\u003c/p\u003e\n\u003cp\u003eAt the start of his career, Ankit practiced at two top-tier U.S. law firms in New York and Washington, D.C., where he worked on a wide variety of matters including commercial litigation, international arbitration, white collar and criminal defense, patent law, and government investigations.\u003c/p\u003e","matters":["\u003cp\u003e\u003cstrong\u003eInvestigations and Criminal Matters\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eCurrently retained, along with Richard Sharpe, as standing risk and compliance counsel for one of the world\u0026rsquo;s largest, U.S. listed, Private Equity/Private Credit funds for all of their Asia Pacific-focused investments.\u003c/p\u003e","\u003cp\u003eConducting an investigation into allegations of financial misconduct (including money laundering) within an Indian listed group of companies, and specifically involving the family of the Founder and Chairman of the group.\u003c/p\u003e","\u003cp\u003eConducting an investigation, on behalf of the Audit Committee of the Board of a large UK-based technology start-up, into allegations of money laundering and financial misconduct made against the CEO by Indian law enforcement.\u003c/p\u003e","\u003cp\u003eRepresenting one of the top private universities in the world in connection with multiple investigations by the U.S. House of Representatives in connection with the University's response to antisemitism and Islamophobia on its campus.\u003c/p\u003e","\u003cp\u003eLed compliance reviews of proposed investment opportunities for one of the largest public pension funds in the world. Managed external counsel and background service providers to conduct investigations and due diligence focused on bribery, corruption, money laundering, and sanctions issues into target entities and individuals.\u003c/p\u003e","\u003cp\u003eLeading compliance reviews and risk assessments for a large Private Equity firm's portfolio companies in India and Indonesia.\u003c/p\u003e","\u003cp\u003eConducted a holistic compliance review and risk assessment for a Fortune 500 Company's China operations\u003c/p\u003e","\u003cp\u003eRepresented a multinational steel producer in conducting a global health and safety review of its manufacturing sites across 30+ jurisdictions. Attended a week-long site assessment at one of the client's largest manufacturing plants, located in Gujarat, India.\u003c/p\u003e","\u003cp\u003eRepresented an individual client in a criminal corruption trial in U.S. federal court in Arkansas arising out of bribery and corruption charges filed by the U.S. Department of Justice.\u003c/p\u003e","\u003cp\u003eRepresented a reinsurance company and its principals in investigations initiated by the U.S. Department of Justice and Securities and Exchange Commission, as well as related civil lawsuits arising out of failed investments by the reinsurance company on behalf of its clients.\u003c/p\u003e","\u003cp\u003eRepresented an international airline before the U.S. Commodities Futures Trading Commission in relation to market manipulation allegations. Prepared submissions to the regulator that successfully warded off any enforcement action.\u003c/p\u003e","\u003cp\u003eRepresented an individual defendant in\u0026nbsp;\u003cem\u003epro bono\u003c/em\u003e\u0026nbsp;murder trial in Maryland state court.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eCivil Litigation and Arbitration\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRepresented a pharmaceutical major in HKIAC arbitration seeking damages for fraudulently induced investments in China. Claims were favorable resolved for the client prior to the hearing.\u003c/p\u003e","\u003cp\u003eRepresented one of the world\u0026rsquo;s largest shipbuilders in two LMAA arbitrations arising out of termination of drillship resale contracts by a drilling contractor. After a 3-week hearing, the Tribunal ruled in the client\u0026rsquo;s favor on almost all of the claims and counterclaims.\u003c/p\u003e","\u003cp\u003eRepresented a Fortune 500 company in multiple actions, including AAA arbitration, against former employees for misappropriation of confidential information in Singapore. Claims were successfully resolved for the client and misappropriated data was destroyed or returned.\u003c/p\u003e","\u003cp\u003eRepresented a U.S. energy company in SIAC arbitration against its Indian licensee. Claims were resolved early and favorably for the client.\u003c/p\u003e","\u003cp\u003eRepresented leading software technology company in the successful defense of a patent infringement action in U.S. federal court that sought to invalidate much of the client's business. Summary judgment was granted in favor of the client on all issues.\u003c/p\u003e","\u003cp\u003eRepresented a leading technology company in a series of class actions filed by customers in courts across the U.S. based on the disclosure of potential security vulnerabilities.\u003c/p\u003e","\u003cp\u003eRepresented JPMorgan Chase and related entities (including Bear Stearns and Washington Mutual) in numerous residential mortgage-backed securities actions filed in U.S. federal and state courts in the wake of the 2008 financial crisis.\u003c/p\u003e","\u003cp\u003eRepresented Morgan Stanley in a U.S. federal class action that alleged a conspiracy to block exchange trading of credit default swaps. The case was settled at an early stage.\u003c/p\u003e","\u003cp\u003eRepresented two large U.S. law firms in pre-complaint mediations arising out of claims of legal malpractice. Both mediations led to a settlement of the claims and a successful outcome for the clients.\u003c/p\u003e","\u003cp\u003eRepresented a pharmaceutical manufacturer in an ICC arbitration arising out of a licensing dispute with one of its competitors in the industry. Claims were resolved through settlement prior to the final hearing.\u003c/p\u003e"]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":11385}]},"capability_group_id":2},"created_at":"2026-01-05T17:55:52.000Z","updated_at":"2026-01-05T17:55:52.000Z","searchable_text":"Bahri{{ FIELD }}Investigations and Criminal Matters\nCurrently retained, along with Richard Sharpe, as standing risk and compliance counsel for one of the world’s largest, U.S. listed, Private Equity/Private Credit funds for all of their Asia Pacific-focused investments.{{ FIELD }}Conducting an investigation into allegations of financial misconduct (including money laundering) within an Indian listed group of companies, and specifically involving the family of the Founder and Chairman of the group.{{ FIELD }}Conducting an investigation, on behalf of the Audit Committee of the Board of a large UK-based technology start-up, into allegations of money laundering and financial misconduct made against the CEO by Indian law enforcement.{{ FIELD }}Representing one of the top private universities in the world in connection with multiple investigations by the U.S. House of Representatives in connection with the University's response to antisemitism and Islamophobia on its campus.{{ FIELD }}Led compliance reviews of proposed investment opportunities for one of the largest public pension funds in the world. Managed external counsel and background service providers to conduct investigations and due diligence focused on bribery, corruption, money laundering, and sanctions issues into target entities and individuals.{{ FIELD }}Leading compliance reviews and risk assessments for a large Private Equity firm's portfolio companies in India and Indonesia.{{ FIELD }}Conducted a holistic compliance review and risk assessment for a Fortune 500 Company's China operations{{ FIELD }}Represented a multinational steel producer in conducting a global health and safety review of its manufacturing sites across 30+ jurisdictions. Attended a week-long site assessment at one of the client's largest manufacturing plants, located in Gujarat, India.{{ FIELD }}Represented an individual client in a criminal corruption trial in U.S. federal court in Arkansas arising out of bribery and corruption charges filed by the U.S. Department of Justice.{{ FIELD }}Represented a reinsurance company and its principals in investigations initiated by the U.S. Department of Justice and Securities and Exchange Commission, as well as related civil lawsuits arising out of failed investments by the reinsurance company on behalf of its clients.{{ FIELD }}Represented an international airline before the U.S. Commodities Futures Trading Commission in relation to market manipulation allegations. Prepared submissions to the regulator that successfully warded off any enforcement action.{{ FIELD }}Represented an individual defendant in pro bono murder trial in Maryland state court.{{ FIELD }}Civil Litigation and Arbitration\nRepresented a pharmaceutical major in HKIAC arbitration seeking damages for fraudulently induced investments in China. Claims were favorable resolved for the client prior to the hearing.{{ FIELD }}Represented one of the world’s largest shipbuilders in two LMAA arbitrations arising out of termination of drillship resale contracts by a drilling contractor. After a 3-week hearing, the Tribunal ruled in the client’s favor on almost all of the claims and counterclaims.{{ FIELD }}Represented a Fortune 500 company in multiple actions, including AAA arbitration, against former employees for misappropriation of confidential information in Singapore. Claims were successfully resolved for the client and misappropriated data was destroyed or returned.{{ FIELD }}Represented a U.S. energy company in SIAC arbitration against its Indian licensee. Claims were resolved early and favorably for the client.{{ FIELD }}Represented leading software technology company in the successful defense of a patent infringement action in U.S. federal court that sought to invalidate much of the client's business. Summary judgment was granted in favor of the client on all issues.{{ FIELD }}Represented a leading technology company in a series of class actions filed by customers in courts across the U.S. based on the disclosure of potential security vulnerabilities.{{ FIELD }}Represented JPMorgan Chase and related entities (including Bear Stearns and Washington Mutual) in numerous residential mortgage-backed securities actions filed in U.S. federal and state courts in the wake of the 2008 financial crisis.{{ FIELD }}Represented Morgan Stanley in a U.S. federal class action that alleged a conspiracy to block exchange trading of credit default swaps. The case was settled at an early stage.{{ FIELD }}Represented two large U.S. law firms in pre-complaint mediations arising out of claims of legal malpractice. Both mediations led to a settlement of the claims and a successful outcome for the clients.{{ FIELD }}Represented a pharmaceutical manufacturer in an ICC arbitration arising out of a licensing dispute with one of its competitors in the industry. Claims were resolved through settlement prior to the final hearing.{{ FIELD }}Ankit Bahri is a Counsel in the Singapore office and a member of the firm’s Government Matters Group.  As both a private practice attorney and in-house counsel, Ankit has represented multi-national clients in a wide range of contentious matters, including investigations, compliance advisory, litigation, and international arbitration.  In particular, Ankit has assisted clients in the energy, engineering and construction, financial services, pharmaceutical, shipping, and technology sectors. \nA U.S.-trained attorney, Ankit has advised clients on government and regulatory investigations relating to fraud, sanctions compliance, money laundering, securities enforcement, and public corruption.  Ankit has worked on investigations involving various international regulators, including the U.S. Department of Justice, the U.S. Securities and Exchange Commission, the U.S. Office of Foreign Assets Control, the U.S. Commodities Futures Trading Commission, the U.K. Financial Conduct Authority, the U.K. Prudential Regulation Authority, and the Monetary Authority of Singapore.\nIn 2021, Ankit was seconded to the Singapore office of a large public pension fund, where he helped manage compliance reviews, focused on identifying potential concerns relating to bribery, corruption, and money laundering, of the fund’s investment opportunities in Asia and Australia.  He has continued to advise clients on compliance due diligence matters since his return to private practice.\nBetween 2019 and 2020, Ankit worked in the Disputes and Government Investigations Legal team at Standard Chartered Bank in Singapore, where he managed government and regulatory investigations, as well as local and cross-border disputes, in jurisdictions across South and Southeast Asia.  He also managed internal investigations for the Bank into allegations of employee misconduct, bribery, corruption, and money laundering.\nAnkit also has substantial experience representing clients in domestic and cross-border litigation in U.S. federal and state courts and in disputes arising under the ICC, SIAC, HKIAC, LMAA, and LCIA Rules of Arbitration.  Ankit's experience spans disputes arising under contract, tort, antitrust, intellectual property, legal malpractice, anticorruption, and securities laws.\nAt the start of his career, Ankit practiced at two top-tier U.S. law firms in New York and Washington, D.C., where he worked on a wide variety of matters including commercial litigation, international arbitration, white collar and criminal defense, patent law, and government investigations. Counsel Nanyang Technological University  University of Michigan University of Michigan Law School District of Columbia New York Singapore Registered Foreign Lawyer Intern, Judge Dolores K. Sloviter, U.S. Court of Appeals for the Third Circuit Investigations and Criminal Matters\nCurrently retained, along with Richard Sharpe, as standing risk and compliance counsel for one of the world’s largest, U.S. listed, Private Equity/Private Credit funds for all of their Asia Pacific-focused investments. Conducting an investigation into allegations of financial misconduct (including money laundering) within an Indian listed group of companies, and specifically involving the family of the Founder and Chairman of the group. Conducting an investigation, on behalf of the Audit Committee of the Board of a large UK-based technology start-up, into allegations of money laundering and financial misconduct made against the CEO by Indian law enforcement. Representing one of the top private universities in the world in connection with multiple investigations by the U.S. House of Representatives in connection with the University's response to antisemitism and Islamophobia on its campus. Led compliance reviews of proposed investment opportunities for one of the largest public pension funds in the world. Managed external counsel and background service providers to conduct investigations and due diligence focused on bribery, corruption, money laundering, and sanctions issues into target entities and individuals. Leading compliance reviews and risk assessments for a large Private Equity firm's portfolio companies in India and Indonesia. Conducted a holistic compliance review and risk assessment for a Fortune 500 Company's China operations Represented a multinational steel producer in conducting a global health and safety review of its manufacturing sites across 30+ jurisdictions. Attended a week-long site assessment at one of the client's largest manufacturing plants, located in Gujarat, India. Represented an individual client in a criminal corruption trial in U.S. federal court in Arkansas arising out of bribery and corruption charges filed by the U.S. Department of Justice. Represented a reinsurance company and its principals in investigations initiated by the U.S. Department of Justice and Securities and Exchange Commission, as well as related civil lawsuits arising out of failed investments by the reinsurance company on behalf of its clients. Represented an international airline before the U.S. Commodities Futures Trading Commission in relation to market manipulation allegations. Prepared submissions to the regulator that successfully warded off any enforcement action. Represented an individual defendant in pro bono murder trial in Maryland state court. Civil Litigation and Arbitration\nRepresented a pharmaceutical major in HKIAC arbitration seeking damages for fraudulently induced investments in China. Claims were favorable resolved for the client prior to the hearing. Represented one of the world’s largest shipbuilders in two LMAA arbitrations arising out of termination of drillship resale contracts by a drilling contractor. After a 3-week hearing, the Tribunal ruled in the client’s favor on almost all of the claims and counterclaims. Represented a Fortune 500 company in multiple actions, including AAA arbitration, against former employees for misappropriation of confidential information in Singapore. Claims were successfully resolved for the client and misappropriated data was destroyed or returned. Represented a U.S. energy company in SIAC arbitration against its Indian licensee. Claims were resolved early and favorably for the client. Represented leading software technology company in the successful defense of a patent infringement action in U.S. federal court that sought to invalidate much of the client's business. Summary judgment was granted in favor of the client on all issues. Represented a leading technology company in a series of class actions filed by customers in courts across the U.S. based on the disclosure of potential security vulnerabilities. Represented JPMorgan Chase and related entities (including Bear Stearns and Washington Mutual) in numerous residential mortgage-backed securities actions filed in U.S. federal and state courts in the wake of the 2008 financial crisis. Represented Morgan Stanley in a U.S. federal class action that alleged a conspiracy to block exchange trading of credit default swaps. The case was settled at an early stage. Represented two large U.S. law firms in pre-complaint mediations arising out of claims of legal malpractice. Both mediations led to a settlement of the claims and a successful outcome for the clients. Represented a pharmaceutical manufacturer in an ICC arbitration arising out of a licensing dispute with one of its competitors in the industry. Claims were resolved through settlement prior to the final hearing.","searchable_name":"Ankit Bahri","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":430705,"version":1,"owner_type":"Person","owner_id":6692,"payload":{"bio":"\u003cp\u003eIsabel Bussarakum focuses on white-collar criminal defense and complex civil litigation.\u0026nbsp; In criminal cases, she\u0026nbsp;has represented individuals accused of\u0026nbsp;wire fraud, money laundering, insider trading, campaign finance violations, customs fraud, health care fraud,\u0026nbsp;false advertising, and violations relating to protest activity,\u0026nbsp;among other allegations.\u0026nbsp; In the civil sector, she has represented companies in a variety of business disputes, including\u0026nbsp;in\u0026nbsp;breach-of-contract, intellectual property, employment, and class action cases.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eIsabel brings first-chair trial and extensive courtroom experience, having previously served as a former Deputy Federal Public Defender in the Central District of California for more than six years.\u0026nbsp; In that capacity, she represented clients under the highest stakes, and in the process of doing so, honed her ability to litigate with creativity, diligence, and\u0026nbsp;persistence.\u0026nbsp; She obtained a judgment of acquittal in a wire fraud and money laundering case, persuaded the government to dismiss a threats charge\u0026nbsp;against a protester, obtained a rare diversion deal\u0026nbsp;in a bank fraud case, and\u0026nbsp;won dismissals in multiple immigration-related offenses.\u0026nbsp; In addition to handling her own caseload, she also served as a supervisor during her last two years.\u003c/p\u003e\n\u003cp\u003ePrior to government service, Isabel worked at a\u0026nbsp;boutique litigation\u0026nbsp;firm, where she represented clients in a wide variety of civil and criminal cases in state and federal court.\u0026nbsp; There, she was part of a trade secret trial team that won a $6.1 million verdict, and she first-chaired an arbitration resulting in a multi-million dollar breach-of-contract award for a studio.\u0026nbsp; Before that, Isabel served as a judicial clerk in the Central District of California.\u003c/p\u003e\n\u003cp\u003e\u003cbr data-cke-eol=\"1\" /\u003e\u003cbr /\u003e\u003c/p\u003e","slug":"isabel-bussarakum","email":"ibussarakum@kslaw.com","phone":null,"matters":null,"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":81,"guid":"81.capabilities","index":0,"source":"capabilities"},{"id":5,"guid":"5.capabilities","index":1,"source":"capabilities"},{"id":11,"guid":"11.capabilities","index":2,"source":"capabilities"}],"is_active":true,"last_name":"Bussarakum","nick_name":"Isabel","clerkships":[{"name":"Judicial Clerk, Michael W. Fitzgerald, Central District of California","years_held":"2013 - 2014"}],"first_name":"Isabel","title_rank":9999,"updated_by":202,"law_schools":[{"id":2605,"meta":{"degree":"J.D.","honors":"","is_law_school":"1","graduation_date":"2011-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":" ","name_suffix":"","recognitions":null,"linked_in_url":null,"seodescription":null,"primary_title_id":14,"translated_fields":{"en":{"bio":"\u003cp\u003eIsabel Bussarakum focuses on white-collar criminal defense and complex civil litigation.\u0026nbsp; In criminal cases, she\u0026nbsp;has represented individuals accused of\u0026nbsp;wire fraud, money laundering, insider trading, campaign finance violations, customs fraud, health care fraud,\u0026nbsp;false advertising, and violations relating to protest activity,\u0026nbsp;among other allegations.\u0026nbsp; In the civil sector, she has represented companies in a variety of business disputes, including\u0026nbsp;in\u0026nbsp;breach-of-contract, intellectual property, employment, and class action cases.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eIsabel brings first-chair trial and extensive courtroom experience, having previously served as a former Deputy Federal Public Defender in the Central District of California for more than six years.\u0026nbsp; In that capacity, she represented clients under the highest stakes, and in the process of doing so, honed her ability to litigate with creativity, diligence, and\u0026nbsp;persistence.\u0026nbsp; She obtained a judgment of acquittal in a wire fraud and money laundering case, persuaded the government to dismiss a threats charge\u0026nbsp;against a protester, obtained a rare diversion deal\u0026nbsp;in a bank fraud case, and\u0026nbsp;won dismissals in multiple immigration-related offenses.\u0026nbsp; In addition to handling her own caseload, she also served as a supervisor during her last two years.\u003c/p\u003e\n\u003cp\u003ePrior to government service, Isabel worked at a\u0026nbsp;boutique litigation\u0026nbsp;firm, where she represented clients in a wide variety of civil and criminal cases in state and federal court.\u0026nbsp; There, she was part of a trade secret trial team that won a $6.1 million verdict, and she first-chaired an arbitration resulting in a multi-million dollar breach-of-contract award for a studio.\u0026nbsp; Before that, Isabel served as a judicial clerk in the Central District of California.\u003c/p\u003e\n\u003cp\u003e\u003cbr data-cke-eol=\"1\" /\u003e\u003cbr /\u003e\u003c/p\u003e"},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":12021}]},"capability_group_id":2},"created_at":"2025-06-18T18:00:35.000Z","updated_at":"2025-06-18T18:00:35.000Z","searchable_text":"Bussarakum{{ FIELD }}Isabel Bussarakum focuses on white-collar criminal defense and complex civil litigation.  In criminal cases, she has represented individuals accused of wire fraud, money laundering, insider trading, campaign finance violations, customs fraud, health care fraud, false advertising, and violations relating to protest activity, among other allegations.  In the civil sector, she has represented companies in a variety of business disputes, including in breach-of-contract, intellectual property, employment, and class action cases.\nIsabel brings first-chair trial and extensive courtroom experience, having previously served as a former Deputy Federal Public Defender in the Central District of California for more than six years.  In that capacity, she represented clients under the highest stakes, and in the process of doing so, honed her ability to litigate with creativity, diligence, and persistence.  She obtained a judgment of acquittal in a wire fraud and money laundering case, persuaded the government to dismiss a threats charge against a protester, obtained a rare diversion deal in a bank fraud case, and won dismissals in multiple immigration-related offenses.  In addition to handling her own caseload, she also served as a supervisor during her last two years.\nPrior to government service, Isabel worked at a boutique litigation firm, where she represented clients in a wide variety of civil and criminal cases in state and federal court.  There, she was part of a trade secret trial team that won a $6.1 million verdict, and she first-chaired an arbitration resulting in a multi-million dollar breach-of-contract award for a studio.  Before that, Isabel served as a judicial clerk in the Central District of California.\n Counsel Columbia University Columbia University Yale University Yale Law School U.S. Court of Appeals for the Ninth Circuit Central District of California California Judicial Clerk, Michael W. Fitzgerald, Central District of California","searchable_name":"Isabel Bussarakum","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":436433,"version":1,"owner_type":"Person","owner_id":3821,"payload":{"bio":"\u003cp\u003eAlexander Blumberg is a senior\u0026nbsp;associate with King \u0026amp; Spalding\u0026rsquo;s Special Matters and Government Investigations practice. His practice focuses on white-collar criminal defense, internal corporate investigations, and complex civil litigation.\u0026nbsp;\u0026nbsp;He also has experience with congressional investigations and compliance counseling.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAlexander joined the firm after serving as a law clerk to the Honorable Beverly B. Martin of the United States Court of Appeals for the\u0026nbsp;Eleventh Circuit as well as the Honorable Leigh Martin May\u0026nbsp;of the United States District Court for the Northern District of Georgia.\u003c/p\u003e\n\u003cp\u003eAlexander graduated from Emory University,\u0026nbsp;\u003cem\u003esumma cum laude\u003c/em\u003e, with a B.A. in Political Science in 2013. He then attended Harvard Law School, where he earned his J.D.,\u0026nbsp;\u003cem\u003ecum laude\u003c/em\u003e, in 2016. While at law school, Alexander served as Supervising Editor for the\u0026nbsp;\u003cem\u003eHarvard Law Review\u003c/em\u003e.\u003c/p\u003e\n\u003cp\u003eAlexander also maintains an active pro bono appellate practice.\u0026nbsp; He has been appointed counsel by the U.S. Court of Appeals for the Eleventh Circuit, and authored briefs and presented oral argument before that Court on behalf of indigent clients.\u003c/p\u003e","slug":"alexander-blumberg","email":"ablumberg@kslaw.com","phone":null,"matters":null,"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":11,"guid":"11.capabilities","index":0,"source":"capabilities"},{"id":2,"guid":"2.capabilities","index":1,"source":"capabilities"},{"id":20,"guid":"20.capabilities","index":2,"source":"capabilities"},{"id":952,"guid":"952.smart_tags","index":3,"source":"smartTags"},{"id":1199,"guid":"1199.smart_tags","index":4,"source":"smartTags"},{"id":766,"guid":"766.smart_tags","index":5,"source":"smartTags"},{"id":1168,"guid":"1168.smart_tags","index":6,"source":"smartTags"},{"id":1188,"guid":"1188.smart_tags","index":7,"source":"smartTags"},{"id":24,"guid":"24.capabilities","index":8,"source":"capabilities"},{"id":687,"guid":"687.smart_tags","index":9,"source":"smartTags"},{"id":1434,"guid":"1434.smart_tags","index":10,"source":"smartTags"}],"is_active":true,"last_name":"Blumberg","nick_name":"Alex","clerkships":[{"name":"Law Clerk, The Honorable Beverly B. Martin, U.S. Court of Appeals for the Eleventh Circuit","years_held":"2016 - 2017"},{"name":"Law Clerk, The Honorable Leigh Martin May, U.S. District Court for the Northern District of Georgia","years_held":"2017 - 2018"}],"first_name":"Alexander","title_rank":9999,"updated_by":202,"law_schools":[{"id":824,"meta":{"degree":"J.D.","honors":"cum laude","is_law_school":"1","graduation_date":"2016-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":" ","name_suffix":"","recognitions":null,"linked_in_url":null,"seodescription":null,"primary_title_id":75,"translated_fields":{"en":{"bio":"\u003cp\u003eAlexander Blumberg is a senior\u0026nbsp;associate with King \u0026amp; Spalding\u0026rsquo;s Special Matters and Government Investigations practice. His practice focuses on white-collar criminal defense, internal corporate investigations, and complex civil litigation.\u0026nbsp;\u0026nbsp;He also has experience with congressional investigations and compliance counseling.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAlexander joined the firm after serving as a law clerk to the Honorable Beverly B. Martin of the United States Court of Appeals for the\u0026nbsp;Eleventh Circuit as well as the Honorable Leigh Martin May\u0026nbsp;of the United States District Court for the Northern District of Georgia.\u003c/p\u003e\n\u003cp\u003eAlexander graduated from Emory University,\u0026nbsp;\u003cem\u003esumma cum laude\u003c/em\u003e, with a B.A. in Political Science in 2013. He then attended Harvard Law School, where he earned his J.D.,\u0026nbsp;\u003cem\u003ecum laude\u003c/em\u003e, in 2016. While at law school, Alexander served as Supervising Editor for the\u0026nbsp;\u003cem\u003eHarvard Law Review\u003c/em\u003e.\u003c/p\u003e\n\u003cp\u003eAlexander also maintains an active pro bono appellate practice.\u0026nbsp; He has been appointed counsel by the U.S. Court of Appeals for the Eleventh Circuit, and authored briefs and presented oral argument before that Court on behalf of indigent clients.\u003c/p\u003e"},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":6419}]},"capability_group_id":2},"created_at":"2025-09-02T04:53:37.000Z","updated_at":"2025-09-02T04:53:37.000Z","searchable_text":"Blumberg{{ FIELD }}Alexander Blumberg is a senior associate with King \u0026amp; Spalding’s Special Matters and Government Investigations practice. His practice focuses on white-collar criminal defense, internal corporate investigations, and complex civil litigation.  He also has experience with congressional investigations and compliance counseling.\nAlexander joined the firm after serving as a law clerk to the Honorable Beverly B. Martin of the United States Court of Appeals for the Eleventh Circuit as well as the Honorable Leigh Martin May of the United States District Court for the Northern District of Georgia.\nAlexander graduated from Emory University, summa cum laude, with a B.A. in Political Science in 2013. He then attended Harvard Law School, where he earned his J.D., cum laude, in 2016. While at law school, Alexander served as Supervising Editor for the Harvard Law Review.\nAlexander also maintains an active pro bono appellate practice.  He has been appointed counsel by the U.S. Court of Appeals for the Eleventh Circuit, and authored briefs and presented oral argument before that Court on behalf of indigent clients. Senior Associate Emory University Emory University School of Law Harvard University Harvard Law School U.S. Court of Appeals for the Eleventh Circuit U.S. District Court for the Middle District of Georgia U.S. District Court for the Northern District of Georgia Georgia Court of Appeals of Georgia Supreme Court of Georgia Atlanta Bar Association Federal Bar Association Harvard Law Review Law Clerk, The Honorable Beverly B. Martin, U.S. Court of Appeals for the Eleventh Circuit Law Clerk, The Honorable Leigh Martin May, U.S. District Court for the Northern District of Georgia","searchable_name":"Alexander Blumberg (Alex)","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":444659,"version":1,"owner_type":"Person","owner_id":5208,"payload":{"bio":"\u003cp\u003eAlana Broe represents health systems, academic medical centers, medical groups, \u0026nbsp;post-acute care providers, and suppliers in various regulatory, operational, and litigation matters. Alana regularly defends healthcare organizations in government investigations and False Claims Act litigation. She also represents hospital systems and healthcare providers in managed care litigation and business disputes with health plans. In addition, Alana advises clients on a wide range of \u0026nbsp;proactive compliance measures, including the No Surprises Act, Stark Law / Anti-Kickback Statute, and HIPAA among others.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAlana also maintains an active pro bono practice, primarily focusing on the representation of human trafficking survivors in a myriad of legal matters, including criminal record expungement, job placement, and custody issues.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eAlana joined King \u0026amp; Spalding following a clerkship at the Supreme Court of Georgia. She graduated from the University of Virginia School of Law, where she served on the editorial board of the\u0026nbsp;\u003cem\u003eVirginia Journal of International Law\u003c/em\u003e\u0026nbsp;and was awarded the Best Brief Award by the school\u0026rsquo;s Legal Research \u0026amp; Writing program. Prior to becoming a lawyer, Alana worked as a legislative specialist for a patient advocacy organization, representing patient interests to Congress and the Food and Drug Administration. Alana earned her undergraduate degree,\u0026nbsp;\u003cem\u003emagna cum laud\u003c/em\u003ee, in Pre-Medicine \u0026ndash; Nutrition Science from Auburn University.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003ePublications\u003c/strong\u003e\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u0026ldquo;No Surprises Act,\u0026rdquo;\u0026nbsp;\u003cem\u003eReimbursement Advisor\u003c/em\u003e, May 2021\u003c/li\u003e\n\u003cli\u003e\u0026ldquo;New Surprise Billing Proposed Rule Raises Potential Issues for Providers,\u0026rdquo;\u0026nbsp;\u003cem\u003eReimbursement Advisor\u003c/em\u003e, July 2021\u003c/li\u003e\n\u003c/ul\u003e","slug":"alana-broe","email":"abroe@kslaw.com","phone":null,"matters":null,"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":24,"guid":"24.capabilities","index":0,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":1,"source":"capabilities"},{"id":11,"guid":"11.capabilities","index":2,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":3,"source":"capabilities"},{"id":952,"guid":"952.smart_tags","index":4,"source":"smartTags"},{"id":1187,"guid":"1187.smart_tags","index":5,"source":"smartTags"}],"is_active":true,"last_name":"Broe","nick_name":"Alana","clerkships":[{"name":"Judicial Clerk, Justice Nels S.D. Peterson, Supreme Court of Georgia","years_held":"2019 - 2020"}],"first_name":"Alana","title_rank":9999,"updated_by":174,"law_schools":[{"id":2410,"meta":{"degree":"J.D.","honors":null,"is_law_school":1,"graduation_date":"2019-01-01 00:00:00 UTC"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":"K.","name_suffix":"","recognitions":null,"linked_in_url":null,"seodescription":null,"primary_title_id":75,"translated_fields":{"en":{"bio":"\u003cp\u003eAlana Broe represents health systems, academic medical centers, medical groups, \u0026nbsp;post-acute care providers, and suppliers in various regulatory, operational, and litigation matters. Alana regularly defends healthcare organizations in government investigations and False Claims Act litigation. She also represents hospital systems and healthcare providers in managed care litigation and business disputes with health plans. In addition, Alana advises clients on a wide range of \u0026nbsp;proactive compliance measures, including the No Surprises Act, Stark Law / Anti-Kickback Statute, and HIPAA among others.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAlana also maintains an active pro bono practice, primarily focusing on the representation of human trafficking survivors in a myriad of legal matters, including criminal record expungement, job placement, and custody issues.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eAlana joined King \u0026amp; Spalding following a clerkship at the Supreme Court of Georgia. She graduated from the University of Virginia School of Law, where she served on the editorial board of the\u0026nbsp;\u003cem\u003eVirginia Journal of International Law\u003c/em\u003e\u0026nbsp;and was awarded the Best Brief Award by the school\u0026rsquo;s Legal Research \u0026amp; Writing program. Prior to becoming a lawyer, Alana worked as a legislative specialist for a patient advocacy organization, representing patient interests to Congress and the Food and Drug Administration. Alana earned her undergraduate degree,\u0026nbsp;\u003cem\u003emagna cum laud\u003c/em\u003ee, in Pre-Medicine \u0026ndash; Nutrition Science from Auburn University.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003ePublications\u003c/strong\u003e\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u0026ldquo;No Surprises Act,\u0026rdquo;\u0026nbsp;\u003cem\u003eReimbursement Advisor\u003c/em\u003e, May 2021\u003c/li\u003e\n\u003cli\u003e\u0026ldquo;New Surprise Billing Proposed Rule Raises Potential Issues for Providers,\u0026rdquo;\u0026nbsp;\u003cem\u003eReimbursement Advisor\u003c/em\u003e, July 2021\u003c/li\u003e\n\u003c/ul\u003e"},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":11864}]},"capability_group_id":2},"created_at":"2026-01-02T15:57:08.000Z","updated_at":"2026-01-02T15:57:08.000Z","searchable_text":"Broe{{ FIELD }}Alana Broe represents health systems, academic medical centers, medical groups,  post-acute care providers, and suppliers in various regulatory, operational, and litigation matters. Alana regularly defends healthcare organizations in government investigations and False Claims Act litigation. She also represents hospital systems and healthcare providers in managed care litigation and business disputes with health plans. In addition, Alana advises clients on a wide range of  proactive compliance measures, including the No Surprises Act, Stark Law / Anti-Kickback Statute, and HIPAA among others.\nAlana also maintains an active pro bono practice, primarily focusing on the representation of human trafficking survivors in a myriad of legal matters, including criminal record expungement, job placement, and custody issues. \nAlana joined King \u0026amp; Spalding following a clerkship at the Supreme Court of Georgia. She graduated from the University of Virginia School of Law, where she served on the editorial board of the Virginia Journal of International Law and was awarded the Best Brief Award by the school’s Legal Research \u0026amp; Writing program. Prior to becoming a lawyer, Alana worked as a legislative specialist for a patient advocacy organization, representing patient interests to Congress and the Food and Drug Administration. Alana earned her undergraduate degree, magna cum laude, in Pre-Medicine – Nutrition Science from Auburn University.\nPublications\n\n“No Surprises Act,” Reimbursement Advisor, May 2021\n“New Surprise Billing Proposed Rule Raises Potential Issues for Providers,” Reimbursement Advisor, July 2021\n Senior Associate Auburn University  University of Virginia University of Virginia School of Law Georgia Supreme Court of Georgia Judicial Clerk, Justice Nels S.D. Peterson, Supreme Court of Georgia","searchable_name":"Alana K. Broe","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":174,"capability_group_featured":null,"home_page_featured":null}]}}